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ABSTRACT 
 
mRNA degradation is a fundamental process that controls both the level and the 
fidelity of gene expression. Using a combination of bioinformatic, genomic, genetic, and 
molecular biology approaches, we have shown that Edc3p, a yeast mRNA decay factor, 
controls the stability of the intron-containing YRA1 pre-mRNA. We found that 
Edc3p-mediated degradation of YRA1 pre-mRNA: 1) is a component of a negative 
feedback loop involved in the autoregulation of YRA1, 2) takes place in the cytoplasm, 3) 
is independent of translation, 4) occurs through a deadenylation-independent decapping 
and 5΄ to 3΄ exonucleotic decay mechanism, and 5) is controlled by specific cis-acting 
elements and trans-regulatory factors. Cis-regulation of YRA1 pre-mRNA degradation is 
complicated and precise. Sequences in exon1 inhibit YRA1 pre-mRNA splicing and/or 
promote pre-mRNA export in a size-dependent but sequence-independent manner. 
Sequences in the intron dictate the substrate specificity for Edc3p-mediated decay. Five 
structurally different but functionally interdependent modules were identified in the YRA1 
intron. Two modules, designated Edc3p-responsive elements (EREs), are required for 
triggering an Edc3p-response. Three other modules, designated translational repression 
elements (TREs), are required for repressing translation of YRA1 pre-mRNA. TREs 
enhance the efficiency of the  response of the EREs to Edc3p by inhibiting 
 viii
translation-dependent nonsense-mediated mRNA decay (NMD). Trans-regulation of 
YRA1 pre-mRNA is governed by Yra1p, which inhibits YRA1 pre-mRNA splicing and 
commits the pre-mRNA to nuclear export, and the RNP export factors, Mex67p and 
Crm1p, which jointly promote YRA1 pre-mRNA export. Mex67p also appears to interact 
with sequences in the YRA1 intron to promote translational repression and to enhance the 
Edc3p response of YRA1 pre-mRNA. These results illustrate how common steps in the 
nuclear processing, export, and degradation of a transcript can be uniquely combined to 
control the expression of a specific gene and suggest that Edc3p-mediated decay may 
have additional regulatory functions in eukaryotic cells. 
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CHAPTER I 
 
Introduction 
 1
This dissertation describes the investigation of a novel, transcript-specific, mRNA-decay 
mechanism in the yeast, Saccharomyces serevisiae. In this mRNA decay mechanism, the 
intron-containing YRA1 pre-mRNA is specifically degraded in the cytoplasm through a 
pathway mediated by Edc3p, a newly identified decapping activator. Importantly, Edc3p-
mediated YRA1 pre-mRNA degradation is a key component of a negative feedback loop 
that autoregulates YRA1, an essential gene encoding a general RNA nuclear export factor. 
To introduce these studies, I will first review the nuclear biogenesis and the 
potential fate of an intron-containing pre-mRNA. I will then review cytoplasmic mRNA 
decay pathways and the cis- and trans-regulation of these pathways. Finally, I will 
summarize previous studies about the YRA1 gene and its autoregulation mechanism, and 
then introduce the specific rationale for the studies in my dissertation. 
 
1. Overview of gene expression and quality control 
 
Gene expression is a multistep process. In eukaryotic cells, the expression of nuclear-
encoded genes starts with transcription to produce pre-mRNAs. During and after 
transcription, the newly synthesized pre-mRNAs are processed by the addition of a 
methyl guanosine cap to the 5΄ ends, by splicing to eliminate introns, and by the addition 
of poly(A) tails to the transcript 3΄ ends.  The processed, mature mRNAs are then 
exported to the cytoplasm.  Once in the cytoplasm, the mRNAs are translated into 
proteins and are eventually degraded by an mRNA decay system.  
 2
Previously, it was believed that gene expression is a linear pathway, i.e., every 
step in gene expression is isolated and independent of the others. However, more and 
more studies indicate that steps in gene expression are actually coordinated (reviewed in 
Kuersten and Goodwin, 2005; Maciag et al., 2006; Maniatis and Reed, 2002; Orphanides 
and Reinberg, 2002). First, almost all nuclear events are coupled. Many factors involved 
in the post-transcriptional events are co-transcriptionally recruited. These recruitments 
are mediated by the C-terminal domain (CTD) of RNA Polymerase II (RNAPII) 
(reviewed in Proudfoot et al., 2002). Moreover, some factors previously thought to 
function in only one specific nuclear event have been found to function in multiple steps, 
or to interact with proteins implicated in different steps (Reviewed in Aguilera, 2005; 
Reed, 2003; Stutz and Izaurralde, 2003). Second, cytoplasmic events are coupled, i.e., 
mRNA translation and degradation are tightly integrated, with degradation of numerous 
mRNAs dependent on their translation (Coller and Parker, 2004; Hilleren and Parker, 
1999; Jacobson and Peltz, 1996; Wilusz and Wilusz, 2004). Global inhibition of 
translational initiation, elongation or termination can increase or decrease the stability of 
different mRNAs (FH, SD, C. Li and AJ, manuscript in preparation). Third, nuclear 
events are also coupled with cytoplasmic events. For example, nuclear splicing is coupled 
to the nuclear export and cytoplasmic fate of an mRNA through the exon-junction 
complex (EJC) in mammalian cells (reviewed in Chang et al., 2007; Kuersten and 
Goodwin, 2005). The extensive nuclear, cytoplasmic, and nuclear-cytoplasmic couplings 
make gene expression efficient. The work in this thesis provides an example of nuclear-
 3
cytoplasmic coupling in which the expression of a specific gene (YRA1) is regulated 
through the coordination of multiple steps of gene expression. 
Since mistakes can occur at each of the many steps of gene expression, cells have 
evolved quality control mechanisms to ensure the production of functional products. For 
example, during the biogenesis of functional mRNAs: 1) aberrant pre-mRNAs generated 
by transcription or processing mistakes are retained in the nucleus and destroyed by the 
nuclear decay system (Bousquet-Antonelli et al., 2000; Burkard and Butler, 2000; 
Hilleren et al., 2001; Houseley et al., 2006; Saguez et al., 2005); 2) mRNAs retained in 
the nucleus due to mutations of mRNA export factors undergo decay by the decay of 
RNA in nucleus (DRN) system (Das et al., 2003); 3) cytoplasmic mRNAs with 
translation defects are degraded through cytoplasmic surveillance mechanisms. mRNAs 
containing premature termination codons, mRNAs lacking translational termination 
codons, and mRNAs impaired in translational elongation are degraded by the nonsense-
mediated decay [NMD], non-stop decay [NSD], and the no-go decay [NGD] pathways, 
respectively (reviewed in Garneau et al., 2007). All these quality controls ensure that only 
properly generated mRNA is translated into functional protein.  
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2. Nuclear pre-mRNA metabolism 
 
2.1 Biosynthesis and modification of nuclear pre-mRNA 
 
Biosynthesis of mRNA starts with transcription. RNAPII, general transcription factors, 
and specific transcription factors are coordinately assembled onto the DNA to form the 
transcription machinery and begin synthesizing pre-mRNAs. During and after 
transcription, nascent transcripts are processed by three biochemically distinct reactions: 
5΄ capping, splicing, and 3΄ end cleavage/polyadenylation.  
Once a nascent transcript reaches 22-25 nt, a m7GpppN cap structure is added to 
the 5΄ end of the transcript. This cap structure is recognized by the nuclear cap-binding 
complex (CBC) which comprises Cbp20p and Cbp80p (Schroeder et al., 2004; Zenklusen 
et al., 2002). Binding of the cap structure by CBC is believed to stabilize the transcript 
byblocking the 5΄-to-3΄ exonucleases (Beelman and Parker, 1995; Das et al., 2003), and 
stimulate spliceosome assembly on the nascent pe-mRNA (Gornemann et al., 2005). 
During transcription, a dynamic complex comprising the small nuclear RNAs (snRNAs) 
U1, U2, U4, U5, and U6, and their associated proteins, is assembled stepwise onto the 
pre-mRNA to form the spliceosome, a machine that eliminates intron from the pre-
mRNA. The spliceosome also affects the process of transcription (reviewed in Maniatis 
and Reed, 2002; Proudfoot et al., 2002), and recruits mRNA export factors to form an 
export-competent mRNP (reviewed in Reed, 2003; Reed and Hurt, 2002). Once 
transcription is complete, the 3΄ end of the nascent transcript is endonucleolytically 
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cleaved at a specific site, and then 70-100 adenosines in yeast, or more than 200 
adenosines in mammalian cells, are added to the cleaved 3΄ end of the transcript. This 
poly(A) tail protects the transcript from 3΄-to-5΄ exonuclease digestion; facilitates export 
of the mature mRNA from the nucleus to the cytoplasm (Brune et al., 2005; Dunn et al., 
2005); and forms a closed loop-structure with the 5΄ end of the transcript promoting 
translation in the cytoplasm. 
Together, these three processing reactions are coordinated with transcription and 
are also tightly coupled to each other as well as to the downstream events of gene 
expression. The processing of pre-mRNA ultimately results in the formation of a mature, 
translatable mRNA with protective structures at its 5΄ and 3΄ ends.   
 
2.2 Export of mRNA 
 
Processed, mature mRNAs need to be exported to the cytoplasm for translation. mRNA 
export is evolutionarily conserved and tightly coupled to transcription and processing 
(reviewed in Cullen, 2003b; Jensen et al., 2003; Reed, 2003; Reed and Hurt, 2002; 
Rodriguez et al., 2004). Currently, two distinct mRNA export pathways have been 
identified.  
The major mRNA export pathway in yeast is diagrammed in Figure 1.1. During 
transcription elongation, the THO complex composed of Hpr1p, Tho2p, Mft1p, and 
Thp2p associates with the transcription machinery, facilitating the loading of Sub2p (a 
DEAD-box RNA-dependent ATPase) and Yra1p (an RNA binding export factor) along 
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the nascent mRNA molecule. The newly formed TREX complex (transcription and 
exporting complex) containing THO, Yra1p, and Sub2p is assembled onto the nascent 
mRNA to form an export-competent mRNP. Mex67p-Mtr2p, an export receptor 
heterodimer, is then recruited to displace Sub2p, binding Yra1p at the previous Sub2p 
binding site. This Mex67p-containing mRNP is targeted to the nuclear periphery by the 
Thp1p-Sac3p complex, a NPC- (nuclear pore complex) associated RNA-binding factor 
(Rodriguez et al., 2004). It has been reported that Mex67p-Mtr2p can also be recruited by 
the association of Sus1p, a component of the SAGA histone-acetylase complex involved 
in transcription initiation, with the NPC-associated Thp1p-Sac3p complex (Rodriguez-
Navarro et al., 2004). This alternative Mex67p-Mtr2p recruiting unit, TREX-2, comprises 
Sac3p, Thp1, Sus1p and Cdc31p. Transient interaction of Mex67p-Mtr2p and a subset of 
nucleoporins containing repeated phenylalanine-glycine (FG) motifs mediates the 
translocation of the export-competent mRNP to the NPC. After being transported through 
the nuclear pores, Mex67p is thought to be removed by Dbp5, a conserved DEAD-box 
ATPase/RNA helicase associated with the cytoplasmic face of NPCs, from the mRNPs 
(Lund and Guthrie, 2005). Activation of Dbp5 requires Gle1p, a cytoplasmic nucleoporin, 
and inositol hexaphosphate (IP6), a signaling molecule (Alcazar-Roman et al., 2006; 
Kohler and Hurt, 2007; Weirich et al., 2006).  
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In higher eukaryotic cells, most cellular mRNAs exit the nucleus via the pathway 
dependent on TAP, the metazoan homolog of Mex67p. However, a small but significant 
subset of cellular mRNAs exits the nucleus via a pathway specifically requiring CRM1, a 
nuclear export receptor for proteins that contain a leucine-rich nuclear export signal 
(reviewed in Hutten and Kehlenbach, 2007). This subset of cellular mRNAs includes: 
IFN-α mRNA (Kimura et al., 2004), cyclin D1 mRNA (Culjkovic et al., 2006), 
cyclooxygenase COX-2 mRNA (Jang et al., 2003), mRNAs containing AU-rich elements 
such as the c-fos mRNA (Brennan et al., 2000; Higashino et al., 2005), mRNAs induced 
in activated T cells such as the CD83 mRNA (Prechtel et al., 2006; Schutz et al., 2006), 
and the tra-2 mRNA in C. elegans (Kuersten et al., 2004). Unlike the TAP-dependent 
pathway, the CRM1-dependent pathway is dependent on Ran-GTP. The CRM1-
dependent pathway is also responsible for the export of several U snRNAs, all rRNAs, 
SRP (signal recognition particle) RNA, and exogenous viral unspliced or spliced mRNAs 
(reviewed in Cullen, 2003b; Hutten and Kehlenbach, 2007; Rodriguez et al., 2004)). In 
yeast, it is not known whether Crm1p, the homolog of metazoan CRM1, also mediates 
export of cellular mRNAs. Currently, it is unclear what determines whether an mRNA is 
exported from the nucleus by the TAP/Mex67p-dependent pathway or the CRM1-
dependent pathway. However, since CRM1 itself is not an RNA-binding protein, and all 
of the CRM1-mediated RNA export is thought to be mediated by adaptor proteins bearing 
leucine-rich nuclear export signals.  
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2.3 Regulated pre-mRNA export 
 
Under normal conditions, endogenous pre-mRNAs are retained in the nucleus. Pre-
mRNA leakage happens when pre-mRNAs accumulate due to splicing mutations or 
impairment of splicing factors (Legrain and Rosbash, 1989; Lopez and Seraphin, 1999; 
Rain and Legrain, 1997). In some circumstances, cells allow export of partially spliced or 
unspliced pre-mRNAs to the cytoplasm, e.g. unspliced virus RNA is exported from the 
nucleus to the cytoplasm in the infected host cell. The virus makes use of the nuclear 
export and translation systems of the host cell for its replication. The spliced virus RNA 
exits the nucleus by the same mechanism used by spliced cellular mRNAs. However, the 
unspliced virus RNA uses specific mechanisms to be exported.  
In simple retroviruses, e.g., the simian type D retrovirus Mason Pfizer Monkey 
Virus (MPMV), export of its unspliced genomic RNA relies on the direct interaction of 
cis-acting RNA elements with cellular factors. The constitutive transport element (CTE) 
in MPMV interacts with TAP/Mex67p and thus results in constitutive export of the 
intron-containing virus RNA (Bachi et al., 2000; Gruter et al., 1998; Pasquinelli et al., 
1997; Saavedra et al., 1997). Interestingly, a CTE is also found in a cellular intron-
containing mRNA. An alternatively spliced cellular TAP pre-mRNA contains a CTE and 
is exported via the CTE-TAP-mediated mechanism (Li et al., 2006).  
Unlike simple retroviruses, complex retroviruses make use of the CRM1-
dependent mechanism to export their unspliced or incompletely spliced viral RNAs. For 
example, the HIV-1 retrovirus encodes a CRM1 recruiting protein Rev, a protein 
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containing a nuclear export signal. Unspliced or incompletely spliced HIV-1 mRNAs 
bind Rev with a structured RNA sequence present in these RNAs, the Rev responsive 
element (RRE) (Hadzopoulou-Cladaras et al., 1989; Hammarskjold et al., 1989; Pollard 
and Malim, 1998). The resulting mRNP complex is exported by virtue of the nuclear 
export signal in Rev which interacts with the cellular export receptor CRM1 (Fornerod et 
al., 1997; Neville et al., 1997). In addition to the Rev protein which is encoded by all 
members of the lentivirus family, there are other adapter proteins that recruit CRM1 to 
facilitate viral pre-mRNA export, such as the distinct human T-cell leukemia virus Rex 
protein (Bogerd et al., 1998) and the K-Rev protein encoded by a family of unrelated 
human endogenous retroviruses termed the HERV-Ks (Yang et al., 1999). 
 
2.4 Quality control of pre-mRNAs 
 
Intron containing pre-mRNAs in yeast can be processed into mRNAs, undergo nuclear 
degradation or be exported for translation or degradation in the cytoplasm. However, pre-
mRNAs are seldom detected in the cytoplasm, because eukaryotic cells have evolved a 
tight quality control system to prevent their accumulation outside the nucleus. This 
quality control is accomplished by RNA nuclear retention and the nuclear turnover 
system. Moreover, pre-mRNAs leaked to the cytoplasm are degraded by the NMD 
pathway.  
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2.4.1 Mechanism of nuclear retention of intron containing pre-mRNA  
 
It is still a mystery how the cell can distinguish between intron-containing pre-
mRNAs, spliced mRNAs and intron-free mRNAs to ensure the first are retained in the 
nucleus while the latter two are exported to the cytoplasm. Since all factors involved in 
nuclear export of mRNAs in yeast bind indiscriminately to both intron-containing and 
intron-free mRNAs (Strasser and Hurt, 2001), it is unlikely that pre-mRNAs are retained 
by differential nuclear export mechanisms. Several studies have shown that pre-mRNA 
retention is linked to splicing, which might kinetically out-compete export of pre-mRNA. 
In addition, components of the nuclear pore also contribute to active retention of pre-
mRNAs.  
 
2.4.1.1 Association of splicing factors with pre-mRNA  
  
An intact 5΄ splice site (5΄SS) and branchpoint are required for nuclear retention of pre-
mRNAs (Legrain and Rosbash, 1989; Rain and Legrain, 1997). Moreover, several 
splicing factors, including Prp6p, Prp9p, U1 snRNA, and Mud2p are required for pre-
mRNA retention (Legrain and Rosbash, 1989; Lopez and Seraphin, 1999; Rain and 
Legrain, 1997). Mutations in these factors lead to inefficient splicing and leakage of pre-
mRNAs into the cytoplasm. However, there is also evidence pointing towards active 
retention of pre-mRNAs via a splicing factor. Mutants of MSL5, a gene coding for the 
branchpoint-binding protein BBP/SF1, which is a component of the splicing commitment 
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complex, lead to a strong defect in nuclear retention of pre-mRNAs while having only 
small effects on splicing in vivo and no effect in vitro (Rutz and Seraphin, 1999; Rutz and 
Seraphin, 2000). All these factors, except Prp6, are involved in early steps of intron 
recognition that precede assembling of the functional spliceosome (Kramer, 1996). 
Therefore, blocking early steps in splicing either in cis or trans can impair the nuclear 
retention of unspliced mRNA.  
 
2.4.1.2 Active retention of pre-mRNA by the nuclear pore  
 
There is evidence that some nuclear pore proteins help retain unspliced pre-mRNAs in 
the nucleus. These NPC components include Mlp1p (myosin-like protein 1), Mlp2p 
(paralogue of Mlp1p), Pml1p (pre-mRNA leakage), and Pml39p (pre-mRNA leakage, 
39kDa). Deletion of any one of these factors impairs pre-mRNA retention but has no 
effect on splicing (Dziembowski et al., 2004; Galy et al., 2004; Palancade et al., 2005; 
Vinciguerra et al., 2005). Moreover, PML39 deletion leads to a specific leakage of 
unspliced mRNAs that is not enhanced by MLP1 deletion, suggesting that Pml39p is an 
upstream effector of the Mlp-controlled pre-mRNA retention pathway (Palancade et al., 
2005). All reports of the active retention of unspliced pre-mRNAs used reporter systems, 
and the role of active processes in retaining endogenous pre-mRNA is still unstudied.  
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2.4.2 Pre-mRNA turnover in the nucleus 
 
Nuclear pre-mRNA, together with mRNAs retained due to defective nuclear export, is 
degraded by a nuclear turnover system. These nuclear pre-mRNAs and mRNAs can be 
degraded from the 3΄-to-5΄ or the 5΄-to-3΄ directions. In 3΄-to-5΄ decay, RNA is degraded 
by the exosome, a complex of at least eleven polypeptides (Bousquet-Antonelli et al., 
2000). In 5΄-to-3΄ decay, RNA degradation involves an unknown decapping activity 
stimulated by the Lsm2-8p complex (Kufel et al., 2004), followed by exonucleolytic 
decay by Rat1p, an essential nuclear exoribonuclease, (Johnson, 1997). In addition to 
direct 5΄-to-3΄ and 3΄-to-5΄ decay mechanisms, nuclear pre-mRNAs containing a specific 
doublestranded structure are cleaved by the nuclear endoribonuclease Rnt1p (Danin-
Kreiselman et al., 2003). 
Which decay pathway predominates in the nucleus appears to depend on the 
specific features of the substrate mRNA. Aberrant pre-mRNA generated by 
transcriptional mistakes or mutations in transcription factors are destroyed by the nuclear 
exosome (Houseley et al., 2006; Saguez et al., 2005). Uncapped pre-mRNA can undergo 
decay by the Rat1p-mediated 5΄-to-3΄ pathway (Saguez et al., 2005). Unspliced pre-
mRNA that fail to assemble spliceosomes, splicing intermediates, and transcripts with 
abnormal 3΄ ends or poly(A) tails are degraded by the nuclear exosome (Bousquet-
Antonelli et al., 2000; Burkard and Butler, 2000; Hilleren et al., 2001). Downstream 
fragments from 3΄ cleavage of the nascent RNA are degraded by the Rat1p-mediated 5΄-
to-3΄ pathway (Saguez et al., 2005). mRNAs that are restricted to the nucleus because of 
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export defects can be degraded through both the 5΄-to-3΄ and the 3΄-to-5΄ pathways (Das 
et al., 2003). Finally, pre-mRNA containing appropriate recognition motifs can be 
cleaved by the endonuclease Rnt1p (Danin-Kreiselman et al., 2003).  
Even though most inappropriately processed pre-mRNAs are degraded in the 
nucleus, pre-mRNAs that escape the nuclear retention system and enter the cytoplasm are 
usually recognized by ribosomes and degraded in a translation-dependent manner by the 
NMD pathway (He et al., 1993; Vilardell et al., 2000). Splicing-defective reporter pre-
mRNAs and splicing intermediates that are exported to cytoplasm are subsequently 
degraded through the general 5΄-to-3΄ pathway by Xrn1p, the cytoplasmic counterpart of 
Rat1p (Hilleren and Parker, 1999), instead of the NMD pathway.  
 
3. Cytoplasmic mRNA degradation  
 
3.1 Overview of mRNA fate in the cytoplasm and significance of mRNA degradation  
 
Once in the cytoplasm, mRNA can engage the translational apparatus and produce 
protein; be directly destroyed by a cytoplasmic mRNA decay system without entering the 
translation pool; and be sequestered into a storage pool for future usage (translation or 
decay). Translatable cytoplasmic mRNAs are always in a kinetic balance or competition 
between translation and mRNA decay. Most mRNAs are degraded by a translation-
dependent mechanism, but some mRNAs are degraded by translation-independent 
mechanisms. 
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The process of mRNA decay has a significant biological role in gene expression. 
mRNA decay rates are regulated in response to various environmental stimuli, specific 
hormones, stage of the cell cycle, viral infection, or cell differentiation. Altered control of 
mRNA decay rates results in aberrant gene expression and human disease, including 
cancer, immunological disorders and coronary disease (Wilusz et al., 2001). In addition, 
mRNA decay also assesses the accuracy of mRNA biogenesis and ensures elimination of 
aberrant transcripts. Therefore, mRNA decay controls both the quantity and quality of 
mRNAs. In doing so, it affects the final quantity and quality of the protein products. Thus, 
it is important to understand how the decay rates of different mRNAs are controlled and 
how aberrant RNAs are recognized and targeted for desctruction.  
 
3.2 Cytoplasmic mRNA decay pathways 
 
3.2.1 General decay pathways 
 
mRNA degradation is a regulated process in eukaryotic cells. Different mRNAs are 
degraded by distinct mechanisms, and each mechanism requires a specific set of 
regulators and catalytic enzymes. In the yeast S. cerevisiae, most wild-type mRNAs are 
degraded through two general and functionally redundant mechanisms: the 
deadenylation-dependent 5΄-to-3΄ pathway and the exosome dependent 3΄-to-5΄ pathway 
(Cao and Parker, 2001; Coller and Parker, 2004; Jacobs Anderson and Parker, 1998) 
(Figure 1.2A). In both pathways, the initial event is the shortening of the poly(A) tail to 
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10 to 12 A’s (Decker and Parker, 1993; Muhlrad et al., 1995). This deadenylation 
reaction is carried out by two functionally redundant deadenylases, the 
Ccr4p/Pop2p/Notp complex and the Pan2p/Pan3p complex (Chen et al., 2002; Daugeron 
et al., 2001; Tucker et al., 2002; Tucker et al., 2001). Deadenylation is the rate-limiting 
step in mRNA decay. After poly(A) shortening, the transcript can be degraded either 
through the 5΄-to-3΄ or through the 3΄-to-5΄ mechanism. In the 5΄-to-3΄ decay pathway, 
transcripts are decapped by the Dcp1p/Dcp2p complex (Beelman et al., 1996; Dunckley 
and Parker, 1999). In this reaction, the m7G capped nucleotide of the mRNA substrate is 
cleaved to yield the products m7GDP and a 5΄-monophosphorylated mRNA. 
Subsequently, the 5΄-monophosphorylated mRNA is rapidly digested by the 5΄-to-3΄ 
exoribonuclease, Xrn1p (Hsu and Stevens, 1993). In the 3΄-to-5΄ decay pathway, 
transcripts are further deadenylated and then digested in the 3΄-to-5΄ direction by the 
cytoplasmic exosome, a ten-subunit exoribonuclease complex (Mitchell et al., 1997). In 
addition to the exosome, the 3΄-to-5΄ decay pathway requires at least two cofactors, Ski7p 
and the Ski2p/Ski3p/Ski8p complex (Araki et al., 2001; Benard et al., 1999; Jacobs 
Anderson and Parker, 1998; van Hoof et al., 2000b). The m7GDP generated by the 
Dcp1p/Dcp2p decapping enzyme in the 5΄-to-3΄ decay pathway and the capped 
oligonucleotides generated by the exosome in the 3΄-to-5΄ decay pathway are cleaved by 
the scavenger decapping enzyme (Dcps) to produce m7GMP (Liu et al., 2002; van Dijk et 
al., 2003). Inactivation of both general decay pathways leads to a synthetic lethal 
phenotype (Jacobs Anderson and Parker, 1998), suggesting that mRNA decay is an 
essential process in yeast. 
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 3.2.2 Specific mRNA decay pathways 
 
In addition to these two general decay pathways, three specific decay pathways have also 
been identified in yeast. These pathways serve, at least in part, as surveillance 
mechanisms that target unique classes of defective mRNAs, including mRNAs containing 
premature translation termination codons (nonsense-mediated mRNA decay [NMD]) 
(Amrani et al., 2006b; Jacobson and Peltz, 2000) (Figure 1.2B), mRNAs lacking 
translation termination codons (non-stop decay [NSD]) (Frischmeyer et al., 2002; van 
Hoof et al., 2002) (Figure 1.2C), and mRNAs impaired in translation elongation (no-go 
decay [NGD]) (Doma and Parker, 2006) (Figure 1.2D). Substrates of the NMD pathway 
include mRNAs transcribed from nonsense alleles or bearing transcription, splicing or 
editing errors; mRNAs with upstream open reading frames; intron-containing pre-
mRNAs that have entered the cytoplasm; mRNAs with initiator AUGs in a poor context 
(“leaky scanning”); and mRNAs with extended 3΄ untranslated reagens (3΄ UTRs) (He et 
al., 2003). While these pathways each use a unique set of specific factors in a translation-
dependent manner to identify their target mRNAs, they also employ the enzymes of the 
general 5΄-to-3΄ or 3΄-to-5΄ decay pathways to carry out mRNA degradation. In the NMD 
pathway, mRNA degradation requires three regulatory factors, Upf1p, Nmd2p (Upf2p) 
and Upf3 (Cui et al., 1995; He et al., 1997; He and Jacobson, 1995; Lee and Culbertson, 
1995; Leeds et al., 1992), and generally proceeds from decapping by the Dcp1p/Dcp2p 
complex to Xrn1p-catalyzed 5΄-to-3΄ decay without prior poly(A) tail shortening (Cao 
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and Parker, 2003; Muhlrad and Parker, 1994). In the NSD pathway, mRNAs are degraded 
directly from the 3΄-end to the 5΄-end by the exosome with the aid of Ski7p and the 
Ski2p/Ski3p/Ski8p complex, bypassing the deadenylation step (Frischmeyer et al., 2002; 
Inada and Aiba, 2005; van Hoof et al., 2002). In the NGD pathway, degradation of 
transcripts requires Dom34p and Hbs1p and initiates endonucleolytically. The resulting 
5΄ and 3΄ fragments are then degraded by the exosome and Xrn1p, respectively (Doma 
and Parker, 2006).  
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4. Regulation of mRNA decay 
 
4.1 Cis-acting elements 
 
The substrate status of a transcript for the different decay pathways can be regulated by 
specific cis-acting elements and their respective trans-regulatory RNA-binding factors. 
The former include sequences accelerating or decelerating the decay rate of the host 
mRNAs. These sequences are defined as “destabilizer elements” and “stabilizer 
elements”, respectively.  
 
4.1.1 Destabilizer elements 
 
Cis-acting sequences that accelerate the decay rates of mRNAs are referred to as 
“destabilizer elements”. They have been identified by their ability to promote rapid decay 
when transferred to an appropriate location within inherently stable mRNAs, and they 
have also been identified by mutational analysis. They are present in unstable yeast 
mRNAs including MFA2, MATα1, HIS3, STE3, SPO13, PPR1, SDH1, HIS3, Ip, OLE1 
and HTB1 (Caponigro and Parker, 1996; Cereghino et al., 1995; Gonzalez and Martin, 
1996; Heaton et al., 1992; Herrick and Jacobson, 1992; LaGrandeur and Parker, 1999; 
Muhlrad and Parker, 1992; Parker and Jacobson, 1990). These elements are located in the 
5΄ UTR, the coding region, or the 3΄ UTR. Strikingly, in all cases examined, destabilizer 
elements promote both rapid deadenylation and rapid decapping of the host mRNAs. 
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They are also proposed to decrease translation initiation (Cereghino et al., 1995; 
Gonzalez and Martin, 1996; Scheffler et al., 1998).  
 Most destabilizer elements have weak consensus sequences. However, a group of 
destabilizer elements containing 50-150 nt sequences rich in adenosines and uridines 
have been identified. The sequence elements are termed AREs (AU-rich elements) and 
are located in the 3΄ UTRs of many but not all mRNAs. AREs are found in mammalian 
mRNAs encoding cytokines, proto-oncogenes and growth factors (Khabar, 2005), and 
also in yeast mRNAs (Vasudevan and Peltz, 2001). Although AREs are identified by 
their capacity to promote degradation of the mRNA, the presence of an ARE can also 
lead to the stabilization of an mRNA, depending on the cellular context and the precise 
stimulus (reviewed in Barreau et al., 2005). In addition, AREs have been reported to be 
able to regulate translation and mRNA export without affecting the abundance of the 
mRNA (Espel, 2005; Kontoyiannis et al., 1999; Vasudevan and Steitz, 2007).  
AREs regulate stability of the mRNAs by binding to ARE-binding proteins 
(ARE-BPs). ARE-BPs have some binding specificity for target AREs, but they are also 
typically functionally redundant, or additive, or even sometimes antagonistic. For 
example, simultaneously decreasing two ARE-BPs (KSRP and BRF1) increases, 
additively, the stability of a reporter mRNA containing an ARE (Gherzi et al., 2004). On 
the contrary, ARE-BPs TTP and HuR compete for the same target ARE in that the former 
decreases and the latter increases stability of the reporter mRNA (Ming et al., 2001). 
ARE and ARE-BP complexes regulate the stability of target mRNAs in the following 
ways: 1) AREs directly interact with the exosome to trigger the 3΄-to-5΄ decay of the 
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mRNA (Anderson et al., 2006). 2) Several ARE-BPs, e.g. AUF1, TTP, and KSRP, 
interact with exosome and are required for exosome-mediated 3΄-to-5΄ decay (Chen et al., 
2001; Gherzi et al., 2004). 3) ARE-BPs, e.g. KSRP and RHAU, bind both to PARN 
deadenylase and to the exosome to enhance 3΄-to-5΄ decay of their target mRNAs (Gherzi 
et al., 2004; Tran et al., 2004). 4) The ARE-BP, TTP, and its homolog BRF-1 associate 
with hDcp1, CCR4 deadenylase, and the exosome to activate both 3΄-to-5΄ and 5΄-to-3΄ 
decay of ARE-containing RNAs (Lykke-Andersen and Wagner, 2005). 5) In microRNA-
guided mRNA degradation, TTP associates with Argonaute proteins to recruit the miR-16 
microRNA to the ARE in TNF-α mRNA (Jing et al., 2005). 
In addition to AREs, a destabilizer element containing UG-rich sequences has 
been identified in yeast. This UG-rich element is recognized by Puf proteins, a family of 
RNA-binding proteins, which promote the accelerated decay of the substrate mRNAs by 
directly binding Pop2p to recruit the deadenylase (Goldstrohm et al., 2006; Goldstrohm et 
al., 2007).  
 
4.1.2 Stabilizer elements 
 
Unlike destabilizer elements, just a few examples of “stabilizer elements” that block rapid 
mRNA decay have been identified. The coding region and the context of the start codon 
of the PGK1 mRNA in yeast, and pyrimidine-rich elements in the 3΄ UTR of α-globin, β-
globin, and α-collagen mRNAs in human are required to make these RNAs stable 
(Garneau et al., 2007; LaGrandeur and Parker, 1999). In addition, a 68-nt region found 3΄ 
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of the final uORF4 of GCN4 mRNA can make a nonsense-containing mRNA resistant to 
NMD (Ruiz-Echevarria et al., 1998). A sequence identified in the 5΄ UTR of YAP1 
mRNA appears to bind the poly(U)-binding protein (Pub1p) to inactivate NMD (Ruiz-
Echevarria and Peltz, 2000).  
 
4.2 mRNA decay enzymes and their regulatory factors 
 
In addition to cis-control, degradation of mRNAs also requires a set of specific trans-
acting factors. These trans-acting factors encompass catalytic enzymes and their 
associated regulatory proteins. They function together to remove the protective structures 
of mRNAs including the poly(A) tail and the cap structure and then rapidly destroy the 
transcript.  
 
4.2.1 The mRNA deadenylating enzymes 
 
 Deadenylation is the first and the rate-limiting step in the two general 5΄-to-3΄ and 
3΄-to-5΄ mRNA decay pathways. Three deadenylase complexes have been identified in 
eukaryotic cells: the CCR4/POP2/NOT complex, the PAN complex, and the PARN 
trimer complex. 
 The major deadenylase is the CCR4/POP2/NOT complex. It contains two 
nucleases, Ccr4p and Pop2p, and several accessory proteins, including Not1p-Not5p, 
Caf4p, Caf16p, Caf40p, and Caf130p (Denis and Chen, 2003; Tucker et al., 2001). This 
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deadenylase is conserved in yeast and metazoans (Albert et al., 2000; Temme et al., 
2004). Ccr4p seems to be the predominant catalytic subunit of this deadenylase complex. 
It is a member of the Mg2+-dependent Exo III family of nucleases (Dlakic, 2000). 
Mutations in the predicted catalytic residues in its C-terminal nuclease domain abolish 
Ccr4p activity in yeast, human, and frog cells (Baggs and Green, 2003; Chen et al., 2002; 
Tucker et al., 2002). In addition, a conserved leucine-rich repeat in Ccr4p is essential for 
binding the Pop2p subunit of the complex and also affects the exonuclease activity (Clark 
et al., 2004). The Pop2p subunit in this complex has also been shown to have deadenylase 
activity (Daugeron et al., 2001; Thore et al., 2003). Pop2p is a member of the RNase D 
family of exonucleases (Daugeron et al., 2001; Moser et al., 1997). The structure of yeast 
Pop2p closely resembles that of the DnaQ proofreading exonuclease (Thore et al., 2003). 
The function of Pop2 might be different under different conditions. For example, 
knockout (in yeast) or knockdown (in cultured fly cells) of Pop2p show deadenylation 
defects (Daugeron et al., 2001; Temme et al., 2004; Tucker et al., 2001). However, yeast 
strains containing full-length Pop2p with point mutations in its active site show no 
deadenylation phenotypic changes, and the catalytic activity of the recombined protein 
complex was not affected in vitro (Chen et al., 2002; Tucker et al., 2002; Viswanathan et 
al., 2004). These observations suggest that Pop2p might enhance the activity of Ccr4p 
under normal conditions and be responsible for deadenylation in some circumstances. 
The CCR4/POP2/NOT complex is mainly in the cytoplasm (Cougot et al., 2004; Huh et 
al., 2003; Temme et al., 2004; Tucker et al., 2002), and its activity is inhibited by Pab1p, 
the major poly(A)-binding protein (Tucker et al., 2002; Viswanathan et al., 2003).  
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The PAN complex consists of Pan2p and Pan3p and is also conserved from yeast 
to metazoans (Boeck et al., 1996; Brown et al., 1996; Uchida et al., 2004). Pan2p is a 
member of an RNase D family of exonucleases (Moser et al., 1997; Zuo and Deutscher, 
2001). It is a Mg2+-dependent enzyme, liberating 5΄-AMP from the 3΄ end of mRNAs and 
is believed to be the catalytic subunit of the complex (Lowell et al., 1992; Uchida et al., 
2004). Pan3p appears to enhance and regulate Pan2p activity by directly interacting with 
Pab1p for general mRNAs or with Dun1p for a specific transcript (RAD5 mRNA) 
(Hammet et al., 2002; Mangus et al., 2003; Sachs and Deardorff, 1992; Uchida et al., 
2004). Pan3p also interacts with the mRNA export receptor Mex67p. This interaction 
might deliver the PAN complex to the nascent mRNP for initial deadenylation of the poly 
(A) tail (Ito et al., 2001). The PAN complex is not the main deadenylase and its main role 
is thought to be an initial shortening of poly(A) tails (Brown and Sachs, 1998; Yamashita 
et al., 2005). It functions for residual deadenylation when the predominant deadenylase is 
deleted (Tucker et al., 2001). The PAN complex is in the cytoplasm in yeast (Huh et al., 
2003) and human cells (Uchida et al., 2004). Unlike the CCR4/POP2/NOT complex, the 
activity of the PAN complex requires that the poly(A)-binding protein (Pab1p in yeast, 
PABPC in metazoans) first binds to the poly(A) tail of the substrate transcript.  
The third deadenylase complex is the PARN trimer (poly(A)-specific 
ribonuclease). Unlike the other two deadenylases, this deadenylase has only been 
identified in vertebrates, C. elegans, and S. pombe (Astrom et al., 1992; Korner and 
Wahle, 1997), but not in S. serevisiae or Drosophila. It is a member of the DEDD 
nuclease family (Zuo and Deutscher, 2001). PARN also releases 5΄-AMP from the 3΄ end 
 26
of target transcripts in a Mg2+-dependent manner. Mutations in predicted catalytic 
residues in PARN inhibit enzyme activity both in vitro and in vivo (Lai et al., 2003; 
Moser et al., 1997; Ren et al., 2002). Like the CCR4/POP2/NOT complex, PARN is 
inhibited by PABPC (Korner and Wahle, 1997; Ren et al., 2002). PARN, but not the 
CCR4/POP2/NOT complex, is the major deadenylase in mammalian mRNA decay 
systems in vitro (Gao et al., 2000) and is required for default deadenylation in X. laevis 
oocytes (Korner et al., 1998). In addition, PARN seems to be required for the rapid 
deadenylation induced by TTP, an ARE-binding protein, and can affect the process of 
NMD (Lai et al., 2003; Lejeune et al., 2003). These observations suggest that PARN may 
be an important mRNA deadenylase in vertebrate cells.  
 
4.2.2 Decapping factors 
 
4.2.2.1 The mRNA decapping enzymes 
 
Decapping is a critical step in both the general 5΄-to-3΄ and the NMD pathways in yeast 
(Coller and Parker, 2004). Decapping has also been implicated in mammalian NMD and 
ARE-mediated decay (Chen and Shyu, 2003; Fenger-Gron et al., 2005; Lejeune et al., 
2003; Yamashita et al., 2005), and in microRNA-guided decay in Drosophila (Behm-
Ansmant et al., 2006; Rehwinkel et al., 2005). 
Genetic and biochemical experiments indicate that mRNA decapping in yeast is 
carried out by the Dcp1p/Dcp2p complex (Beelman et al., 1996; Dunckley and Parker, 
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1999; LaGrandeur and Parker, 1998; Steiger et al., 2003). Recent experimental evidence 
suggests that mRNA decapping in human cells is carried out by a structurally related 
complex (containing hDcp1p and hDcp2p) possessing one additional factor, Hedls 
(Fenger-Gron et al., 2005). Genetic, biochemical, and structural data indicate that Dcp2p 
is the catalytic subunit in both yeast and human cells (Beelman et al., 1996; Cohen et al., 
2005; Dunckley and Parker, 1999; LaGrandeur and Parker, 1998; Lykke-Andersen, 2002; 
Piccirillo et al., 2003; Steiger et al., 2003; Van Dijk et al., 2002; Wang et al., 2002). Dcp2 
proteins from different species all contain a conserved Nudix (nucleoside diphosphate 
linked moiety X) motif in their N-terminal domains, but are divergent in their C-terminal 
domains (Beelman et al., 1996; Cohen et al., 2005; Dunckley and Parker, 1999; 
LaGrandeur and Parker, 1998; Lykke-Andersen, 2002; Piccirillo et al., 2003; Steiger et 
al., 2003; Van Dijk et al., 2002; Wang et al., 2002). In vitro, the N-terminal domains of S. 
cerevisiae, S. pombe, and human Dcp2p cleave the cap structure at the 5΄ end of mRNA 
(She et al., 2006; Van Dijk et al., 2002; Wang et al., 2002), releasing m7GDP and 5΄-
monophosphorylated RNA, a preferred substrate for the Xrn1p 5΄-to-3΄ exoribonuclease. 
In contrast to the scavenger decapping enzyme, human and yeast Dcp2p do not bind to a 
free cap structure and prefer capped, longer mRNA substrates (Piccirillo et al., 2003; 
Steiger et al., 2003). Structural analysis reveals that the N-terminal domain of S. pombe 
Dcp2p contains two sub-domains, an all-helical N-terminal sub-domain required to bind 
Dcp1p, and a C-terminal sub-domain that is a classic Nudix fold of pyrophosphate 
hydrolytic enzymes (She et al., 2006). The Dcp1p subunit (including both isoforms 
[hDcp1a and hDcp1b] in humans) (Lykke-Andersen, 2002) is likely to perform an 
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essential regulatory function in the decapping complex. Deletion of DCP1 results in a 
complete block to mRNA decapping in vivo (Beelman et al., 1996), and recombinant 
Dcp1p greatly stimulates the decapping activity of Dcp2p in vitro (Steiger et al., 2003). 
Initial bioinformatics analysis of hDcp1p and more recent high-resolution structural 
analysis of yeast Dcp1p show that Dcp1p is a member of a new protein family that 
contains an EVH1/WH1 (Ena/VASP homology 1/Wiskott-Aldrich syndrome protein 
homology 1) domain (Callebaut, 2002; She et al., 2004).  
The precise function of Dcp1p in the process of mRNA decapping is currently 
unknown. The presence of an EVH1/WH1 domain and the observation that this domain is 
a protein-protein interaction module (Callebaut, 2002) suggest that Dcp1p may function 
at least in part to link the decapping enzyme to other decapping regulators. Interestingly, 
Dcp1p and Dcp2p from several different species have also been localized to special 
cytoplasmic foci called P-bodies (Cougot et al., 2004; Ingelfinger et al., 2002; Sheth and 
Parker, 2003). In yeast and mammalian cells, mRNA decay intermediates of the 5΄-to-3΄ 
decay pathway are also found in P-bodies, suggesting that some mRNA decapping could 
occur in these cytoplasmic structures (Cougot et al., 2004; Sheth and Parker, 2003). 
 
4.2.2.2 Activators of mRNA decapping 
 
Decapping is an irreversible step in mRNA decay that leads to rapid exonucleolytic 
degradation of the body of a transcript. Genetic data in yeast indicate that mRNA 
decapping is a highly regulated process (Coller and Parker, 2004). In addition to the 
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Dcp1p/Dcp2p decapping enzyme, mRNA decapping in vivo requires specific regulatory 
factors that are required for efficient decapping, but not for decapping per se. 
Accordingly, these factors are generally referred to as activators of mRNA decapping 
(Coller and Parker, 2004).    
Several classes of mRNA decapping activators have been identified in yeast. One 
class includes Pat1p (Bonnerot et al., 2000; Wyers et al., 2000), a protein of unknown 
biochemical properties, Dhh1p, a member of the DEAD helicase family (Coller et al., 
2001; Fischer and Weis, 2002), and the Lsm1p-Lsm7 proteins, a putative RNA-binding 
complex (Bouveret et al., 2000; Tharun et al., 2000; Tharun and Parker, 2001). These 
factors are all activators of the general 5΄-to-3΄ decay pathway. Inactivation or deletion of 
any of these factors results in the accumulation of deadenylated, capped transcripts, but 
does not eliminate the accumulation of 5΄-to-3΄ decay intermediates for both stable and 
unstable mRNAs (Bonnerot et al., 2000; Bouveret et al., 2000; Tharun et al., 2000; 
Tharun and Parker, 2001). The precise functions of these activators are still largely 
unknown, but the following observations have provided some insight: 1) these factors 
interact with each other and with the decapping enzyme complex (Bouveret et al., 2000; 
Tharun et al., 2000; Tharun and Parker, 2001), 2) these factors exhibit genetic interaction 
with translation initiation factors (Bonnerot et al., 2000; Wyers et al., 2000), 3) Pat1p, 
eIF4E, and Pab1p can co-exist in an mRNP complex and Pat1p, Lsm1-7p, Dcp1p, and 
Dcp2p can co-exist in a different mRNP complex (Bouveret et al., 2000; Tharun et al., 
2000; Tharun and Parker, 2001), 4) two homologs of Dhh1p (the Me31b protein in 
Drosophila and the Xp54 protein in Xenopus) function in maternal mRNA storage 
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(Ladomery et al., 1997; Nakamura et al., 2001), and 5) mRNA decapping and translation 
are in competition (see below). Coller and Parker proposed that these factors activate 
mRNA decapping by promoting the exit of an mRNA from translation and the 
subsequent assembly of a decapping complex (Coller and Parker, 2004).  
The second class of decapping activators includes the three highly conserved 
NMD factors, Upf1p, Nmd2p/Upf2p, and Upf3p (Jacobson and Peltz, 2000). Upf1p, a 
109 kD protein, is a member of RNA helicase superfamily I and contains N-terminal 
Zn++-finger/RING domains and a C-terminal helicase domain (Altamura et al., 1992; 
Kadlec et al., 2006; Koonin, 1992; Leeds et al., 1991). Purified Upf1p has RNA-binding, 
as well as RNA-dependent ATPase and RNA unwinding activities (Bhattacharya et al., 
2000; Czaplinski et al., 1995). Nmd2p/Upf2p is an acidic 127 kD protein with multiple 
MIF4G (middle portion of eIF4G) domains (Cui et al., 1995; He and Jacobson, 1995; 
Kadlec et al., 2004). Upf3p is a basic 45 kD protein with an RNP domain and NLS- and 
NES-like sequences (Lee and Culbertson, 1995). Structural and biochemical analysis of 
the human Upf2/Upf3b protein complex demonstrates that the complex, but not Upf3b 
alone, has RNA-binding activity (Kadlec et al., 2004). Deletion of Upf1p, Nmd2p/Upf2p, 
or Upf3p results in the selective accumulation of capped nonsense-containing mRNAs, 
but does not eliminate decapping of these mRNAs (He and Jacobson, 2001). The precise 
functions of Upf1p, Nmd2p, and Upf3p in the decapping of nonsense-containing mRNAs 
remain largely unknown, but important clues have been derived from the following 
observations: 1) the Upf/Nmd factors interact with each other and Upf1p also interacts 
with the Dcp2p subunit of the decapping enzyme (He et al., 1996; He et al., 1997; He and 
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Jacobson, 1995), 2) these factors play a direct role in translation termination and 
physically interact with the Sup35p and Sup45p release factors (Czaplinski et al., 1998), 3) 
the Upf/Nmd factors are polyribosome-associated (Atkin et al., 1995; Atkin et al., 1997; 
Mangus and Jacobson, 1999), and 4) in vitro, premature termination is aberrant and this 
aberrant event is linked to Upf1p function (Amrani et al., 2004). Collectively, these data 
imply that the Upf/Nmd factors are recruited to ribosomes by recognizing premature 
translation termination codons and that they subsequently recruit and/or activate the 
decapping enzyme on nonsense-containing mRNA substrates.  
The third class of decapping activators includes Edc1p, Edc2p, and Edc3p (Coller 
and Parker, 2004). These factors have been identified either as high-copy suppressors of 
in vivo decapping defects caused by mutations in the DCP1 and DCP2 genes or as factors 
that interact with the decapping enzyme (Dunckley et al., 2001; Kshirsagar and Parker, 
2004). Edc1p and Edc2p are small, RNA-binding proteins and, in vitro, both proteins 
stimulate the decapping activity of the Dcp1p/Dcp2p decapping enzyme (Schwartz et al., 
2003; Steiger et al., 2003). Edc3p is an Lsm-like protein with a long C-terminal extension 
(Albrecht and Lengauer, 2004; Anantharaman and Aravind, 2004). Edc3p is conserved in 
eukaryotes and contains an N-terminal Lsm domain, a middle FDF domain that is 
enriched in polar and charged residues, and a C-terminal YjeF-N domain of unknown 
function that is also found in prokaryotic proteins (Albrecht and Lengauer, 2004; 
Anantharaman and Aravind, 2004). Genome-wide proteomic analyses show that Edc3p 
co-purifies with the Dcp1p/Dcp2p decapping enzyme and two-hybrid analysis indicates 
that Edcp3p interacts with Dcp1p, Dcp2p, and Dhh1p (Gavin et al., 2002; Ho et al., 2002; 
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Ito et al., 2001; Uetz et al., 2000). The Lsm domain of fly EDC3 mediates DCP1 binding 
and P-body targeting (Tritschler et al., 2007). Interestingly, depletion of Edc1p, Edc2p, or 
Edc3p does not affect general decapping rates of wild-type mRNAs or the decapping 
rates of nonsense-containing mRNAs (Dunckley et al., 2001; Kshirsagar and Parker, 
2004), suggesting that these factors may be required for the decapping of specific 
mRNAs. It was found that Edc3p directly controls RPS28B mRNA degradation through a 
deadenylation-independent decapping mechanism that requires the Dcp1p/Dcp2p 
decapping enzyme and a cis-regulatory element located in the 3΄ UTR of RPS28B mRNA 
(Badis et al., 2004). As described below, our genome-wide microarray analysis together 
with other experiments showed that YRA1 pre-mRNA is another substrate of Edc3p.   
 
4.2.2.3 Interrelationships between translation and mRNA decapping 
 
The cap structure is not only a substrate for the decapping enzyme (Piccirillo et al., 2003; 
Steiger et al., 2003; Van Dijk et al., 2002), but also a binding site for eIF4E, a factor that 
promotes translation initiation (von der Haar et al., 2004). These findings suggest that, in 
vivo, mRNA translation and decapping are in competition. One implication of the 
competition model is that factors that promote translation will act as inhibitors of mRNA 
decapping. Consistent with this notion, mutations in genes encoding eIF4E, eIF4G, and 
eIF4A that strongly inhibit translation initiation increase the rate of decapping of both 
stable and unstable mRNAs (Schwartz and Parker, 1999; Schwartz and Parker, 2000); 
depletion of the poly(A)-binding protein, Pab1p, which also has an important role in 
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translation initiation, promotes deadenylation-independent decapping (Caponigro and 
Parker, 1995); purified eIF4E can directly inhibit the activity of the decapping enzyme in 
vitro (Schwartz and Parker, 2000); and a temperature-sensitive allele of eIF4E (cdc33-42) 
can suppress the in vivo decapping defect caused by a dcp1 partial loss-of-function allele 
(Schwartz and Parker, 2000). A second implication of the competition model is that some 
decapping activators function, at least in part, to repress mRNA translation. This idea is 
supported by the finding that recognition of a premature stop codon by Upf1p represses 
translation of nonsense-containing mRNAs. More recently, it has been shown that Pat1p 
and Dhh1p, two decapping activators of the general 5΄-to-3΄ decay pathway, are 
independently required for general translation repression under glucose or amino acid 
deprivation (Coller and Parker, 2005). In addition, Dhh1p and its human homolog can 
repress mRNA translation in vitro (Coller and Parker, 2005).  
 
4.2.3 Factors involved in the 3΄-to-5΄ decay pathways 
 
4.2.3.1 Exosome  
 
The catalytic exosome and some regulators are required in the general 3΄-to-5΄ decay 
pathway, non-stop decay pathway and nonsense-mediated 3΄-to-5΄ decay pathway. The 
yeast exosome has nuclear and cytoplasmic forms sharing at least 10 essential 
components (Allmang et al., 1999b; Mitchell et al., 1997). Among these components, 
Rrp4p, Ski6p (Rrp41p) and Rrp44p (Dis3p) have 3΄-to-5΄ exoribonuclease activity in 
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vitro, and the other members (Rrp40p, Rrp42p, Rrp43p, Rrp45p, Rrp46p and Mtr3p) 
except Csl4p (Ski4p) have high sequence homology to the Escherichia coli 3΄-to-5΄ 
exoribonucleases, RNase PH and PNPase (for reviews see (Mitchell and Tollervey, 2000; 
van Hoof and Parker, 1999)). The nuclear exosome has additional subunits: Rrp6p, a 
protein also possessing 3΄-to-5΄ exoribonuclease activity (Allmang et al., 1999b; Briggs et 
al., 1998; Burkard and Butler, 2000), Rrp47p (Mitchell et al., 2003), a putative nucleic-
acid-binding protein, as well as Mtr4p/Dob1p, a putative RNA helicase (van Hoof et al., 
2000a). The cytoplasmic exosome degrades mRNAs, whereas the nuclear exosome 
processes small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and rRNAs, 
in addition to degrading aberrant nuclear RNA precursors of many types, including pre-
mRNAs, pre-tRNAs and pre-rRNAs  or mRNAs restrained in the nucleus (Allmang et al., 
1999a; Jacobs Anderson and Parker, 1998; Mitchell et al., 1997).  
 
4.2.3.2 SKI factors  
 
Four activators contribute to exosome-mediated cytoplasmic general 3΄-to-5΄ pathway, 
non-stop decay and nonsense-mediated 3΄-to-5΄ decay: Ski2p, Ski3p, Ski8p, Ski7p (Araki 
et al., 2001; Jacobs Anderson and Parker, 1998; Mitchell and Tollervey, 2003; Takahashi 
et al., 2003; van Hoof et al., 2002; van Hoof et al., 2000b).  Ski2p, Ski3p, Ski8p and 
Ski7p are a putative RNA helicase, a tetratricopeptide-repeat protein, a protein containing 
WD motif, and a putative GTPase, respectively (Benard et al., 1999; Matsumoto et al., 
1993; Rhee et al., 1989; Widner and Wickner, 1993). Ski2p, Ski3p, and Ski8p form a 
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stable heterotrimeric complex in the cytoplasm (Brown et al., 2000). Within the Ski 
complex, Ski3p serves as a scaffold protein with its C terminus interacting with Ski8p, 
and the sub-C terminus interacting with Ski2p, while no direct interaction between Ski2p 
and Ski8p was found (Wang et al., 2005). The Ski2p/Ski3p/Ski8p complex may act to 
recruit the exosome to the mRNA or remodel the mRNP to allow access by the exosome 
(Jacobs Anderson and Parker, 1998). The other SKI factor, Ski7p, interacts with the 
Ski2p/Ski3p/Ski8p complex via its interaction with Ski8p and Ski3p but not Ski2p (Wang 
et al., 2005). Ski7p is a GTP-binding protein containing a C-terminal domain that 
resembles the GTPase domains of translation elongation factor EF1α and termination 
factor eRF3 (Benard et al., 1999; van Hoof et al., 2000b). However, the N-terminal 
domain, but not the C-terminal GTPase domain, of Ski7p is necessary and sufficient for 
exosome-mediated general 3΄-to-5΄ mRNA decay by interacting with the exosome and 
the Ski2p/Ski3p/Ski8p complex (Araki et al., 2001). Instead, the C-terminal domain of 
Ski7p is required for nonstop decay by binding to the empty A site on ribosomes stalled 
at the end of a transcript lacking a stop codon (van Hoof et al., 2002). Furthermore, Ski7p 
interacts with Upf1p and is required in the nonsense-mediated 3΄-to-5΄ mRNA decay in 
yeast (Takahashi et al., 2003).  
 
5. Autoregulation of YRA1  
 
Yra1p is an essential RNA-binding protein encoded by the spliced YRA1 transcript. It is a 
small RNA-binding protein first identified on the basis of its potent RNA annealing 
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activity in vitro (Portman et al., 1997). It was subsequently shown to be essential for 
mRNA export (Strasser and Hurt, 2000) and to be recruited to mRNA co-transcriptionally 
(Abruzzi et al., 2004; Lei et al., 2001; Lei and Silver, 2002; Strasser and Hurt, 2000). As 
an adaptor, Yra1p recruits Mex67p, the mRNA export receptor, to form an export-
competent mRNA. Current views about the role of Yra1p in RNA export are reviewed in 
the “Export of mRNA” section of this chapter. In addition, over-expressing Yra1p has a 
dominant–negative effect, arresting cell growth (Espinet et al., 1995). Recent data show 
that Yra1p is required for S phase entry and plays a role in DNA replication by recruiting 
Dia2p, a protein of the ubiquitin ligase family involved in DNA replication and genome 
stability (Swaminathan et al., 2007).  
The YRA1 gene is one of the 5% of budding yeast genes that undergo splicing. It 
contains a 766-nt intron, the second largest intron in the yeast genome; its intron is 
located far downstream of the translation initiation codon; and its branch-point region 
diverges from the consensus motif common to the vast majority of yeast intron-
containing pre-mRNAs (Portman et al., 1997; Strasser and Hurt, 2000). Previous studies 
suggested that YRA1 expression is controlled through an autoregulated negative feedback 
loop (Preker and Guthrie, 2006; Preker et al., 2002; Rodriguez-Navarro et al., 2002). The 
YRA1 intron is required for this autogenous regulation of Yra1p expression, which causes 
a dominant negative growth phenotype when elevated. Replacement of the intron with the 
intron sequences from other genes can partially recover the autoregulation of YRA1 
(Rodriguez-Navarro et al., 2002). Guthrie and colleagues proposed that inefficient co-
transcriptional splicing is required for maintaining the appropriate levels of Yra1p (Preker 
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and Guthrie, 2006). However, the underlying mechanism of YRA1 autoregulation remains 
unknown.  
 
6. Rationale of this work  
 
The detection of physical interactions between Edc3p and the Dcp1p/Dcp2p decapping 
enzyme (Gavin et al., 2002; Ho et al., 2002; Ito et al., 2001; Uetz et al., 2000) strongly 
suggests that Edc3p plays a role in mRNA decay. To assess the role of Edc3p in mRNA 
decay, we analyzed the effect of EDC3 deletion on global RNA accumulation using high-
density genome-wide microarrays in the yeast model system. Our analysis identified only 
two transcripts, the RPS28B mRNA and the YRA1 pre-mRNA, that are up-regulated when 
EDC3 is deleted. The RPS28B mRNA codes for a 40S ribosomal protein (Lecompte et al., 
2002) and the spliced product of YRA1 pre-mRNA codes for Yra1p which has an 
essential function in an early stage of mRNA export, as reviewed above. Interestingly, in 
a similar screen, the RPS28B transcript was shown by the Jacquier group to be the sole 
differentially expressed mRNA they could detect in edc3Δ cells (Badis et al., 2004). Their 
experiments showed that Edc3p directly controls RPS28B mRNA degradation through a 
deadenylation-independent decapping mechanism that requires the Dcp1p/Dcp2p 
decapping enzyme and a cis-regulatory element located in the 3΄ UTR of RPS28B mRNA. 
In addition, they found that: 1) the expression of the RPS28B gene is autoregulated 
through a negative feedback loop, 2) RPS28B autoregulation is dependent on the Edc3p-
mediated degradation of its mRNA, and 3) the RPS28B protein in vivo binds to the cis-
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regulatory element in the 3΄ UTR of RPS28B mRNA. Both YRA1 and RPS28B are 
autoregulated. Moreover, both have sequence anomalies: YRA1 has a long, unusual intron 
and RPS28B has a long, unusual 3΄ UTR. Finally, both are regulated by Edc3p.These 
observations raised our interest and led us to ask how Edc3p regulates the expression of 
YRA1.In the following studies, we focused on the effect of Edc3p on YRA1 pre-mRNA 
and tested two hypotheses: that Edc3p is engaged in the autoregulation of YRA1 by 
regulating the stability of the YRA1 pre-mRNA and that regulation of Edc3p-mediated 
YRA1 pre-mRNA degradation is achieved by the combined effects of cis-acting elements 
and trans-regulatory factors.  
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CHAPTER II 
 
YRA1 Autoregulation Requires Nuclear Export and 
Cytoplasmic Edc3p-mediated Degradation of its Pre-
mRNA 
 
 
Running title: Transcript-specific degradation mediated by Edc3p 
 
 
 
Attribution: Dr. Daniel Zenklusen carried out the fluorescent in situ hybridization (FISH) 
experiment. 
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SUMMARY 
 
Autoregulatory loops often provide precise control of the level of expression of specific 
genes that encode key regulatory proteins. Here we have defined a pathway by which 
Yra1p, a yeast mRNA export factor, controls its own expression. We show that YRA1 
exon1 sequences in cis and Yra1p in trans inhibit YRA1 pre-mRNA splicing and commit 
the pre-mRNA to nuclear export. Mex67p and Crm1p jointly promote YRA1 pre-mRNA 
export and, once in the cytoplasm, the pre-mRNA is degraded by a 5΄ to 3΄ decay 
mechanism that is dependent on the decapping activator Edc3p and on specific sequences 
in the YRA1 intron. These results illustrate how common steps in the nuclear processing, 
export, and degradation of a transcript can be uniquely combined to control the 
expression of a specific gene and suggest that Edc3p-mediated decay may have additional 
regulatory functions in eukaryotic cells. 
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INTRODUCTION 
 
mRNA degradation, an integral event in gene expression, provides post-transcriptional 
titration of transcript levels and ensures the elimination of aberrant mRNAs or those that 
have exited the translation-competent state (Parker and Song, 2004). Two general and 
functionally redundant mechanisms, the deadenylation-dependent 5΄ to 3΄ pathway and 
the exosome-mediated 3΄ to 5΄ pathway, are responsible for the decay of most mRNAs in 
yeast (Coller and Parker, 2004). Subsequent to poly(A) shortening, substrates of the 5΄ to 
3΄ pathway are decapped by the Dcp1p/Dcp2 decapping enzyme complex  and then 
digested exonucleolytically by the 5΄ to 3΄ exoribonuclease, Xrn1p (Coller and Parker, 
2004), whereas those subject to 3΄ to 5΄ decay are deadenlylated and then degraded by the 
ten-subunit exosome complex of 3΄ to 5΄ exonucleases (Mitchell et al., 1997). 
Components of both pathways are also utilized by several cytoplasmic translation-
dependent mRNA surveillance mechanisms that target mRNAs containing premature 
termination codons (nonsense-mediated mRNA decay [NMD]), mRNAs lacking 
translational termination codons (non-stop decay [NSD]), and mRNAs impaired in 
translational elongation (no-go decay [NGD]) (Doma and Parker, 2006; Frischmeyer et 
al., 2002; Jacobson and Peltz, 1996; van Hoof et al., 2002).  
 Almost all mRNAs subject to 5΄ to 3΄ decay, whether normal or aberrant, are 
shunted into the pathway as a consequence of specific decapping activators (Coller and 
Parker, 2004). For example, the decapping of conventional mRNAs is promoted by Pat1p, 
Dhh1p, and the Lsm1p-7p complex (Coller and Parker, 2004), and Upf1p, Nmd2p/Upf2p, 
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and Upf3p serve a similar function for NMD substrates (He and Jacobson, 2001). The 
precise mechanism of action of these decapping activators has yet to be elucidated, but it 
is thought that they promote both departure from the translation pathway and recruitment 
of the Dcp1p/Dcp2p complex (Coller and Parker, 2004; Coller and Parker, 2005). 
Additional potential regulators of decapping have been identified either as high-copy 
suppressors of in vivo decapping defects caused by mutations in the DCP1 and DCP2 
genes or as factors that interact with the decapping enzyme (Dunckley et al., 2001; 
Kshirsagar and Parker, 2004). These regulators include Edc1p, Edc2p, and Edc3p. 
Interestingly, depletion of each these factors does not affect general decapping rates of 
wild-type mRNAs or the decapping rates of nonsense-containing mRNAs (Dunckley et 
al., 2001; Kshirsagar and Parker, 2004), suggesting that these factors may be required for 
the decapping of specific mRNAs. 
 Cytoplasmic mRNA decay pathways can also play a role in the degradation of 
intron-containing pre-mRNAs. Normally, such pre-mRNAs are retained in the nucleus to 
be processed to mRNAs and are rarely exported to the cytoplasm. Pre-mRNAs that fail to 
complete splicing or 3΄-end formation are usually degraded by the nuclear exosome 
(Bousquet-Antonelli et al., 2000; Torchet et al., 2002). However, cis-mutations in the 5΄ 
splice site or the branchpoint region or trans-mutations in several splicing factors 
(including Prp6p, Prp9p, and the U1 snRNA), or the Mlp1p nuclear retention factor, 
result in the export of pre-mRNAs to the cytoplasm (Galy et al., 2004; Hilleren and 
Parker, 2003; Legrain and Rosbash, 1989; Rain and Legrain, 1997). As shown by our 
previous studies, pre-mRNAs that escape the nuclear retention system and enter the 
 43
cytoplasm are usually recognized by ribosomes and degraded in a translation-dependent 
manner by the NMD pathway (He et al., 1993; Vilardell et al., 2000).  
 We have been using microarray analysis to better understand the function of the 
cytoplasmic mRNA decay pathways (He et al., 2003). Application of this methodology to 
the NMD and 5΄ to 3΄ decay pathways identified endogenous substrates of the respective 
pathways and provided insights into the determinants of substrate status (He et al., 2003). 
Here, we report that comparable delineation of the substrates of Edc3p identified a 
specific cytoplasmic decay pathway involved in the degradation of intron-containing 
YRA1 pre-mRNA. Subsequent investigation of the means by which YRA1 pre-mRNA is 
actively exported to the cytoplasm revealed a complex autoregulatory network that 
involves splicing inhibition, Crm1p-mediated nuclear export, and Edc3p-mediated 
decapping of the pre-mRNA.  
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RESULTS 
 
Deletion of EDC3 Selectively Stabilizes YRA1 Pre-mRNA 
To assess the role of Edc3p in mRNA decay, we utilized high-density oligonucleotide 
microarrays to analyze the effect of EDC3 deletion on global RNA accumulation. Five 
independent expression profiling experiments were carried out with EDC3 and edc3Δ 
strains and differentially expressed transcripts were initially identified based on three 
stringent criteria. First, the hybridization signal values of a specific transcript in the wild-
type and the edc3Δ strains had to have a relative change of at least 2-fold and an absolute 
change of at least 200 units. Second, these changes had to be reproducible in at least 80% 
of the independent replicate experiments. Third, these changes had to demonstrate 
statistically significant P values ≤0.05. To our surprise, this data analysis revealed that, 
among the 7839 potential transcripts analyzed, only a single transcript met these criteria. 
In edc3Δ cells, the EDC3 mRNA itself was decreased more than 10-fold relative to its 
level in wild-type cells (Table 2.4), consistent with the fact that the edc3Δ strain harbors a 
complete EDC3 deletion. Although this observation validated the overall experiment, we 
reasoned that our stringent criteria may have overlooked at least two classes of transcripts. 
For example, highly expressed transcripts are prone to signal saturation and intron-
containing transcripts might be missed since the oligonucleotide probes on our arrays do 
not differentiate intron-containing pre-mRNA signals from mRNA signals. We, therefore, 
lowered the analysis stringency by eliminating the minimum 2-fold change requirement 
and reanalyzed our data. This new analysis identified four additional differentially 
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expressed transcripts in the edc3Δ strain: two transcripts showed increased expression 
and two others showed decreased expression (Table 2.4). One of the up-regulated 
transcripts is encoded by the RPS28B gene and codes for a 40S ribosomal protein 
(Lecompte et al., 2002). The other up-regulated transcript is encoded by the YRA1 gene 
and codes for an hnRNP-like protein (Yra1p) involved in an early stage of mRNA export 
(Portman et al., 1997; Strasser and Hurt, 2000). The two down-regulated transcripts, 
encoded by the URA1 and URA4 genes, may well reflect our use of the URA3 gene as a 
selectable marker for replacement of the EDC3 coding region. URA1, URA3, and URA4 
all code for enzymes involved in uracil biosynthesis (Denis-Duphil, 1989) and the 
decreased expression of URA1 and URA4 transcripts in the edc3Δ strain is presumably 
related to the expression of URA3, not to the deletion of EDC3.  
Significantly, the RPS28B transcript, identified in a similar screen as the sole 
differentially expressed mRNA in edc3Δ cells, has been shown to be degraded through an 
Ecd3p-mediated mRNA decay pathway (Badis et al., 2004). Thus, in this study, we 
focused our analysis on the YRA1 transcript(s). The YRA1 gene contains an intron in the 
middle of its coding region and has the potential to produce an intron-containing pre-
mRNA and a mature mRNA. To validate our microarray data and to identify the RNA 
species affected by deleting EDC3, we examined the steady-state levels of the YRA1 
transcripts in EDC3 and edc3Δ strains. As shown in Figure 2.1A, deletion of EDC3 had 
no effect on the level of YRA1 mRNA, but resulted in a five-fold increase in YRA1 pre-
mRNA. As controls, we found that deletion of EDC3 did not affect the levels of the 
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intron-lacking CYH2 and PGK1 mRNAs or the intron-containing CYH2 and DBP2 pre-
mRNAs (data not shown).  
To determine whether Edc3p plays a direct role in YRA1 pre-mRNA degradation, 
we monitored YRA1 pre-mRNA decay kinetics subsequent to inhibiting transcription. 
This analysis revealed that the YRA1 pre-mRNA has a half-life >60 min in edc3Δ cells 
and ~15 min in EDC3 cells (Figure 2.1B). In contrast, deletion of EDC3 did not alter the 
decay rate of the YRA1 mRNA (t1/2~6 min). Deletion of EDC3 also did not alter the decay 
rates of the CYH2, PGK1, and RPS28A mRNAs (data not shown). Taken together, these 
results indicate that Edc3p directly controls YRA1 pre-mRNA degradation.  
 
YRA1 Pre-mRNA is Degraded Through a 5΄ to 3΄ Decay Mechanism 
To elucidate the mechanism of YRA1 pre-mRNA decay, we analyzed its level in strains 
containing deletions of genes encoding well characterized factors involved in 
deadenylation, the general 5΄ to 3΄ or 3΄ to 5΄ decay pathways, or the NMD pathway. 
Among these factors, only deletion of the genes encoding Dcp1p, a component of the 
decapping enzyme, and Xrn1p, the cytoplasmic 5΄ to 3΄ exoribonuclease, affected YRA1 
pre-mRNA levels (Figure 2.2A). Compared to the level in wild-type cells, deletion of 
these two genes resulted in 5- to 10-fold increases in YRA1 pre-mRNA levels. In contrast, 
deletion of the genes encoding all the other factors, including the major cytoplasmic 
deadenylase, Ccr4p (Tucker et al., 2002), the exosome components, Ski2p and Ski7p, the 
decapping activators, Pat1p, Dhh1p, Lsm1p, and Lsm7p, and the NMD factors, Upf1p, 
Nmd2p, and Upf3p, had no effect on YRA1 pre-mRNA accumulation (Figures 2.2A, 2.2B, 
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and 2.2C). These results indicate that YRA1 pre-mRNA is degraded by a 5΄ to 3΄ 
mechanism that requires decapping by Dcp1p and Dcp2p, and 5΄ to 3΄ exonucleolytic 
digestion by Xrn1p.  
 
Edc3p-mediated YRA1 Pre-mRNA Degradation Occurs in the Cytoplasm 
The observation that YRA1 pre-mRNA degradation requires Dcp1p and Xrn1p, two 
cytoplasmic factors, strongly suggests that Edc3p-mediated degradation of YRA1 pre-
mRNA occurs in the cytoplasm. To test this hypothesis, we assessed the subcellular 
localization and levels of YRA1 pre-mRNA in wild-type, edc3Δ, dcp1Δ, and xrn1Δ strains 
by fluorescent in situ hybridization (FISH) analysis. We utilized sets of Cy3- and Cy5-
labelled oligonucleotide probes to respectively detect YRA1 intron and exon sequences. In 
wild-type cells, the exon signal was detected in the nucleus and cytoplasm, whereas the 
intron signal was mainly detected in the nucleus, co-localizing with the exon signal and 
likely reflecting nascent YRA1 transcripts (Figure 2.3A, panels a,b,c). Compared to the 
YRA1 exon and intron signals in wild-type cells, edc3Δ, xrn1Δ, dcp1Δ, and  xrn1Δedc3Δ  
cells all showed significant increase in both the exon and intron signals in the cytoplasm. 
In addition, the cytoplasmic intron signals in these cells co-localized largely with the 
exon signals (Figure 2.3A, panels e-t). Interestingly, dcp1Δ cells displayed a local 
enrichment of YRA1 pre-mRNA in cytoplasmic dots, suggesting that YRA1 pre-mRNA 
may enter P-bodies but fail to be degraded due to the lack of Dcp1p (Figure 2.3A, panels 
q-t). These data demonstrate that YRA1 pre-mRNA degradation occurs after the transcript 
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has been exported to the cytoplasm and that when degradation is inhibited by deleting 
EDC3, DCP1, or XRN1, YRA1 pre-mRNA accumulates in the cytoplasm. 
We also analyzed the effects of inactivation or deletion of nuclear decay factors 
on YRA1 pre-mRNA accumulation. We found that neither inactivation of the 5΄ to 3΄ 
exoribonuclease, Rat1p, an essential component of the nuclear 5΄ to 3΄ decay pathway 
(Bousquet-Antonelli et al., 2000), nor deletion of the gene encoding Rrp6p, a component 
of the nuclear exosome involved in the nuclear 3΄ to 5΄ decay pathway (Bousquet-
Antonelli et al., 2000), affected YRA1 pre-mRNA levels (Figure 2.3B and 2.3C). Taken 
together, these results indicate that Edc3p-mediated YRA1 pre-mRNA degradation occurs 
in the cytoplasm. 
 
Edc3p Activates, But Does Not Catalyze Decapping of the YRA1 Pre-mRNA 
To define the functional role of Edc3p inYRA1 pre-mRNA decay, we analyzed YRA1 pre-
mRNA cap status. As shown in Figure 2.2D, YRA1 pre-mRNAs that accumulate in edc3Δ 
and dcp1Δ cells are essentially all in the capped fraction. In contrast, pre-mRNA 
transcripts that accumulate in xrn1Δ cells are essentially all in the uncapped fraction. 
However, the pre-mRNAs that accumulate in edc3Δxrn1Δ cells contain both capped 
(~40%) and uncapped (~60%) species, demonstrating that deletion of EDC3 inhibits but 
does not eliminate decapping and that Edc3p activates but does not catalyze decapping of 
YRA1 pre-mRNA.  
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Edc3p-mediated Degradation of YRA1 Pre-mRNA is a Component of an 
Autoregulatory Negative Feedback Loop  
Previous studies indicated that YRA1 regulates its own expression through a negative 
feedback loop and that this autoregulation requires the YRA1 intron (Preker et al., 2002; 
Rodriguez-Navarro et al., 2002). Our observation that Edc3p is required for YRA1 pre-
mRNA degradation raised the possibility that Edc3p plays a role in YRA1 autoregulation. 
To test this notion, we examined the effects of increasing YRA1 gene copy number on the 
levels of its pre-mRNA, mRNA, and protein in wild-type and edc3Δ strains. As shown in 
Figure 2.4A, introduction of extra copies of the intron-containing YRA1 allele altered 
neither YRA1 mRNA levels nor Yra1p levels in EDC3 and edc3Δ strains. Interestingly, 
introduction of extra copies of YRA1 differentially affected YRA1 pre-mRNA levels, 
resulting in only a 2-fold increase in the EDC3 strain but a 24-fold increase in the edc3Δ 
strain. In contrast to the intron-containing YRA1 allele, introduction of extra copies of an 
intron-lacking YRA1 allele increased the levels of YRA1 mRNA 4-fold and Yra1p 3-fold 
in both the EDC3 and edc3Δ strains. These results confirm that Yra1p negatively 
regulates its own level of expression (Preker et al., 2002; Rodriguez-Navarro et al., 2002), 
and further indicate that Edc3p-mediated YRA1 pre-mRNA degradation is a component of 
this negative feedback loop. Since Edc3p-mediated YRA1 pre-mRNA degradation occurs 
in the cytoplasm (see above), this result also suggests that Yra1p regulates its expression 
by inhibiting YRA1 pre-mRNA splicing and effecting or promoting pre-mRNA nuclear 
export. 
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Yra1p Autoregulation Requires Two Functionally Distinct cis-regulatory Elements 
As described above, YRA1 autoregulation likely involves splicing inhibition, nuclear 
export, and cytoplasmic degradation of YRA1 pre-mRNA. To identify the cis-regulatory 
elements involved in these functions, we constructed chimeric RNAs encompassing 
segments of the YRA1 transcript and other non-Edc3p substrate RNAs and examined their 
decay phenotypes in wild-type, upf1Δ, edc3Δ, and upf1Δedc3Δ strains. We included the 
upf1Δ strains in this analysis because we speculated that chimeric RNAs that fail to 
autoregulate are likely to be degraded by the NMD pathway. YRA1 exon1, intron, and 
exon2 sequences were replaced with the corresponding parts of the CYH2, MER2, and 
RPS51A pre-mRNAs, three transcripts that differ in splicing efficiency (during vegetative 
growth, the CYH2 and MER2 pre-mRNAs are inefficiently spliced, but the RPS51A pre-
mRNA is efficiently spliced; (He et al., 1993). In addition, we also replaced YRA1 exon1 
with the HIS3 coding sequence. Analyses of the steady-state levels of these chimeric pre-
mRNAs and their spliced products in wild-type, upf1Δ, edc3Δ, and upf1Δedc3Δ strains 
led to several important observations. First, replacement of YRA1 exon1 with the CYH2 
or MER2 exon1, or the HIS3 coding sequence differentially affected pre-mRNA splicing 
efficiency. Substitution of YRA1 exon1 with the shorter CYH2 exon1 (285 nt vs. 48 nt) 
dramatically increased the splicing efficiency of the pre-mRNA, as negligible C-Y-Y pre-
mRNA signals were detected in the wild-type, upf1Δ, edc3Δ, and upf1Δedc3Δ strains but 
high levels of mRNA accumulated in these strains (Figure 2.4B). In contrast, substitution 
of YRA1 exon1 by the comparably sized MER2 exon1 (315 nt), or by a longer HIS3 
coding region (633 nt), did not improve the splicing efficiency of the pre-mRNA. 
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Interestingly, like wild-type YRA1 pre-mRNA, both the M-Y-Y and H-Y-Y pre-mRNAs 
accumulated to high levels in edc3Δ strains (Figures 2.4B and 2.5A). Second, 
replacement of the YRA1 intron with the CYH2, MER2, or RPS51A intron did not alter 
pre-mRNA splicing efficiency but, in each case, resulted in a pre-mRNA that is 
insensitive to Edc3p, but sensitive to Upf1p (Figures 2.4C and 2.5B). Third, replacement 
of YRA1 exon2 with the CYH2, MER2 or RPS51A exon2 did not alter pre-mRNA splicing 
efficiency and, in each case, resulted in a pre-mRNA that behaved the same as the wild-
type YRA1 pre-mRNA (Figures 2.4D and 2.5C). We also noted that the levels of mRNAs 
generated from the Y-Y-C and Y-Y-R pre-mRNAs were greatly increased in all four 
yeast strains (Figure 2.4D). This is most likely due to increased stability of these chimeric 
mRNAs. These results indicate that sequences in exon1 and the intron of the YRA1 pre-
mRNA are required for Yra1p autoregulation and that these sequences have distinct 
functions. Sequences in exon1 inhibit YRA1 pre-mRNA splicing and effect or promote 
nuclear export of the pre-mRNA while sequences in the intron dictate the substrate 
specificity for Edc3p-mediated decay. Consistent with these conclusions, deletion 
analysis of YRA1 pre-mRNA showed that: a) a 252-nt internal deletion in exon1 
promoted more efficient splicing of the YRA1 pre-mRNA; b) a 462-nt internal deletion in 
the intron did not significantly improve the splicing efficiency but resulted in a pre-
mRNA that is degraded by NMD; and c) a 352-nt internal deletion in exon 2 did not 
affect YRA1 autoregulation and resulted in a pre-mRNA that behaved the same as wild-
type YRA1 pre-mRNA (Figure 2.4E). 
 
 52
YRA1 Exon1 Sequences Inhibit its Pre-mRNA Splicing in a Size-dependent But 
Sequence-independent Manner 
Since YRA1 exon1 appeared to regulate its pre-mRNA splicing through a size-dependent 
but sequence-independent mechanism (see above) we analyzed the effects of shortening 
YRA1 exon1 or replacing exon1 coding sequences with their complementary sequences. 
This analysis revealed that incremental deletions of exon1 resulted in incremental 
increases in YRA1 mRNA levels in EDC3 and edc3Δ strains (Figure 2.6A). Importantly, 
the incremental increases in YRA1 mRNA levels in both strains were all accompanied by 
corresponding decreases in YRA1 pre-mRNA levels in the edc3Δ strain (Figure 2.6A). 
These data show that YRA1 exon1 functions to inhibit pre-mRNA splicing in cis. 
Figure 2.6A also reveals that the splicing efficiency of mutant pre-mRNAs 
correlates positively with the size of deletions and thus negatively with the size of the 
remaining exon1, suggesting that the inhibitory function of exon1 on YRA1 pre-mRNA 
splicing is dictated by its length. Replacing the YRA1 exon1 coding sequence with its 
complementary sequence resulted in a pre-mRNA that behaved very similarly to the 
wild-type pre-mRNA, i.e., it was inefficiently spliced and degraded by the Edc3p-
mediated decay pathway (Figure 2.6B). Since the complementary sequences of exon1 
function as well as the coding sequences the ability of YRA1 exon1 to inhibit its pre-
mRNA splicing must be dictated by its size, but not its primary sequence. 
Our analysis of exon1 deletion mutants in the edc3Δ strain also revealed an 
inverse correlation between the levels of YRA1 pre-mRNA and mRNA (Figure 2.6A). 
This observation, combined with the fact that Edc3p-mediated YRA1 pre-mRNA 
 53
degradation occurs in the cytoplasm, suggests that YRA1 pre-mRNA splicing and nuclear 
export are functionally linked and compete for common substrates. One explanation for 
this effect is that exon1 functions primarily to inhibit pre-mRNA splicing in cis and thus 
results in nuclear export of the pre-mRNA. Alternatively, YRA1 exon1 could primarily 
promote nuclear export of its pre-mRNA and, as a consequence, inhibit pre-mRNA 
splicing. To distinguish these possibilities, we tested whether cis-mutations that inhibit 
splicing can bypass the regulatory function of YRA1 exon1. We used yra1-N84, a 
complete loss-of-regulation allele that contains a 252-nt deletion in the coding region of 
exon1 and encodes a pre-mRNA that is efficiently spliced, as evidenced by high levels 
mRNA but almost no pre-mRNA in wild-type, upf1Δ, edc3Δ, and upf1Δedc3Δ strains 
(Figure 2.6C). We found that mutations in the 5΄ splice site (m5SS) or the branch point 
region (mBB2), which block splicing prior to the first step of splicing (Jacquier et al., 
1985; Parker and Guthrie, 1985), greatly reduced or eliminated splicing of the yra1-N84 
pre-mRNA in wild-type, upf1Δ, edc3Δ, and upf1Δedc3Δ strains (Figure 2.6C). 
Remarkably, the m5SS and mBB2 mutations also restored yra1-N84 pre-mRNA to wild-
type pre-mRNA regulation, i.e., the yra1-N84-m5SS and yra1-N84-mBB2 pre-mRNAs 
accumulated to high levels in edc3Δ strains (Figure 2.6C). In contrast, mutation of the 3΄ 
splice site (m3SS), which inhibits the second step of splicing (Rymond et al., 1987), 
reduced yra1-N84 pre-mRNA splicing only modestly, as significant levels of yra1-N84 
mRNA accumulated in upf1Δ cells (Figure 2.6C). The modest effect of the m3SS 
mutation on yra1-N84 pre-mRNA splicing is likely due to the use of alternative 3΄ 
splicing signals in exon2 and the sensitivity of yra1-N84 mRNA to UPF1 probably 
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reflects the creation of a premature stop codon as a consequence of alternative 3΄ splicing. 
Significantly, the m3SS mutation did not restore the yra1-N84 pre-mRNA to wild-type 
YRA1 pre-mRNA regulation. These data show that cis-mutations that inhibit the first but 
not the second step of YRA1 pre-mRNA splicing completely suppress the defect caused 
by the N84 deletion and thus result in a bypass of the regulatory function of YRA1 exon1. 
These results indicate that: a) the primary function of YRA1 exon1 is to inhibit YRA1 pre-
mRNA splicing, not to promote YRA1 pre-mRNA nuclear export and b) YRA1 exon1 
most likely exerts its inhibitory function at or before the first step of the splicing pathway. 
 
Yra1p Autoregulates its Level of Expression by Inhibiting YRA1 Pre-mRNA 
Splicing and Committing the Pre-mRNA to Nuclear Export 
To further understand the role of Yra1p in its autoregulation, we examined the effects of 
mutations in the YRA1 gene on levels of YRA1 pre-mRNA and mRNA in an edc3Δ 
background. We reasoned that some loss of function mutations may also fail to 
autoregulate. We first analyzed yra1-1, a ts allele whose encoded protein contains 
multiple amino acid substitutions and is defective in mRNA export even when cells are 
grown at room temperature (Strasser and Hurt, 2000). As shown in Figure 2.6D, when 
cells were grown at 25°C (t=0) or were shifted to 37°C for 30 min, edc3Δyra1-1 cells 
accumulated significantly lower levels of YRA1 pre-mRNA than edc3ΔYRA1 cells. In 
contrast, under these two growth conditions, edc3Δyra1-1 cells accumulated significantly 
higher levels of YRA1 mRNA than edc3ΔYRA1 cells. The lower YRA1 pre-mRNA to 
mRNA ratios in edc3Δyra1-1 cells indicate that the yra1-1 allele is defective in 
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autoregulation and suggest that Yra1p regulates its own expression by inhibiting YRA1 
pre-mRNA splicing.  
To test this idea further, we analyzed the effects of eliminating Yra1p. In this 
experiment, we generated a yra1-AUA allele that encodes a G→A substitution (AUG to 
AUA) in the translation initiation codon. This mutation eliminated Yra1p production and 
resulted in a complete loss of YRA1 function, as assessed by western blotting analysis and 
a genetic complementation assay (data not shown). We cloned the yra1-AUA allele, as 
well as the wild-type YRA1 gene, into low-copy plasmids and introduced these plasmids 
into EDC3 and edc3Δ strains that contain chromosomal deletions of both YRA1 and YRA2 
but harbor YRA2 on a high-copy plasmid. YRA2 codes for Yra2p, a yeast homolog of 
Yra1p that has been previously shown to suppress the lethality of YRA1 deletion when 
overexpressed (Zenklusen et al., 2001). Wild-type YRA1 generated low levels of YRA1 
mRNA in both EDC3 and edc3Δ cells and high levels of YRA1 pre-mRNA in an edc3Δ 
background (Figure 2.5E). These data show that introduction of wild-type YRA1 into 
yra1Δ strains recapitulated YRA1 autoregulation, and suggest that overexpression of 
YRA2 has little or no effect on YRA1 autoregulation. Compared to wild-type YRA1, the 
yra1-AUA allele generated 6-fold higher levels of YRA1 mRNA in both EDC3 and edc3Δ 
cells, and generated a 3-fold lower level of YRA1 pre-mRNA in edc3Δ cells (Figure 2.6E). 
These data indicate that YRA1-AUA pre-mRNA is efficiently spliced in both yra1Δ strains, 
an effect attributable to the absence of Yra1p, not the AUA mutation. We justify the latter 
conclusion because, when the yra1-AUA allele was introduced into EDC3 and edc3Δ 
strains that contain the endogenous YRA1 gene, the yra1-AUA allele behaved the same as 
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wild-type YRA1, in that yra1-AUA pre-mRNA was inefficiently spliced and a high level 
of this pre-mRNA accumulated in an edc3Δ background (Figure 2.6E). Taken together, 
these results indicate that, in the absence of Yra1p, YRA1 pre-mRNA is efficiently spliced, 
suggesting that Yra1p regulates its level of expression by inhibiting splicing of its pre-
mRNA. 
A role for Yra1p in the inhibition of its pre-mRNA splicing raised the question of 
its primary function in YRA1 autoregulation. One possibility is that Yra1p primarily 
promotes YRA1 pre-mRNA export and, as a consequence, inhibits YRA1 pre-mRNA 
splicing. A second possibility is that Yra1p primarily inhibits YRA1 splicing and, as a 
consequence, promotes or commits the pre-mRNA to nuclear export. A third possibility 
is that Yra1p is required for both splicing inhibition and active nuclear export. To 
distinguish these possibilities, we tested whether cis-mutations that inhibit YRA1 pre-
mRNA splicing can bypass the regulatory function of Yra1p. Accordingly, we introduced 
the same m5SS, mBB2, and m3SS mutations described above into the 5΄ splice site, the 
branch-point region, and the 3΄ splice site of the yra1-AUA intron. We cloned the 
resulting alleles into low-copy plasmids that were then introduced into the EDC3 and 
edc3Δ strains that contain chromosomal deletions of both YRA1 and YRA2 but harbor 
YRA2 on a high-copy plasmid. Northern analysis revealed that the m5SS and mBB2 
mutations fully restored yra1-AUA pre-mRNA to wild-type regulation but the m3SS 
mutation did not (Figure 2.6E). These data show that cis mutations (m5SS and mBB2) 
that inhibit the first but not the second step of YRA1 pre-mRNA splicing completely 
suppress the YRA1 autoregulation defect caused by Yra1p elimination, thus bypassing the 
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regulatory function of Yra1p. These results indicate that the primary autoregulatory 
function of Yra1p is to inhibit YRA1 pre-mRNA splicing, thus committing the pre-mRNA 
to nuclear export, and that Yra1p likely inhibits at or before the first step of YRA1 pre-
mRNA splicing.  
 
Autoregulation of YRA1 Expression Involves Mex67p 
Mex67p, a general mRNA export factor in yeast, interacts genetically and physically with 
Yra1p (Strasser and Hurt, 2000; Zenklusen et al., 2001). To assess whether Mex67p plays 
a role in YRA1 autoregulation, we utilized the ts mex67-5 allele and analyzed the effect of 
its inactivation on the accumulation of YRA1 pre-mRNA and mRNA in edc3Δ cells. 
mex67-5edc3Δ and MEX67edc3Δ cells grown at 25°C accumulated comparable levels of 
YRA1 pre-mRNA and mRNA (Figure 2.7A, compare t0 samples). At 37°C, the same 
strains exhibited dramatically different YRA1 expression patterns (Figure 2.7A), including: 
a) MEX67edc3Δ cells had slightly decreased but sustained levels of YRA1 pre-mRNA 
during a 24 min time course, but the same transcript decreased rapidly in mex67-5edc3Δ 
cells; b) MEX67edc3Δ cells had significantly lower levels of YRA1 mRNA at 24 min than 
at 0 min whereas mex67-5edc3Δ cells accumulated similar mRNA levels at both time 
points; and c) at the 12 and 24 min time points mex67-5edc3Δ cells accumulated a novel 
YRA1 transcript migrating slightly slower than normal YRA1 mRNA. Since this RNA 
species hybridized with an mRNA-specific oligonucleotide that spanned the junction of 
YRA1 exons 1 and 2 and also to an oligonuclotide complementary to sequences 92-nt 
downstream of the mapped canonical poly(A) site (Figure 2.7B), we conclud that it was 
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comprised of YRA1 mRNA with an extended 3΄-UTR. MEX67edc3Δ cells also 
accumulated a YRA1 RNA species of similar size at 12 and 24 min. However, this RNA 
hybridized to an intron-specific oligonucleotide, but not to the mRNA-specific 
oligonucleotide and the 3΄-UTR oligonucleotide (data not shown), suggesting that it is a 
3΄ to 5΄ decay intermediate of YRA1 pre-mRNA.  
Our observation that, at 37°C, mex67-5edc3Δ cells accumulated lower levels of 
YRA1 pre-mRNA but higher levels of YRA1 mRNA than the MEX67edc3Δ strain, and 
that mex67-5edc3Δ cells also accumulated YRA1 mRNA with an extended 3΄-UTR, 
suggests that inactivation of Mex67p alters nuclear YRA1 pre-mRNA metabolism. For 
example, Mex67p might inhibit YRA1 pre-mRNA splicing and commit the pre-mRNA to 
nuclear export such that inactivation of Mex67p would allow a fraction of newly 
synthesized YRA1 pre-mRNA normally committed to nuclear export to adopt an 
alternative fate and proceed to the splicing pathway. Consistent with this interpretation, 
we found that the effects of inactivating Mex67p on YRA1 mRNA expression were 
dependent on ongoing transcription since simultaneous inhibition of transcription with 
thiolutin and thermal inactivation of Mex67p function resulted in decreased expression of 
YRA1 mRNA and eliminated the formation of YRA1 mRNA with extended 3΄-UTRs 
(Figure 2.7C). Additional control experiments revealed that inactivation of Mex67p did 
not affect the level of the CYH2 pre-mRNA, an NMD substrate. At 37°C, mex67-5edc3Δ 
and MEX67edc3Δ strains accumulated similar levels of this pre-mRNA as well as its 
mRNA product (Figure 2.7A). These results indicate that the effect of Mex67p 
inactivation on pre-mRNA splicing is specific for YRA1 pre-mRNA.  
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Thermal inactivation of Mex67p resulted in almost complete disappearance of 
YRA1 pre-mRNA in mex67-5edc3Δ cells in 24 min (Figure 2.7A). While this rapid 
disappearance is at least partially attributable to a loss of Mex67p inhibition of YRA1 pre-
mRNA splicing, other mechanisms must be operative. Since, in steady-state, YRA1 pre-
mRNA is predominantly cytoplasmic in edc3Δ cells (Figure 2.3A) and since, in a 
MEX67edc3Δ background, YRA1 pre-mRNA has a half-life of ≥60 min (Figure 2.1B), the 
rapid disappearance of YRA1 pre-mRNA in mex67-5edc3Δ cells must be due principally 
to accelerated cytoplasmic decay of the pre-mRNA. In turn, this suggests that Mex67p is 
a component of the cytoplasmic YRA1 pre-mRNP and functions to repress YRA1 pre-
mRNA translation and thus inhibit NMD. To test this hypothesis, we assessed whether 
deletion of UPF1, DCP1, or XRN1 could restore the steady-state levels of YRA1 pre-
mRNA in mex67-5edc3Δ cells at 37°C. Indeed, Figure 2.7D shows that deletion of UPF1 
restored YRA1 pre-mRNA levels at early time points and deletion of DCP1 or XRN1 
restored YRA1 pre-mRNA levels at almost all time points. These results indicate that 
inactivation of Mex67p also triggers rapid cytoplasmic degradation of YRA1 pre-mRNA 
by NMD. Our observation that deletion of UPF1 resulted in a partial restoration and 
deletion of DCP1 or XRN1 results in a complete restoration of YRA1 pre-mRNA levels at 
37°C in mex67-5 edc3Δ cells suggests that, when NMD is inactivated, the YRA1 pre-
mRNA is degraded by an alternative mechanism, most likely the general 5΄ to 3΄ decay 
pathway, as we have observed previously for other nonsense-containing mRNAs (He et 
al., 2003). Taken together, the data of Figure 2.7 show that inactivation of Mex67p 
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promotes YRA1 pre-mRNA splicing and triggers rapid cytoplasmic degradation of the 
pre-mRNA by NMD.  
 
YRA1 Pre-mRNPs are Exported to the Cytoplasm by the Crm1p-mediated Export 
Pathway 
Genome-wide two-hybrid analyses have identified an interaction between Edc3p and 
Crm1p (Ito et al., 2001), a result that we have confirmed (Figure 2.8A). Since the human 
Crm1p homolog is implicated in the nuclear export of unspliced or incompletely spliced 
HIV RNAs in mammalian cells (Cullen, 2003a), the yeast Edc3p:Crm1p interaction 
suggested the possibility that Crm1p is involved in YRA1 pre-mRNA nuclear export. To 
assess the physiological relevance of the Edc3p:Crm1p interaction, we used yeast strains 
harboring the leptomycin-sensitive CRM1-T539C allele and analyzed the effect of 
inhibition of Crm1p function by leptomycin treatment. In both EDC3 and edc3Δ cells, 
leptomycin treatment resulted in increased accumulation of YRA1 mRNA and the 
appearance of a novel YRA1 mRNA with an extended 3΄-UTR (Figure 2.8A and 2.8B). 
The increased accumulation of YRA1 mRNA and the appearance of YRA1 mRNA with an 
extended 3΄-UTR in both EDC3 and edc3Δ cells after leptomycin treatment are likely to 
reflect one of the consequences of inhibition of Crm1p-mediated YRA1 pre-mRNA 
nuclear export. A simple interpretation of these results is that, when Crm1p function is 
inhibited, a fraction of newly synthesized YRA1 pre-mRNA that is normally committed to 
nuclear export adopts an alternative fate and proceeds to the splicing pathway. Consistent 
with this interpretation, we found that the effect of leptomycin treatment on YRA1 mRNA 
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expression is dependent on both ongoing transcription and splicing of YRA1 pre-mRNA 
(Figures 2.8C, 2.8D and 2.8E).  
Leptomycin treatment also resulted in the accumulation of longer YRA1 pre-
mRNA transcripts in both EDC3 and edc3Δ cells (Figure 2.8E). These longer pre-mRNA 
species hybridize with an oligonuclotide probe downstream of the mapped canonical 
poly(A) site (Figure 2.8B), indicating that  these transcripts have an extended 3΄-UTR. 
The accumulation of mRNAs with extended 3΄-UTRs has been observed in many yeast 
mRNA export mutant strains and is a general characteristic of mRNA nuclear export 
defects (Forrester et al., 1992; Hammell et al., 2002). Interestingly, as observed for other 
mRNAs, YRA1 pre-mRNAs with extended 3΄-UTRs are also the target of the nuclear 
exosome surveillance system (Torchet et al., 2002). When Crm1p is functional, 
elimination of the exosome component Rrp6p had no effect on levels of the pre-mRNA 
transcripts encoded by either endogenous wild-type YRA1 or by the exogenous yra1-
mBB2 allele in both EDC3 and edc3Δ backgrounds (Figures 2.3C and 2.8E-t0). In 
contrast, when Crm1p function is inhibited by leptomycin, deletion of RRP6 resulted in 
increased accumulation of YRA1 and yra1-mBB2 pre-mRNA transcripts with an extended 
3΄-UTR in both EDC3 and edc3Δ backgrounds (Figure 2.8E). These results show that 
inhibition of Crm1p function leads a fraction of newly synthesized YRA1 pre-mRNAs 
that normally commit to nuclear export to adopt yet another alternative fate and be 
degraded by the nuclear exosome.  
In both EDC3 and edc3Δ backgrounds, inhibition of Crm1p function by 
leptomycin treatment did not alter the metabolism of several other intron-containing pre-
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mRNAs and intron-lacking mRNAs (Figure 2.8A). These include the intron-containing 
CYH2 and MER3 pre-mRNAs that are substrates of the NMD pathway; the RPS28B 
mRNA, a second substrate of the Edc3p-mediated decay pathway; and the PGK1 and 
RPS28A mRNAs, substrates of the general 5΄ to 3΄ and 3΄ to 5΄ decay pathways. We thus 
conclude that YRA1 pre-mRNPs are transported to the cytoplasm by the Crm1p-mediated 
export pathway and that, when this pathway is inhibited, the pre-mRNA transcripts are 
trapped in the nucleus and either spliced to generate mRNA or degraded by the nuclear 
exosome. In contrast to inactivation of Mex67p, inhibition of Crm1p function by 
leptomycin did not alter the YRA1 pre-mRNA decay rate in edc3Δ cells (compare Figures 
2.8C and 2.1B), indicating that Crm1p function is not required for the cytoplasmic 
degradation of YRA1 pre-mRNA.  
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DISCUSSION 
 
YRA1 Pre-mRNA is a Cytoplasmic Substrate for Edc3p-mediated 5΄ to 3΄ Decay 
Intron-containing pre-mRNAs are generally processed or degraded within the nucleus 
and rarely enter the cytoplasm (Bousquet-Antonelli et al., 2000; Legrain and Rosbash, 
1989). In the limited instances where such export occurs these transcripts are often 
degraded by the translation-dependent NMD pathway (He et al., 2003; He et al., 1993; 
Vilardell et al., 2000). As shown here, the intron-containing YRA1 pre-mRNA is a notable 
exception to this rule. A sizeable fraction of YRA1 pre-mRNA can be exported to the 
cytoplasm and subsequently degraded via an NMD-independent 5΄ to 3΄ mechanism that 
requires the Dcp1p/Dcp2p decapping enzyme, the Xrn1p exoribonuclease, and a specific 
regulator, Edc3p.  
 The atypical localization of this decay pathway is surprising, but is consistent with 
the results of several independent approaches. Cytoplasmic localization of Edc3p-
mediated YRA1 pre-mRNA degradation follows from: a) the involvement of the 
Dcp1p/Dcp2p complex and Xrn1p, two cytoplasmic ribonucleases (Figure 2.2A), b) the 
in situ detection of YRA1 pre-mRNA in the cytoplasm of edc3Δ, dcp1Δ, or xrn1Δ cells 
(Figure 2.3A), c) the resistance of YRA1 pre-mRNA degradation to inactivation or 
depletion of the nuclear exonucleases, Rat1p or Rrp6p (Figures 2.3B and 2.3C), and d) 
the unchanged levels of YRA1 mRNA in edc3Δ cells (Figure 2.1), a result to be contrasted 
to the increased levels of mature mRNAs that generally follow the inhibition of intron-
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containing pre-mRNA degradation in the nucleus (Bousquet-Antonelli et al., 2000; 
Danin-Kreiselman et al., 2003). 
  
Edc3p Activates Decapping of YRA1 Pre-mRNA 
Our results indicate that Edc3p activates, but does not catalyze decapping of YRA1 pre-
mRNA. In light of the physical interactions between Edc3p and Dcp1p or Dcp2p (Gavin 
et al., 2002; Ho et al., 2002; Ito et al., 2001), this activation may reflect Edc3p 
recruitment of the decapping enzyme or one of its subunits. In the general 5΄ to 3΄ decay 
pathway, decapping requires the functions of Dhh1p, Pat1p, and the Lsm1-7p complex 
(Coller and Parker, 2004) and, in the NMD pathway, decapping requires the functions of 
Upf1p, Nmd2p/Upf2p, and Upf3p (He and Jacobson, 2001). Like Edc3p, all of these 
factors function as decapping activators (Coller and Parker, 2004). Edc3p-mediated 
decapping has several unique features, of which the most notable is its limited number of 
substrate transcripts. At present, we cannot exclude the possibility that Edc3p targets a 
much larger set of mRNAs that are underrepresented in conventional microarray analyses, 
e.g., transcripts lacking poly(A) tails. Another unique feature of Edc3p-mediated 
decapping is that it requires specific cis-regulatory elements in its target transcripts. For 
YRA1 pre-mRNA, we mapped the cis-element to its intron (Figure 2.4) and, in RPS28B 
mRNA, the cis-element has been localized to its 3΄ UTR (Badis et al., 2004). These 
sequence requirements indicate that Edc3p substrate specificity is likely dictated by a 
specific structure and/or composition of the target mRNPs. While specific mRNP 
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structures may also be required for other decapping activators, these structures do not 
appear to be mRNA-specific (Coller and Parker, 2004).  
 While our data and those of a previous study (Badis et al., 2004) demonstrate that 
decapping activation by Edc3p is transcript-specific, several observations also suggest 
that Edc3p may have a general function in decapping: a) Edc3p appears to exist in a 
complex with Dcp1p and Dcp2p in vivo (Gavin et al., 2002; Ho et al., 2002), b) Edc3p 
and Dcp1p have comparable numbers of molecules per cell (Huh et al., 2003), and c) 
simultaneous inactivation of Edc3p and mutation of DCP1 or DCP2 promotes synthetic 
or additive effects on both cell growth and decapping of reporter mRNAs (Kshirsagar and 
Parker, 2004). Given that mRNA decapping is likely to be a multi-step process in vivo 
(Coller and Parker, 2004), Edc3p may function at a step that is not rate-limiting for 
general mRNA decapping (Kshirsagar and Parker, 2004) or may have a function that is 
redundant with another component of the decapping complex.  
 
YRA1 Autoregulation: Yra1p Inhibits Pre-mRNA Splicing and Commits the 
Transcript to Nuclear Export 
Our observation that introduction of extra copies of the intron-containing YRA1 gene into 
EDC3 or edc3Δ strains altered neither the YRA1 mRNA level nor the Yra1p level in these 
cells but yielded a >10-fold, higher  level of YRA1 pre-mRNA in edc3Δ cells (Figure 2.4) 
confirms that  YRA1 autoregulates its own expression through a negative feedback loop 
(Preker et al., 2002; Rodriguez-Navarro et al., 2002) and further indicates that Edc3p-
mediated YRA1 pre-mRNA degradation is a component of YRA1 autoregulation. 
 66
 Further experiments defined the functional role of Yra1p in its autoregulation. 
Since inactivation or depletion of Yra1p resulted in increased accumulation of YRA1 
mRNA in EDC3 or edc3Δ cells, but diminished accumulation of YRA1 pre-mRNA in 
edc3Δ cells, Yra1p must inhibit YRA1 pre-mRNA splicing (Figures 2.6D and 2.6E). 
Moreover, since cis mutations (m5SS and mBB2) that inhibit the first but not the second 
step (m3SS) of YRA1 pre-mRNA splicing completely suppress the autoregulation defect 
caused by Yra1p depletion (Figure 2.6E), Yra1p must inhibit its pre-mRNA splicing at or 
before the first step of the splicing reaction. These observations also indicate that the sole 
function of Yra1p in its autoregulation is to inhibit YRA1 pre-mRNA splicing and that 
Yra1p per se is not required for nuclear export of its pre-mRNA. Combined with our 
observation that yra1-AUA pre-mRNA is efficiently exported to the cytoplasm in the 
presence of Yra1p, but is efficiently spliced in the nucleus in the absence of Yra1p 
(Figure 2.6E), these findings also suggest that Yra1p inhibits YRA1 pre-mRNA splicing 
by committing the transcript to nuclear export. A simple interpretation of these data is 
that YRA1 pre-mRNA splicing and nuclear export compete for common substrates and 
that, by enhancing nuclear export of its pre-mRNA, Yra1p inhibits its splicing.  
 
Autoregulatory Roles of the Intron and Exon1 
We have identified two functionally distinct cis-regulatory elements that are involved in 
YRA1 autoregulation: exon1 inhibits YRA1 pre-mRNA splicing and the intron is required 
for Edc3p-mediated YRA1 pre-mRNA degradation (Figures 2.4, 2.5, and 2.6). 
Unexpectedly, splicing autoregulation by exon1 was found to be dictated by its length, 
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not by specific sequences, and cis mutations that inhibit the first but not the second step 
of YRA1 pre-mRNA splicing completely suppress the autoregulation defect caused by the 
N84 deletion of exon1 (Figure 2.6). These findings indicate that: exon1 exerts its 
inhibitory function at or before the first step of the splicing reaction, the sole 
autoregulatory role of exon1 is to inhibit YRA1 pre-mRNA splicing, and exon1 per se is 
not required for nuclear export of YRA1 pre-mRNA. Further, the shared autoregulatory 
roles, as well as the identical patterns of genetic interactions with cis-acting mutations in 
YRA1 pre-mRNA, strongly suggest that Yra1p’s inhibitory function on YRA1 pre-mRNA 
splicing is mediated through exon1.  
The primacy of size, not sequence, for the splicing inhibition function of YRA1 
exon1 also indicates that the position of the YRA1 intron, rather than the intron itself, is 
the major determinant in YRA1 autoregulation. This contrasts with a previous conclusion 
that intron size is the major determinant in YRA1 autoregulation (Preker and Guthrie, 
2006). Although this discrepancy may reflect differences in experimental designs and 
assays for splicing efficiency, our conclusion is strongly supported by the following 
observations. First, internal deletions in exon1 can result in more than 8-fold increases in 
the level of YRA1 mRNA (Figure 2.6A), but internal deletions in the intron had little (<2-
fold) or no comparable effect (Figure 2.4E, and data not shown). Second, replacing the 
YRA1 intron with any of five other introns (from the CYH2, MER2, RPS51A, RPL25, or 
UBC8 transcripts) differing in size and splicing efficiency had little or no effect on YRA1 
mRNA levels (Figures 2.4B and 2.4C; (Rodriguez-Navarro et al., 2002). Third, an intron 
position effect on splicing has also been seen with pre-mRNAs derived from the MER2 
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gene and from an ACT1 reporter gene (Klinz and Gallwitz, 1985; Nandabalan and Roeder, 
1995).  
Our observation that the inhibitory function of YRA1 exon 1 on YRA1 pre-mRNA 
splicing is dependent on its length, but not specific sequences, suggested a kinetic 
component to YRA1 autoregulation. Given that Yra1p normally functions in an early 
stage of mRNA export and this function is linked to polymerase II transcription 
elongation through the THO complex (Strasser et al., 2002), this kinetic component is 
likely to reflect a time window in which Yra1p is recruited to the polymerase II 
elongation complex and loaded onto a nascent mRNP. Such loading may be dictated by 
both the rate of elongation and the nuclear Yra1p concentration and we suggest that, for 
intron-containing pre-mRNAs, co-transcriptional packaging of Yra1p onto a nascent 
mRNP likely promotes the recruitment of the mRNA export receptor Mex67p and thus 
inhibits spliceosome assembly. For YRA1 autoregulation, high Yra1p levels would thus 
favor the packaging of Yra1p into YRA1 pre-mRNPs, commit the pre-mRNA to nuclear 
export, and as a consequence, inhibit pre-mRNA splicing. Given that the vast majority of 
yeast introns are located at the 5΄ ends of their genes (Spingola et al., 1999), tight control 
of nuclear Yra1p levels could be an important mechanism that prevents premature 
nuclear export of intron-containing pre-mRNAs.  
  
Roles of Mex67p and Crm1p in YRA1 autoregulation 
Our data indicate that, in addition to Yra1p and Edc3p, YRA1 autoregulation also requires 
the functions of two general nuclear export factors, Mex67p and Crm1p. Since the 
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inactivation of Mex67p or Crm1p function both resulted in decreased accumulation of 
YRA1 pre-mRNA in edc3Δ cells, increased accumulation of normal YRA1 mRNA, and 
the appearance of YRA1 mRNA with an extended 3΄UTR in EDC3 and edc3Δ cells, it 
appears that Mex67p and Crm1p jointly promote YRA1 pre-mRNA nuclear export. Given 
that Mex67p is a general mRNA export receptor (Hieronymus and Silver, 2003; Hurt et 
al., 2000) and that Crm1p function is usually not required for mRNA export (Neville and 
Rosbash, 1999), the YRA1 pre-mRNA nuclear export requirement for both factors 
indicates that the YRA1 pre-RNP is exported to the cytoplasm by a mechanism that is 
distinct from the general Mex67p-mediated mRNA export pathway. Although the precise 
functions and the functional order of Mex67p and Crm1p in YRA1 pre-mRNA export are 
currently not clear, the facts that the function of Yra1p is linked to transcription 
elongation and that Yra1p physically interacts with Mex67p suggest that Mex67p is 
likely recruited earlier than Crm1p to YRA1 pre-mRNP. One possibility is that Yra1p first 
recruits Mex67p to nascent YRA1 pre-mRNP. However, the general mRNA export 
function of Mex67p is subsequently inhibited in this YRA1 pre-mRNP and Mex67p, in 
turn, serves as a unique adaptor to access the Crm1p-mediated export pathway. 
Consistent with this possibility is the observation that the Mex67p C-terminal domain 
contains a Rev-like NES and exhibits NES activity (Strasser et al., 2000).  
Our observation that inactivation of Mex67p, but not Crm1p, triggers rapid 
degradation of YRA1 pre-mRNA by NMD in edc3Δ cells indicates that Mex67p has a 
second function in YRA1 autoregulation, i.e., it may be a component of the cytoplasmic 
YRA1 pre-mRNP and impart Edc3p substrate specificity. Since inactivation of Mex67p 
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leads to rapid degradation of YRA1 pre-mRNA by NMD and activation of NMD is 
dependent on translation, these observations argue that Mex67p functions at least in part 
by repressing YRA1 pre-mRNA translation. The possibility that this mRNA export factor 
has a general role in mRNA translation is consistent with observations that. a) Mex67p 
shuttles between the nucleus and the cytoplasm (Segref et al., 1997), b) at steady-state, a 
significant fraction of Mex67p is localized to the cytoplasm and associated with 
polyribosomes (Segref et al., 1997; Windgassen et al., 2004), and c) the mex67-5 
mutation causes aberrant accumulation of Mex67p in the cytoplasm (Segref et al., 1997).   
 
A Model for YRA1 Autoregulation 
To integrate Yra1p-mediated splicing inhibition, Crm1p-mediated nuclear export, and 
Edc3p-mediated cytoplasmic degradation of YRA1 pre-mRNA, we propose the following 
model for YRA1 autoregulation: When nuclear Yra1p levels are low, YRA1 is transcribed 
into pre-mRNA that, in turn, is spliced to mRNA. The mature YRA1 mRNA is exported 
to the cytoplasm, translated to generate Yra1p, and the latter imported into the nucleus, 
recruited to elongating pol II, and then packaged into nascent mRNPs to serve a function 
in general mRNA export. However, when nuclear Yra1p levels reach a threshold, Yra1p 
is likely recruited to the YRA1 gene during an early phase of transcription elongation and 
packaged into nascent YRA1 pre-mRNPs. Yra1p then recruits Mex67p, inhibiting pre-
mRNA splicing and commiting the pre-mRNA to export. The pre-mRNA would then be 
exported to the cytoplasm by the Crm1p-dependent pathway where it would be degraded 
by the Edc3p-dependent pathway.  
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The molecular mechanism uncovered here for YRA1 autoregulation is reminiscent 
of Rev-mediated unspliced pre-mRNA nuclear export that is required for HIV replication 
(Cullen, 2003a). This observation suggests that Rev may target the same cellular 
component or pathway as Yra1p to promote nuclear pre-mRNA export. The existence of 
a specific cytoplasmic pathway dedicated to YRA1 pre-mRNA degradation also raises the 
question of the biological function of this pathway. In contrast to the general decay 
pathways that control mRNA levels, and the quality control pathways that eliminate 
aberrant transcripts, the Edc3p-mediated decay pathway may serve a regulatory function, 
e.g., it may utilize Crm1p-mediated YRA1 pre-mRNA export to regulate the level of a key 
nuclear factor or coordinate mRNA decay activity with other cellular processes.  
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EXPERIMENTAL PROCESURES 
 
Yeast Strains 
All strains used in this study are listed in Table 2.1. Strains containing deletions of EDC3, 
UPF1, DCP1, XRN1, SKI2, SKI7, CCR4, or RRP6 were constructed by gene replacement 
(Guthrie and Fink, 1991), using DNA fragments harboring the corresponding null alleles. 
Each genomic DNA deletion was confirmed by PCR analysis. Strains containing 
deletions of DHH1, PAT1, LSM1, or LSM7 were purchased from Open Biosystems. 
Strains harboring the temperature-sensitive rpb1-1, prt1-1, or sup45-2 alleles were 
constructed by the pop-in and pop-out technique (Guthrie and Fink, 1991). Strains 
harboring the temperature-sensitive yra1-1 allele were constructed by plasmid shuffling 
(Guthrie and Fink, 1991).  
 
Plasmids 
All plasmids used in this study are listed in Table 2.2. YRA1 exon1, intron, or exon2 
chimeric alleles were all constructed through in vivo recombination in yeast cells as 
described previously (He et al., 1996). YRA1 alleles harboring deletions of exon1, intron, 
or exon2 sequences, or containing insertions of a stem-loop structure, were generated by 
PCR and molecular cloning. YRA1 alleles harboring mutations in the YRA1 translation 
initiation codon, the 5΄ splice site, the branch-point region, or the 3΄ splice site were 
generated using the QuikChange Site-DirectedMutagenesis Kit (Stratagene). All YRA1 
alleles were confirmed by DNA sequencing.  
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Oligonucleotides 
The oligonucleotides used in this study were obtained from Operon, Inc., and are listed in 
Table 2.3. 
 
Cell Growth Conditions 
Cells were grown in YPD medium (Microarray analysis and Figures 2.1, 2.2, 2.3A, and 
2.7), or in synthetic complete (SC) medium lacking tryptophan (Figures 2.4, 2.5, 2.6A, 
2.6B, 2.6C, and 2.6E-right side), uracil (Figures 2.3B, 2.3C and 2.6D), histidine (Figure 
2.8B and 2.8D), uracil and tryptophan (Figure 2.6E-left side), or histidine and tryptophan 
(Figure 2.8E and 2.8F) to select for plasmids. Cultures (15 ml) not involving drug 
treatment or temperature shifts were grown at 30°C to an OD600 of 0.7 and harvested by 
centrifugation. Cell pellets were frozen on dry ice and then stored at -80°C until RNA 
was isolated. Cultures involving drug treatment were grown at 30°C to an OD600 of 0.7 in 
a large volume and then concentrated five-fold in the same medium. Where appropriate, 
the following were added to concentrated cultures: cycloheximide (100 µg/ml), 
leptomicin (100 ng/ml), or thiolutin (15µg/ml). Drug-treated cells (2ml) were harvested at 
different time points. For temperature shifts, cells were first grown at 25°C and then 
treated as described previously (He and Jacobson, 1995). 
 
Microarray Analysis 
Five independent expression profiling experiments were carried out for isogenic wild-
type (HFY114) and edc3Δ (CFY25) strains using Affymetrix Yeast Genome S98 Arrays. 
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Microarray procedures, including RNA isolation, cRNA preparation, microarray 
hybridization, and data analysis, were as previously described (He et al., 2003), with the 
following modifications: First, all microarrays were analyzed with Affymetrix 
Microarray Suite 5.0 software. Second, a transcript was considered to be differentially 
expressed if it met two of three previously defined criteria, i.e., it must have an absolute 
change threshold of 200 units and a change P value ≤0.05. The entire data set can be 
found at: http://jacobsonlab.umassmed.edu/cgi-bin/pubcontents.cgi?pubcontents=2006-
Feng.  
 
Yeast Two-hybrid Analysis 
Two-hybrid interactions between full-length Crm1p fused to the LexA DNA- binding 
domain and full-length Edc3p fused to the Gal4p activation domain were assayed as 
described previously (He et al., 1997).  
 
RNA Analysis 
RNA isolation and northern blotting procedures were as described previously (He and 
Jacobson, 1995). Transcript-specific signals were quantified with a Storm 
phosphorimager and normalized to levels of the 18S rRNA or SCR1 RNA, a stable RNA 
polymerase III transcript. RNA immunoprecipitations with monoclonal anti-2,2,7-
trimethylguanosine antibodies (Calbiochem) were performed as described previously (He 
and Jacobson, 2001). 
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Analysis of mRNA Decay Rate  
mRNA decay rates were measured as previously described (Herrick et al., 1990). RNA 
decay curves were generated by plotting log RNA levels versus the relative time of 
transcription shut off. k, the slope of the RNA decay curve, is determined by liear 
regression equation lnAt=lnA0-kt (A0 is the RNA concentration at time 0, At is the RNA 
concentration at time t after transcription shut off). t1/2=0.693/k.  
 
Protein Analysis 
Preparation of whole cell extracts and western blotting procedures were as described 
previously (Maderazo et al., 2000). Blots were probed with polyclonal antibodies targeted 
to Yra1p (a generous gift from Dr. Francoise Stutz, University of Geneve) or Pab1p, with 
the latter polypeptide serving as a loading control. 
 
In situ Hybridization 
RNA-FISH analysis was carried out using Cy3 and Cy5 fluorochrome-conjugated 
oligonucletides as described at http://www.singerlab.org/protocols/insitu_yeast.htm.
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FIGURE LEGENDS 
 
Figure 2.1. YRA1 Pre-mRNA is Selectively Stabilized in edc3Δ Cells   
(A) Northern analysis of YRA1 pre-mRNA and mRNA levels in EDC3 and edc3Δ cells.   
(B) Determination of YRA1 pre-mRNA and mRNA half-lives. Cultures of wild-type and 
edc3Δ cells harboring the rpb1-1 allele were shifted from 25°C to 37°C to inactivate 
transcription by RNA polymerase II and samples were taken for northern analysis at 
different times after the shift.  
In panels A and B blots were hybridized with probes complementary to YRA1 and SCR1 
transcripts, with the latter serving as a loading control.  
 
Figure 2.2. YRA1 Pre-mRNA is Degraded by Deadenylation-independent Decapping 
and 5΄ to 3΄ Exonucleolytic Digestion  
(A-C) Northern analysis of YRA1 pre-mRNA and mRNA in yeast strains containing 
deletions of genes encoding: (A) the principal NMD factors, a subunit of the decapping 
enzyme, or the 5΄ to 3΄ exoribonuclease; (B) decapping activators of the general 5΄ to 3΄ 
mRNA decay pathway; or (C) components of the cytoplasmic exosome or the major 
cytoplasmic deadenylase complex. Blots were hybridized to a SCR1 probe to serve as a 
loading control. 
(D) Analysis of the 5΄ cap status of the YRA1 pre-mRNA by anti-m7G 
immunoprecipitation and northern blotting. T: total input RNA, S: supernatant 
(uncapped), P: pellet (capped).   
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 Figure 2.3. Edc3p-mediated YRA1 Pre-mRNA Degradation Occurs in the 
Cytoplasm  
(A) Localization of YRA1 pre-mRNA in wild-type, edc3Δ, xrn1Δ, xrn1Δedc3Δ, dcp1Δ, 
and rrp6Δ strains by in situ hybridization (FISH). Intron probes were labeled with Cy3 
(green) and exon probes were labeled with Cy5 (red). DAPI labeling was used to identify 
the position of the nucleus. The corresponding merged and phase-contrast images are 
shown on the right side of the figure. 
(B) Effect of inactivation of Rat1p on levels of YRA1 pre-mRNA and mRNA. Rat1-1 or 
rat1-1xrn1Δ cells were grown in SC minus uracil medium at 25°C and then shifted to 
37°C for 30, 60, and 120 min. The levels of YRA1 pre-mRNA and mRNA were analyzed 
by northern blotting. 
(C) Effect of depletion of Rrp6 on the levels of YRA1 pre-mRNA and mRNA. Cells of the 
indicated genotypes were grown in YEPD medium and the levels of YRA1 pre-mRNA 
and mRNA in these cells were analyzed by northern blotting. Note that rrp6Δ cells 
accumulated higher levels of YRA1 mRNA than RRP6 cells. The simplest explanation for 
this observation is that, in wild-type cells, a fraction of the YRA1 pre-mRNA that is 
committed to the splicing pathway is degraded by the nuclear exosome. 
 
Figure 2.4. YRA1 Autoregulation Requires Edc3p and Two Distinct Regulatory 
Elements Localized in Exon1 and the Intron of YRA1 Pre-mRNA 
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(A) The effects of overexpressing intron-containing or intron-lacking YRA1 alleles on the 
levels of YRA1 pre-mRNA, mRNA, and Yra1p in EDC3 and edc3Δ strains.  
(B-D) Effects of replacing YRA1 exon1 (B), intron (C), and exon2 (D) with different 
sequences on YRA1 pre-mRNA and mRNA expression. A three-letter code was used to 
denote the order of exon1, intron, and exon2 of each chimeric construct, with the first 
letter of each of these genes specifying its origin. Y: YRA1, C: CYH2, M: MER2, R: 
RPS51A, and H: HIS3.   
(E) Effects of internal deletions in YRA1 exon1, intron, or exon2 on YRA1 pre-mRNA and 
mRNA expression. 
In panels B, C, D, and E YCp low-copy plasmids harboring the wild-type YRA1 gene, or 
a chimeric or deletion allele (depicted above the corresponding blots), were introduced 
into wild-type (1), upf1Δ (2), edc3Δ (3), or upf1Δ edc3Δ (4) strains and the levels of the 
respective pre-mRNAs and mRNAs encoded by these alleles were analyzed by northern 
blotting. The positions of chimeric or mutant pre-mRNAs and mRNAs are marked by Δ 
and *, respectively. Northern blots were hybridized to a SCR1 or an 18S rRNA probe to 
serve as loading controls. Pab1p served as a loading control for the western blot in panel 
A. 
  
Figure 2.5. Cis-acting Determinants of YRA1 Expression. Alterations of YRA1 pre-
mRNA and mRNA expression mediated by: (A) replacing YRA1 exon1 with MER2 
exon1, (B) replacing the YRA1 intron with the MER2 intron; and (C) replacing YRA1 
exon2 with MER2 exon2 were analyzed. YCp low-copy plasmids harboring a chimeric 
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allele (depicted above the corresponding blots) were introduced into wild-type (1), upf1Δ 
(2), edc3Δ (3), or upf1Δ edc3Δ (4) strains and the levels of the respective pre-mRNAs and 
mRNAs encoded by these alleles were analyzed by northern blotting. Blots A, B, and C 
were hybridized to MER2 exon1, intron, or exon2-specific probes, respectively. The 
positions of chimeric pre-mRNAs and mRNAs are indicated. Y: YRA1, and M: MER2. 
Blots were hybridized to a SCR1 probe to serve as a loading control. 
 
Figure 2.6. YRA1 Exon1 and Yra1p are cis- and trans-acting Negative Regulators of 
YRA1 Pre-mRNA Splicing 
(A-C) and (E) Effects on the levels of YRA1 pre-mRNA and mRNA engendered by: (A) 
internal deletions in YRA1 exon1; (B) substituting YRA1 exon1 coding sequences with 
their complementary sequences; (C) mutations in the 5΄ splice site, the 3΄ splice site, or 
the branchpoint region of the YRA1 intron; and (E) mutations in the translation initiation 
codon, 5΄ splice site, 3΄ splice site, and branchpoint region of the YRA1 intron in the 
presence or absence of Yra1p. Note that, in panel B, the replaced complementary 
sequence does not contain in-frame premature stop codons. 
In panels A, B, C, and E plasmids carrying the wild-type YRA1 gene, or one of the mutant 
YRA1 alleles (depicted above the corresponding northern blots), were introduced into 
different yeast strains and the levels of the respective pre-mRNAs and mRNAs encoded 
by these alleles were analyzed by northern blotting. The relevant genotypes of yeast 
strains used in these experiments are indicated (panel A) or denoted by numbers in panels 
B, C, and E: 1: wild-type, 2: upf1Δ, 3: edc3Δ, 4: upf1Δ edc3Δ, 5: EDC3 yra1Δ yra2Δ 
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(YEplac112-YRA2), and 6: edc3Δ yra1Δ yra2Δ (YEplac112-YRA2). In panel A, the levels 
of mutant YRA1 pre-mRNAs and mRNAs in edc3Δ cells were quantified, normalized to 
the corresponding wild-type pre-mRNA and mRNA levels, and graphed below the 
northern blot. Blots were hybridized to a SCR1 probe to serve as a loading control. 
(D) Cells of the indicated genotypes were grown in SC minus uracil medium at 25°C and 
then shifted to 37°C. The levels of YRA1 pre-mRNA and mRNA were analyzed by 
northern blotting. 
 
Figure 2.7. YRA1 Autoregulation Requires the Function of Mex67p 
 (A) Inactivation of Mex67p alters the levels of the YRA1, but not the CYH2 pre-mRNA 
and mRNA and also results in the accumulation of an atypical YRA1 RNA species in 
edc3Δ cells.  
(B) Inactivation of Mex67p promotes accumulation of YRA1 mRNA with an extended 3΄-
UTR. RNA samples from time points 0 and 24 min of the Mex67-5 EDC3 and Mex67-5 
edc3Δ strains shown in panel A were analyzed with a YRA1 oligonucleotide probe that 
spans exon1 and exon2 (Left), an oligonucleotide probe downstream of the YRA1 
translation termination codon (Middle), or an oligonucleotide probe downstream of the 
canonical poly(A) addition site (Right).  
(C) The effects of Mex67p inactivation on YRA1 mRNA level and the accumulation of 
YRA1 mRNA with an extended 3΄-UTR requires ongoing transcription.  
(D) Deletion of UPF1, DCP1 or XRN1 restores YRA1 pre-mRNA levels at 37°C in 
mex67-5 edc3Δ cells.  
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In panels A, C, and D, yeast strains of the indicated genotypes were grown at 25°C and 
then shifted to 37°C and the levels of YRA1 or CYH2 transcripts were analyzed by 
northern blotting. In panel C, thiolutin was added to cell cultures just before the 
temperature shift. A putative 3΄ to 5΄ decay intermediate of YRA1 pre-mRNA detected in 
the MEX67edc3Δ strain in panel A is marked by *. Blots were hybridized to a SCR1 
probe to serve as a loading control. 
 
Figure 2.8. Crm1p Mediates YRA1 Pre-mRNP Export to the Cytoplasm 
(A) Crm1p Interacts With Edc3p in the Yeast Two-hybrid System. Yeast plasmids 
harboring LexA(DB)-CRM1 and Gal4(AD)-EDC3 fusions were co-transformed into the 
L40 tester strain. Transformants were selected and the β-galactosidase activity of 
individual transformants was assayed on plates containing X-Gal.  
(B) Inhibition of Crm1p function increases expression of YRA1 mRNA, but slightly 
decreases expression of other control RNAs including the CYH2 and MER3 pre-mRNAs, 
and the RPS28A, RPS28B, and PGK1 mRNAs 
(C) Inhibition of Crm1p promotes accumulation of YRA1 pre-mRNA and mRNA with 
extended 3΄-UTRs. RNA samples from the indicated time points of the EDC3 and edc3Δ 
strains shown in panel A were analyzed with the same set of oligonucleotide probes used 
in Figure 2.7B.   
(D-E) Leptomycin-promoted increases in YRA1 mRNA levels and the accumulation of 
YRA1 mRNA with an extended 3΄-UTR requires ongoing transcription (D) and YRA1 pre-
mRNA splicing (E). 
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(F) YRA1 pre-mRNA defective in splicing becomes a target of the nuclear exosome when 
Crm1p function is inhibited. 
In panels B, D, E, and F, yeast strains of the indicated genotypes (all harboring the 
CRM1-T539C allele) were treated with leptomycin and the effect on YRA1 pre-mRNA 
and mRNA were analyzed by northern blotting. In panel D, thiolutin and leptomycin 
were simultaneously added to EDC3 and edc3Δ cells. In panel E, a YCp plasmid 
harboring the YRA1 gene or its yra1-m5SS allele, as well as the empty vector, were 
introduced into EDC3 and edc3Δ strains. In panel F, a YCp plasmid harboring the yra1-
mBB2 allele was introduced into yeast strains of the indicated genotypes. Blots were 
hybridized to a SCR1 or an 18S rRNA probe to serve as loading controls. 
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TABLE 2.1. Yeast Strains Used in this Study
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TABLE 2.2. Plasmids Used in this Study
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TABLE 2.3. Oligonucleotides Used in this Study
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TABLE 2.4. Transcripts Differentially Expressed in edc3Δ Cells 
Five independent expression profiling experiments were carried out with wild-
type (EDC3) and edc3Δ strains. Our data analysis indicates that only five 
transcripts (represented by seven probe sets) are differentially expressed in the 
edc3Δ strain. The raw signal values of each of these probe sets in different 
experiments (A, B, C, E, and G) are shown in the table.
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Edc3p-mediated Cytoplasmic YRA1 Pre-mRNA 
Degradation Requires Multiple Intronic Modular 
Elements, Translational Repression, and Mex67p 
 
 
 
Running title: cis and trans regulation of Edc3p-mediated  
YRA1 pre-mRNA decay 
 
 
 102
SUMMARY 
 
mRNA decay pathways regulate gene expression and ensure transcript quality control, 
two principles illustrated by Edc3p-mediated cytoplasmic degradation of yeast YRA1 pre-
mRNA. Here, we have delineated the cis- and trans-regulators of this transcript-specific 
decay mechanism. Our experiments revealed five structurally distinct but functionally 
interdependent modular elements in the YRA1 intron, of which two control Edc3p 
substrate specificity and three mediate translational repression of YRA1 pre-mRNA. We 
find that translational repression requires Mex67p, but not Edc3p, and serves to enhance 
the Edc3p substrate specificity by preventing YRA1 pre-mRNA from becoming a 
substrate for nonsense-mediated mRNA decay (NMD). Degradation of YRA1 pre-mRNA, 
an integral part of YRA1 autoregulation, thus appears to proceed through a series of 
ordered events, including translational repression, substrate recognition by Edc3p, 
recruitment of the Dcp1p/Dcp2p decapping enzyme, and activation of decapping.  
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INTRODUCTION 
 
mRNA degradation controls the level of gene expression and ensures transcript quality 
control. In the yeast Saccharomyces cerevisiae, degradation of wild-type mRNAs 
generally proceeds from poly(A) shortening to either decapping and 5΄ to 3΄ 
exonucleolytic digestion or to exosome-mediated 3΄ to 5΄ decay (Anderson and Parker, 
1998; Cao and Parker, 2001; Coller and Parker, 2004; Garneau et al., 2007; Mitchell et al., 
1997). Yeast mRNAs containing premature translation termination codons are degraded 
by nonsense-mediated mRNA decay (NMD), a mechanism for deadenylation-
independent entry into either the 5΄ to 3΄ or 3΄ to 5΄ decay pathways (Amrani et al., 2006a; 
Cao and Parker, 2003; Mitchell and Tollervey, 2003; Muhlrad and Parker, 1994). Intron-
containing pre-mRNAs are normally retained and processed in the nucleus (Bousquet-
Antonelli et al., 2000; Kufel et al., 2004; Moore, 2002), but are sometimes exported to the 
cytoplasm and degraded by the NMD pathway as a consequence of in-frame termination 
codons present in the introns (He et al., 1993; Vilardell et al., 2000). However, we have 
recently shown that the intron-containing YRA1 pre-mRNA evades the NMD pathway in 
the cytoplasm and is degraded by a transcript-specific decay pathway mediated by the 
decapping activator, Edc3p (Dong et al., 2007). Genome-wide microarray analysis has 
indicated that this Edc3p-mediated decay pathway principally targets only two transcripts, 
YRA1 pre-mRNA and RPS28B mRNA (Badis et al., 2004; Dong et al., 2007).  
The substrate status of a transcript for the different decay pathways can be 
regulated by specific cis-acting elements and their respective trans-regulatory RNA-
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binding factors. The former include the extensively characterized AU-rich and UG-rich 
elements present in the 3΄-untranslated regions (3΄-UTRs) of diverse eukaryotic mRNAs, 
sequences whose interacting proteins can accelerate transcript-specific decay by 
recruitment of the PARN and Ccr4p deadenylases, the exosome, or the Dcp1p/Dcp2p 
decapping enzyme (Anderson et al., 2006; Barreau et al., 2005; Goldstrohm et al., 2007; 
Mukherjee et al., 2002). For RPS28B mRNA, a stem-loop structure in its 3΄-UTR was 
shown to bind Rps28bp, which, in turn, interacted with Edc3p to recruit the decapping 
enzyme (Badis et al., 2004).  
Edc3p-mediated YRA1 pre-mRNA degradation is dependent on the presence of 
the YRA1 intron and appears to require the function of the general mRNA export factor 
Mex67p (Dong et al., 2007). Here, we have dissected the intronic decay-regulating 
element and the role of Mex67p in Edc3p-mediated YRA1 pre-mRNA decay. Our 
experiments delineated five structurally distinct but functionally interdependent modules. 
Two modules dictate Edc3p substrate specificity and are designated as Edc3p responsive 
elements (EREs). The other three modules, designated as translational repression 
elements (TREs), inhibit the translation of YRA1 pre-mRNA. This translational repression 
requires Mex67p, but not Edc3p, and prevents YRA1 pre-mRNA from becoming a 
substrate for the NMD pathway. 
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RESULTS 
 
YRA1 Pre-mRNA is Translationally Repressed by a Mechanism Independent of 
Edc3p Activity 
YRA1 pre-mRNA contains multiple in-frame nonsense codons in its intron and, as such, 
could be considered to be a typical NMD substrate when present in the cytoplasm (He et 
al., 2003; He et al., 1993). Nevertheless, upon export from the nucleus, this pre-mRNA is 
degraded by the Edc3p-mediated decay pathway, not the NMD pathway. Since activation 
of NMD is dependent on translation, the NMD resistance of YRA1 pre-mRNA could be 
attributable to translational repression of the transcript. Moreover, since YRA1 pre-mRNA 
is still resistant to NMD in the absence of Edc3p (Dong et al., 2007), the hypothetical 
translational repression mechanism must not require Edc3p. To assess these possibilities, 
we utilized sucrose gradient fractionation to analyze polyribosome profiles of 
cytoplasmic extracts derived from wild-type and edc3Δ strains, and then determined the 
distribution of YRA1 pre-mRNA in these gradients by northern blotting. As shown in 
Figure 3.1A, the majority of the YRA1 pre-mRNA population in wild-type cells was 
present in the non-polysomal mRNP fractions (70%), with only modest representation in 
the polyribosome fractions (30%). In contrast, most of the YRA1 mRNA (75%) was 
associated with the polyribosome fractions and only 25% was located in the mRNP 
fractions. These results suggest that YRA1 pre-mRNA is indeed translationally repressed 
in wild-type cells whereas YRA1 mRNA is not. Deletion of EDC3 did not affect the 
overall polyribosome profile and only mildly altered the distribution of YRA1 pre-mRNA 
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in the gradient (Figure 3.1B). In edc3Δ cells, the majority (64%) of pre-mRNA transcripts 
was still present in the mRNP fractions. Likewise, the distribution of YRA1 mRNA was 
essentially unaffected by deletion of EDC3. In control experiments, deletion of EDC3 did 
not alter the distribution of the CYH2 mRNA. CYH2 mRNA was predominantly localized 
to polyribosomal fractions in both wild-type and edc3Δ extracts (data not shown). These 
results indicate that, in spite of its cytoplasmic localization (Dong et al., 2007), YRA1 pre-
mRNA accumulating in wild-type or edc3Δ cells is translationally repressed, and Edc3p 
plays little, if any, role in establishing this repression.  
 
Edc3p-mediated YRA1 Pre-mRNA Degradation Does Not Require Translation  
The observed translational repression of YRA1 pre-mRNA suggests that Edc3p-mediated 
YRA1 pre-mRNA degradation occurs independently of translation. To test this idea, we 
carried out two sets of experiments. First, we examined the effects of trans inhibition of 
translation initiation, elongation, or termination on YRA1 pre-mRNA accumulation. In 
these experiments, initiation was inhibited by using the temperature-sensitive prt1-1 
allele to inactivate Prt1p, a component of the translation initiation factor eIF3 complex 
(Keierleber et al., 1986); elongation was inhibited by treating cultures with the drug 
cycloheximide (Zhang et al., 1997); and termination was inhibited by using the 
temperature-sensitive sup45-2 allele to inactivate Sup45p, the yeast paralog of eukaryotic 
release factor 1 (eRF1) (Stansfield et al., 1997). We evaluated the effects of each of these 
three translation blocks in both EDC3 and edc3Δ backgrounds and found that none of 
them affected the accumulation of YRA1 pre-mRNA. EDC3 strains all accumulated low 
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levels of YRA1 pre-mRNA before or after translational inhibition and edc3Δ strains all 
accumulated high levels of YRA1 pre-mRNA before or after any of the three translation 
blocks (Figure 3.2A). As controls, we found that each of the three translation blocks 
caused 2- to 5-fold increases in the expression of nonsense-containing can1-100 and 
ade2-1 mRNAs (data not shown). These results show that inhibition of any of the three 
basic steps in translation has no effect on the degradation of YRA1 pre-mRNA and that, 
even when general translation is inhibited, YRA1 pre-mRNA is still degraded in an 
Edc3p-dependent manner.  
Second, we examined whether inclusion of a cis-acting inhibitor of translation 
initiation in the 5΄-UTR of YRA1 pre-mRNA has any effect on the decay of that transcript. 
In this experiment, we inserted a stem-loop structure known to inhibit translation 
initiation (Beelman and Parker, 1994) 31 nt upstream of the YRA1 initiator AUG and 
analyzed the steady-state levels of the resulting SL31-YRA1 pre-mRNA in wild-type, 
upf1Δ, edc3Δ, and upf1Δedc3Δ cells.  Northern blotting analyses indicated that the SL31-
YRA1 pre-mRNA behaved like the wild-type pre-mRNA, i.e., it accumulated to low 
levels in wild-type or upf1Δ cells, but increased 5-fold in edc3Δ or upf1Δedc3Δ cells 
(Figure 3.2C). As a control, we also inserted the stem-loop structure into the 5΄-UTR of 
the yra1 C-775 allele. This allele contains a large 5΄ deletion of the YRA1 intron and 
codes for a pre-mRNA that is degraded by the NMD pathway but not by the Edc3p-
mediated pathway (Figure 3.2C). As expected, SL31-C-775 pre-mRNA containing this 
stem-loop structure was stabilized more than 3-fold in cells with wild-type NMD function 
(Figure 3.2C). These data show that inclusion of a cis-acting inhibitor of translation in the 
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5΄-UTR of YRA1 pre-mRNA does not affect its decay behavior. Collectively, the 
experiments utilizing cis- or trans-inhibition of protein synthesis indicate that Edc3p-
mediated YRA1 pre-mRNA degradation does not require concomitant translation of the 
transcript and suggest that translational repression may be an important component of 
Edc3p-mediated YRA1 pre-mRNA decay.  
Interestingly, cis and trans inhibition of translation differentially affected the 
degradation of YRA1 mRNA. Cis-inhibition of initiation or trans-inhibition of elongation 
promoted stabilization of the YRA1 mRNA, whereas trans-inhibition of initiation or 
termination appeared to destabilize the same transcript (Figures 3.2A and 3.2C). This 
result indicates that different modes of translational inhibition can have different 
consequences for mRNA stability, a conclusion borne out by genome-wide analyses of 
transcript levels in prt1-1, sup45-2, and cycloheximide-treated cells (FH, SD, C. Li, and 
AJ, manuscript in preparation).  
 
Edc3p-mediated YRA1 Pre-mRNA Degradation Requires Multiple Elements of the 
YRA1 Intron  
Replacing the YRA1 intron with the intron of the CYH2, MER2 or RPS51A genes yields, 
in each case, a pre-mRNA that is degraded by the NMD pathway (Dong et al., 2007). 
This intron dependence of Edc3p-mediated YRA1 pre-mRNA degradation, as well as the 
observation that YRA1 pre-mRNA is translationally repressed, suggests that the YRA1 
intron may have two cytoplasmic functions, i.e., repressing pre-mRNA translation and 
recruiting Edc3p to YRA1 pre-mRNPs. To delineate the cis-acting elements involved in 
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these potential regulatory functions, we generated a set of YRA1 pre-mRNA transcripts 
harboring 3΄ or 5΄ deletions of the YRA1 intron and analyzed the effects of each of the 
intron deletions on the steady-state levels of YRA1 pre-mRNA in wild-type, upf1Δ, edc3Δ, 
and upf1Δedc3Δ cells. Each of the mutant YRA1 pre-mRNA transcripts contain in-frame 
nonsense codons and we, therefore, included upf1Δ strains in these analyses because 
some intron deletions that inactivate Edc3p-mediated decay may simultaneously render a 
transcript sensitive to NMD.  
Deletions from the 3΄ end of the intron yielded three distinct pre-mRNA decay 
phenotypes. First, deletions up to nt 744 (including constructs N-942, N-852, N-771, N-
753, and N-744; Figure 3.3A) left the YRA1 pre-mRNA decay phenotypes unchanged. 
Much like full-length wild-type YRA1 pre-mRNA, the pre-mRNA transcripts encoded by 
these alleles showed increased accumulation (at least 5-fold) only in edc3Δ and 
upf1Δedc3Δ cells (Figure 3.3B), indicating that these transcripts are still degraded 
exclusively by the Edc3p-mediated pathway. Second, further deletions from nt 744 to nt 
372 (including constructs N-711, N-543, N-399, and N-372; Figure 3.3A) resulted in 
partial activation of NMD without complete elimination of Edc3p-mediated decay. The 
pre-mRNA transcripts encoded by these alleles showed modest increases in upf1Δ or 
edc3Δ strains, but exhibited dramatic increases in the upf1Δedc3Δ strain (Figure 3.3C), 
indicating that these transcripts are degraded by either the Edc3p pathway or the NMD 
pathway. Since activation of NMD requires translation, these results suggest that 
sequences 5΄ of nt 744 of the YRA1 intron are not required for the Edc3p response per se, 
but are required for repressing YRA1 pre-mRNA translation, thus inhibiting NMD. 
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Finally, further deletions from nt 372 (including constructs N-342 and N-312, Figure 
3.3A) resulted in full activation of NMD and the elimination of Edc3p-mediated decay. 
The pre-mRNA transcripts encoded by these alleles showed increased accumulation only 
in upf1Δ and upf1Δedc3Δ cells (Figure 3.3D), indicating that these transcripts are 
degraded exclusively by the NMD pathway. These results suggest that sequences 5΄ of nt 
372 of the YRA1 intron are required for the Edc3p response. Since the smallest transcript 
capable of responding to Edc3p is that derived from construct N-372, which contains 
intron sequences from nt 286-372, this region must contain a ERE and we designate this 
segment as module A.   
Deletions from the 5΄ end of the intron, up to nt 559 (including constructs C-397, 
C-544, C-549, C-553, and C-559; Figure 3.4A), did not affect the YRA1 pre-mRNA 
decay phenotype. All of the pre-mRNA transcripts encoded by these alleles accumulated 
to higher levels only in edc3Δ and upf1Δedc3Δ cells (Figure 3.4B), indicating that these 
transcripts are degraded exclusively by the Edc3p pathway. Further 5΄ deletions, from nt 
559 to nt 673 of the intron (including constructs C-565, C-574, C-625, C-637, C-649, C-
661, and C-673; Figure 3.4A), eliminated the Edc3p response. Interestingly, and in sharp 
contrast to the 3΄ deletions described above, these deletions did not result in the activation 
of NMD. The pre-mRNA transcripts encoded by these alleles accumulated to higher 
levels than the full-length YRA1 pre-mRNA in wild-type cells, but exhibited similar 
levels in all four strains (Figure 3.4C). These results indicate that the region between nt 
559-673 of the YRA1 intron is required for triggering Edc3p-mediated decay. This 
segment must also contain an ERE and we designate this region as module B.  
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Further 5΄ deletions, from nt 673 to 943 (including constructs C-679, C-685, C-
715, C-853, and C-943; Figure 3.4A) resulted in the activation of NMD.  The pre-mRNA 
transcripts encoded by these alleles maintained the same levels in wild-type and edc3Δ 
cells, but increased in abundance 2- to 5-fold in upf1Δ and upf1Δedc3Δ cells (Figure 
3.4D). These results suggest that these transcripts are primarily degraded by NMD and 
indicate that sequences downstream of nt 673 might function in repressing YRA1 pre-
mRNA translation and thus inhibit the NMD pathway. Since the 3΄ deletion analyses 
suggested that sequences upstream of nt 744 inhibit NMD, the region from nt 673-744 is 
most likely involved in repressing YRA1 pre-mRNA translation. Accordingly, we 
consider it to function as a TRE and designate this region as module C.  
Taken together, we identified three intronic regions that are involved in the decay 
of YRA1 pre-mRNA. Modules A and B are required for the Edc3p response, and module 
C appears to function in repressing YRA1 pre-mRNA translation, thus inhibiting the 
transcript’s susceptibility to NMD.  
 
Functional Interdependence of the Intron Modules Controlling the Degradation of 
YRA1 Pre-mRNA 
Our analysis of 5´ and 3´ deletions of the YRA1 intron identified three critical regions 
(“modules”) that are involved in Edc3p-mediated YRA1 pre-mRNA decay (See Figures 
3.3 and 3.4). Modules A and B are EREs and are required for the Edc3p response. 
Module C is a TRE and is required for inhibiting YRA1 pre-mRNA degradation by NMD. 
The presence of two distinct EREs that lack synergistic activity suggests that the EREs 
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may have redundant functions. In addition, although module C is required for inhibiting 
NMD, it is unknown whether this TRE is sufficient for this inhibitory function. To 
address these issues, we generated YRA1 pre-mRNAs harboring internal deletions or 
containing different internal fragments of the YRA1 intron and analyzed the decay 
phenotypes of these transcripts in wild-type, upf1Δ, edc3Δ, and upf1Δedc3Δ cells. These 
experiments, described below, revealed two additional modules (D and E) involved in the 
translational repression of YRA1 pre-mRNA and delineated the functional relationships of 
all five modules in Edc3p-mediated YRA1 pre-mRNA decay. 
 
Modules B and C lack independent activities in Edc3p-mediated YRA1 pre-mRNA decay 
The module A ERE can function independently to trigger a partial Edc3p response (see 
Figure 3.3). To assess whether modules B and C also have independent activities, we 
generated YRA1 alleles harboring different fragments of the module B/C region and 
analyzed the decay phenotypes of YRA1 transcripts encoded by these alleles. As shown in 
Figure 3.5, YRA1 pre-mRNAs harboring an intact module B (alleles I-R4-NR5 and I-R4-
NR2) or C (alleles I-F1B-R6A and I-F13-R6A) or both modules B and C (alleles I-R4-
NR6A and I-F1-R6A) are all sensitive to UPF1 deletion but insensitive to EDC3 deletion, 
indicating that these transcripts are all degraded by the NMD pathway. These results 
indicate that modules B and C each lack an independent activity in Edc3p-mediated YRA1 
pre-mRNA decay.  
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ERE modules A and B have redundant activities in Edc3p-mediated YRA1 pre-mRNA 
decay 
To test whether the two EREs have redundant functions, we generated a set of complete 
loss-of-function deletions of either module A or module B and analyzed the effects of 
these deletions on YRA1 pre-mRNA decay. In contrast to complete deletion of both 
modules A and B (Figure 3.4, allele C-673), complete deletion of either module A 
(Figure 3.6, alleles R1 and R2) or module B (Figure 3.6, alleles F13, F14, F15 and F2) 
had no effect on YRA1 pre-mRNA decay. YRA1 pre-mRNAs harboring each of these 
deletions behaved like the wild-type YRA1 pre-mRNA. All these pre-mRNAs are 
sensitive to EDC3 deletion but are insensitive to UPF1 deletion, indicating that these 
transcripts are all degraded by the Edc3p-mediated decay pathway. These results argue 
that ERE modules A and B function redundantly in Edc3p-mediated YRA1 pre-mRNA.  
 
ERE modules A and B exhibit distinct functional interactions with TRE modules C and D 
To further assess the potential functional interactions and redundancy of YRA1 intron 
modules A, B and C, we generated YRA1 pre-mRNAs containing combinations of 
different modules and analyzed the steady-state levels of the transcripts encoded by these 
alleles in wild-type, upf1Δ, edc3Δ, and upf1Δedc3Δ cells. As already shown in Figure 
3.3C, N-711 pre-mRNA, a transcript containing modules A and B, behaved like N-372 
pre-mRNA, a transcript containing only module A. These two transcripts had slightly 
increased levels in upf1Δ or edc3Δ cells, but showed dramatic increases in upf1Δedc3Δ 
cells (compared to wild-type cells), suggesting that they are susceptible to either NMD or 
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Edc3p-mediated decay. However, transcripts containing modules A and C (allele AR3-
F2-NR6C in Figure 3.7A, and alleles A-F2-NR7 and A-F14B-NR6C in Figure 3.8A,) 
exhibited the same specificity for the Edc3p-mediated pathway as did full-length YRA1 
pre-mRNA, with its level increased 5-fold in edc3Δ and upf1Δedc3Δ cells compared to 
that observed in wild-type and upf1Δ cells (Figures 3.7B and 3.8B). However, when 
module A was combined with each of the fragments that lack an intact module C (Figure 
3.8, alleles F5, F6, and F8), the transcripts behaved like the YRA1 pre-mRNA that 
contains module A alone (Figure 3.3, allele N372). These transcripts were degraded by 
either NMD or the Edc3p pathway. These results indicate that ERE module A 
collaborates with TRE module C to promote Edc3p-mediated YRA1 pre-mRNA decay.  
In contrast to what we observed for module A, transcripts containing modules B 
and C (allele I-F1A-R6A in Figure 3.7A, and alleles I-R4-NR6A and I-F1-R6A in Figure 
3.5A) exhibited specificity for NMD but not for the Edc3p-mediated pathway, with its 
level increased in upf1Δ and upf1Δedc3Δ cells compared to that observed in wild-type 
and edc3Δ cells (Figures 3.7B and 3.5B). Notably, transcripts containing modules B and 
C plus downstream sequences up to nt 942, (allele I-F1-F16N in Figure 3.7A and allele I-
R4-F16N in Figure 3.9A), exhibited specificity for the Edc3p-mediated pathway 
comparable to that manifested by full-length YRA1 pre-mRNA, with its level increased 5-
fold in edc3Δ and upf1Δedc3Δ cells compared to that observed in wild-type and upf1Δ 
cells (Figures 3.7B and 3.9B). This result suggests that the segment downstream of 
module C, from nt 745 to nt 942, is also involved in Edc3p-mediated YRA1 pre-mRNA 
degradation and we, therefore, designated this region as module D. Significantly, when 
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module B was combined with a fragment that contains the region except module A and C 
(Figure 3.9, allele dA-C), the transcript behaved like an NMD substrate. These data show 
that ERE module B collaborates with TRE modules C and D to promote Edc3p-mediated 
YRA1 pre-mRNA decay. 
 
TRE Modules C, D, and E Inhibit YRA1 Pre-mRNA Degradation by NMD  
Interestingly, transcripts containing modules C and D (allele I-F15B-F16N in Figure 3.7A, 
and alleles I-F14-F16N and I-F14A-F16N in Figure 3.9A), still exhibited specificity for 
NMD but not for the Edc3p pathway, with its level increased in upf1Δ and upf1Δedc3Δ 
cells compared to that observed in wild-type and edc3Δ cells (Figures 3.4B and 3.9B). 
However, transcripts containing modules C and D plus downstream sequences up to nt 
1052 (allele C-673 in Figure 3.4A and allele F15B-NR15 in Figure 3.10A) are refractory 
to the NMD and the Edc3p pathways (Figures 3.4C and 3.10B). This result suggests that 
the segment downstream of module D, from nt 942-1052, also plays a role in YRA1 pre-
mRNA degradation. We designated this region as module E. As described below, 
modules C, D, and E can function together to repress YRA1 pre-mRNA translation and 
they were, therefore, all designated as TREs.  
 
 Taken together, these experiments indicate that YRA1 pre-mRNA degradation 
likely involves five intronic sequence elements (Figure 3.7A). These five modules appear 
to encompass two distinct functions and to exhibit partially redundant activities (Figure 
3.6). Modules A and B are required for the Edc3p response. Modules C, D, and E are not 
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required for the Edc3p response per se, but are most likely involved in repressing YRA1 
pre-mRNA translation since these modules together can inhibit NMD. Importantly, a 
combination of modules A and C, or B, C, and D, is sufficient to trigger a robust Edc3p 
response. These results indicate that the respective ERE and TRE activities appear to 
function synergistically in YRA1 pre-mRNA decay. 
 
YRA1 Intron Modules C, D, and E Mediate Translational Repression of YRA1 Pre-
mRNA 
The deletion analyses described above implicate YRA1 intron modules C, D, and E in the 
repression of YRA1 pre-mRNA translation because deletion of these three modules 
activates degradation of the respective YRA1 pre-mRNA transcripts by NMD, and YRA1 
pre-mRNA transcripts containing modules C, D, and E but lacking the two EREs are 
refractory to NMD. To further assess the role of modules C, D, and E in the translational 
repression of YRA1 pre-mRNA, we examined the translation status of pre-mRNAs that 
contain or lack these modules. In this experiment, polysome profiles of two different 
YRA1 pre-mRNA transcripts were analyzed by northern blotting subsequent to sucrose 
gradient fractionation of cytoplasmic extracts of wild-type or upf1Δ cells. The first 
transcript, C-565 pre-mRNA (Figure 3.4A), contains intact modules C, D, and E, but 
lacks the two EREs, and is refractory to both Edc3p-mediated decay and NMD (Figure 
3.4C). The second transcript, C-775 pre-mRNA (Figure 3.2B), is almost identical to C-
565 pre-mRNA except that it lacks module C and part of module D. This transcript is 
susceptible to NMD but not to Edc3p-mediated decay (Figure 3.2C). We analyzed the 
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first transcript in wild-type cells but the second transcript in upf1Δ cells, because the 
second transcript is susceptible to NMD and has low abundance in wild-type cells. As 
shown in Figure 3.11A, the majority (62%) of the C-565 transcript in wild-type cells was 
present in the non-polysomal fractions, with only modest representation in the 
polyribosome and 80S fractions (38%). In contrast, the majority (80%) of the C-775 
transcript in upf1Δ cells was present in the polyribosome and 80S fractions, with only 
modest representation (20%) in the non-polysomal fractions (Figure 3.11B). These data 
show that the C-565 transcript, which contains intact modules C, D, and E, is largely 
translationally repressed. In contrast, the C-775 transcript, which contains only a part of 
module D and the entirety of module E, is actively engaged in translation. Consistent 
with these observations, we found that inclusion of the initiation-inhibiting stem-loop 
structure in the 5΄-UTR of C-755 pre-mRNA caused a significant shift of the transcript 
from the polyribosome and 80S fractions to the non-polyribosomal fractions, with 42% of 
the transcript now located in the former and 58% in the latter fractions (Figure 3.11C). 
These experiments provide direct evidence that YRA1 intron modules C, D, and E 
function in repressing YRA1 pre-mRNA translation and suggest that this translation 
repressing activity requires the combined actions of all three modules.  
Our observation that intron modules C, D, and E play a role in repressing YRA1 
pre-mRNA translation further indicates that translational repression is an important 
component of Edc3p-mediated YRA1 pre-mRNA decay. However, the complexity of the 
YRA1 intron elements and their functional interaction patterns raises the question of 
whether modules C, D, and E are only involved in translational repression or have 
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additional regulatory functions (e.g., Edc3p substrate specificity). To address this issue, 
we tested whether cis-inhibition of translation initiation can suppress the defect caused by 
deletion of modules C, D, and E. In this experiment, we used the yra1 F7 and N-399 
alleles. The F7 allele contains module A, a part of module D, and the entire module E and 
the N-399 allele contains only module A (Figures 3.11D and 3.3A). We inserted a stem-
loop structure 31 nt upstream of the initiator AUG codon of the F7 and N-399 alleles to 
generate the SL31-F7 and SL31-N-399 alleles (Figure 3.11D), respectively, and analyzed 
the decay phenotypes of the transcripts encoded by these alleles in wild-type, upf1Δ, 
edc3Δ, and upf1Δedc3Δ cells. Unlike the F7 and N-399 transcripts, which are partial 
Edc3p substrates (Figures 3.11E and 3.3C), the SL31-F7 and SL31-N-399 pre-mRNAs 
behaved like bona fide Edc3p substrates, i.e., they accumulated to the same levels in 
wild-type and upf1Δ cells, but increased at least 3-fold in edc3Δ and upf1Δedc3Δ cells 
(Figure 3.11E, see bands marked with an arrowhead). These data show that cis-inhibition 
of translation initiation suppresses the defect caused by partial or complete deletion of 
modules C, D, and E and restores the Edc3p response of a module A-containing partial 
Edc3p substrate. These results indicate that the principal function of YRA1 intron modules 
C, D, and E is the repression of YRA1 pre-mRNA translation. 
Consistent with previous observations (Figure 3.2C and (Beelman and Parker, 
1994), the spliced product of the SL31-F7 pre-mRNA accumulated to elevated levels in 
all four strains (Figure 3.11B, see bands marked by asterisks), presumably reflecting 
stabilization of the mRNA caused by the inhibition of its translation.  
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Mex67p is a Component of the Cyoplasmic YRA1 pre-mRNP and Functions in 
Repressing YRA1 pre-mRNA Translation to Enhance Edc3p-mediated Decay 
As described above, our data indicate that Edc3p-mediated decay of YRA1 pre-mRNA 
depends on a translational repression mechanism that requires specific intron segments 
but not Edc3p. These results implicate at least one other trans-acting factor in this process. 
Since inactivation of Mex67p triggers rapid degradation of YRA1 pre-mRNA by NMD in 
edc3Δ cells (Dong et al., 2007), and NMD requires translation while Edc3p-mediated 
decay does not, we considered the possibility that Mex67p is a critical determinant of 
YRA1 pre-mRNA translational repression.  
To assess the role of Mex67p in translational repression, we tested whether 
tethering of this protein can inhibit the translation-dependent process of NMD. In this 
experiment, we initially used the intron-containing yra1 F7 and R1-F7 alleles. The R1-F7 
allele is almost identical to the F7 allele except that it lacks a functional module A 
(Figure 3.12). Since the pre-mRNA transcript encoded by the F7 allele is partially 
sensitive to deletion of either UPF1 or EDC3 (Figure 3.11E) it must be a substrate for 
NMD and Edc3p. In contrast, the pre-mRNA transcript encoded by the R1-F7 allele must 
be a bona fide NMD substrate since this transcript is sensitive only to elimination of 
Upf1p but not to elimination of Edc3p (Figure 3.12). Two tandem MS2 coat protein 
binding sites were inserted into the intronic regions immediately upstream of the module 
D sequences of the F7 and R1-F7 alleles, generating alleles F7-MS2 and R1-F7-MS2 
(Figure 3.13). The plasmids respectively harboring the F7-MS2 or R1-F7-MS2 alleles 
were then co-transformed with a plasmid encoding an MS2 coat protein/Mex67p fusion 
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protein (MS2p-Mex67p) into wild-type, upf1Δ, edc3Δ, and upf1Δedc3Δ strains and the 
steady-state levels of the F7-MS2 and R1-F7-MS2 transcripts in the resulting strains were 
determined.  
As shown in Figure 3.13B, when MS2p-Mex67p was not co-expressed, the F7-
MS2 transcript behaved the same as the F7 transcript lacking the MS2 binding sites 
(compare with Figure 3.11E). The F7-MS2 transcript was a substrate for both NMD and 
Edc3p since its levels increased modestly in upf1Δ and edc3Δ cells, but increased 
substantially in upf1Δedc3Δ cells when compared to its level in wild-type cells (Figure 
3.13B, lanes a-d). However, when MS2p-Mex67p was co-expressed, the F7-MS2 
transcript behaved like a bona fide Edc3p substrate, i.e., its level increased in edc3Δ cells, 
but was essentially unchanged in upf1Δ cells (Figure 3.13B, lanes m-p). These results 
show that tethering of Mex67p inhibits degradation of the transcript by NMD yet 
promotes its degradation by the Edc3p-mediated pathway. In contrast to the F7-MS2 
transcript, co-expression of MS2p-Mex67p did not change the decay phenotype of the 
R1-F7-MS2 transcript. The latter pre-mRNA maintained its status as an NMD substrate, 
with its level increased significantly in upf1Δ and upf1Δedc3Δ cells but essentially 
unchanged in edc3Δ cells (Figure 3.13C, lanes m-p). These results indicate that the ability 
of tethered Mex67p to inhibit NMD depends on a functional ERE in the same pre-mRNA. 
As controls, we also analyzed the effects of tethering other proteins to the F7-MS2 or R4-
F7-MS2 transcripts in wild-type, upf1Δ, edc3Δ, and upf1Δedc3Δ cells. The results of 
these experiments indicated that tethered Edc3p, Crm1p, Sub2p, and Yra1p did not 
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significantly affect the decay phenotypes of the F7-MS2 or R4-F7-MS2 transcripts 
(Figures 3.13B and 3.13C). 
To determine whether the NMD-inhibitory effect of tethering Mex67p requires 
additional cis elements besides the module A ERE, we analyzed two additional intron-
containing yra1 alleles, F12-MS2, and N-399-MS2. These two alleles are identical to the 
F7-MS2 allele except that F12-MS2 lacks module D and N-399-MS2 lacks both modules 
D and E. Much like the F7-MS2 transcripts, the transcripts encoded by the F12-MS2 or 
N-399-MS2 alleles are also substrates for both NMD and Edc3p. However, our results 
indicated that tethering Mex67p neither inhibited the degradation by NMD nor promoted 
the degradation by Edc3p for either of these transcripts (Figure 3.13D).  
Taken together, our data show that tethering Mex67p to YRA1 pre-mRNA can 
inhibit its translation and this inhibitory effect requires at least intron modules A and D. 
Mex67p is thus likely to be a component of the cytoplasmic YRA1 pre-mRNP that 
functions in repressing YRA1 pre-mRNA translation.    
 
The YRA1 Intron Elements Are Conserved among Saccharomyces Species 
To assess the biological significance of YRA1 intron elements, we first identified 
putative YRA1 orthologs from other yeast species. We performed BLASTN searches of 
the fungi database using the S. cerevisiae YRA1 coding sequence as a query. We then 
aligned the genomic DNA sequences of YRA1 orthologs of the yeast species. The results 
showed that the sizes of YRA1 exons are similar and their sequences display high 
conservation. On the contrary, the size of YRA1 intron varies significantly, ranging from 
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418 nts in Candida lusitaniae to 1297 nts in Candida glabrata. Interestingly, the size of 
YRA1 intron in Saccharomyces species is similar. We then performed ClustalW to 
identify the conserved regions of the YRA1 DNA sequences in 4 Saccharomyces species 
including S. cerevisae, S. paradoxus, S. bayanus, S. kudriavzevi. As shown in Figure 3.14 
and Table 3.1, the coding sequences of YRA1 are highly conserved. Exon1 sequences and 
exon2 sequences exhibit 81% and 64% identities. The entire intron sequences only show 
49% identities. Significantly, modules A and C display 78% and 76% identities, 
respectively. Modules B, D, and E display 56%, 43%, and 65% identities, respectively. In 
contrast, the non-element region, sequences between modules A and B, display only 20% 
identity. We also used Mfold software (Zuker, 2003) to analyze the potential secondary 
structure of modules A and C. We found that the highly conserved regions of modules A 
and C from the 4 Saccharomyces species form the almost identical potential secondary 
structures. For example, the regions highlighted in Figure 3.15A are 100% conserved in 
the 4 Saccharomyces species. These computational analyses suggest that the cis-elements 
required for YRA1 pre-mRNA degradation are evolutionally conserved in the yeast 
Sacchromyces species. Modules A and C display high identity in both primary sequences 
and secondary structures, suggesting that the functions of these two modules are also 
highly conserved. Modules B, D, and E display divergences in both primary sequences 
and secondary structures (data not shown), suggesting that the functions of these modules 
are divergent during the course of evolution.   
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DISCUSSION 
 
Cytoplasmic Edc3p-mediated YRA1 Pre-mRNA Degradation is Independent of 
Translation 
Edc3p-mediated YRA1 pre-mRNA decay occurs in the cytoplasm (Dong et al., 2007). In 
contrast to other cytoplasmic decay pathways, such as the NMD and the general 5΄ to 3΄ 
decay pathways (Amrani et al., 2006a; Coller and Parker, 2004; Jacobson and Peltz, 
2000), our data indicate that Edc3p-mediated YRA1 pre-mRNA decay is independent of 
translation. This conclusion is supported by several observations, notably: 1) YRA1 pre-
mRNA is in a translationally repressed state in wild-type and edc3Δ cells (Figures 3.1A 
and 3.1B), 2) trans-inhibition of general translation initiation, elongation, or termination 
has no significant effect on the steady-state levels of YRA1 pre-mRNA in both EDC3 and 
edc3Δ backgrounds (Figure 3.2A), and 3) inclusion of a cis-inhibitor of translation 
initiation in the 5΄-UTR of YRA1 pre-mRNA also has no effect on its decay (Figure 3.2C).  
Our finding that Edc3p-mediated YRA1 pre-mRNA decay does not involve 
translation explains why this transcript is resistant to NMD despite the fact that it 
resembles a typical NMD substrate (He et al., 2003). The translation independence of 
YRA1 pre-mRNA decay also raises the possibility that Edc3p-mediated decay initiates 
immediately after nuclear export of the transcript or that decay may even be physically 
linked to export. The latter notion is further supported by the observation that Edc3p 
interacts with Crm1p, one of the YRA1 pre-mRNA export factors (Dong et al., 2007).  
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Edc3p-mediated YRA1 Pre-mRNA Degradation is Controlled by Multiple Intronic 
Elements with Both Independent and Interdependent Functions 
Our analyses of the consequences of deleting specific segments of the YRA1 intron 
identified five distinct modules critical for Edc3p-mediated YRA1 pre-mRNA decay that 
appear to have both independent and interdependent functions. Modules A and B, 
spanning nt 286-372 and 543-672, respectively, are required for triggering an Edc3p 
response and are thus bona fide EREs (Figures 3.3C and 3.4C). Modules C, D and E, 
spanning nt 673-744, 745-942, and 943-1052, respectively, are required for inhibiting 
translation and translation-dependent NMD and, therefore, function as TREs (Figures 
3.4C, 3.4D, 3.11A, and 3.10).  
Although the deletion analyses revealed discrete roles for modules A, B, C D, and 
E, our observation that each of these modules except module A lacks an independent 
activity indicates that these intron modules function interdependently to ensure Edc3p-
mediated YRA1 pre-mRNA degradation. This conclusion is supported by the synergistic 
effects observed when different types of modules (i.e., EREs and TREs) are combined to 
promote efficient Edc3-mediated decay (module C is combined with module A or 
modules C and D are combined with module B) (Figures 3.7B, 3.8 and 3.9), or when the 
same type of modules (e.g., TREs C, D, and E) are combined to promote translational 
repression of YRA1 pre-mRNA (Figures 3.4C and 3.10). The lack of synergistic effects 
when the two ERE modules (A and B) are combined (allele N-711, Figure 3.3), and the 
fact that these two ERE modules have different functional requirements for TRE modules 
C and D (Figures 3.7B, 3.8 and 3.9), suggest that the two ERE modules likely perform at 
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least partially redundant functions in Edc3p-mediated YRA1 pre-mRNA decay. The 
underlying molecular mechanisms for the observed synergistic effects of YRA1 intron 
modules are currently not clear, but may be indicative of cooperative binding to these 
intron modules by different factors or different modules by the same factor. 
The observation that the YRA1 intron contains two different functional elements, 
and that ERE module A, or the combination of TRE modules C, D, and E, exhibit 
independent activity indicates that the YRA1 intron modules perform at least two essential 
yet physically separable functions in Edc3p-mediated YRA1 pre-mRNA decay. The EREs 
appear to dictate Edc3p substrate specificity and most likely function to recruit Edc3p to 
the YRA1 pre-mRNP whereas the TREs repress YRA1 pre-mRNA translation, thus 
preventing degradation of the pre-mRNA by translation-dependent NMD and promoting 
degradation by the Edc3p pathway. Since elimination of the two EREs does not have any 
significant effects on TRE-mediated translational repression of YRA1 pre-mRNA (Figure 
3.11A), and in contrast, the elimination of the three TREs causes partial loss but does not 
eradicate the ERE-mediated Edc3p response (Figure 3.3C), the function of the TREs is 
independent of that of the EREs. However, the function of the EREs is partially 
dependent on that of TREs. These observations suggest that TRE-mediated translational 
repression is epistatic to ERE-mediated recruitment of Edc3p. When combined with the 
fact that Edc3p interacts with the Dcp1/Dcp2 decapping enzyme (Decker et al., 2007; 
Fromont-Racine et al., 2000; Gavin et al., 2002; Ho et al., 2002; Ito et al., 2001; 
Kshirsagar and Parker, 2004; Tritschler et al., 2007; Uetz and Hughes, 2000), these 
functional data indicate that Edc3p-mediated YRA1 pre-mRNA degradation is a highly 
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regulated process that is most likely carried out through a series of ordered events 
including translational repression, recognition by Edc3p, recruitment of the decapping 
enzyme, and finally activation of decapping.  
A key conundrum of EDC3 regulation is why the positioning, sequence, and 
function of the YRA1 ERE and TRE regulatory elements manifest so little similarity to 
the cis-element regulating decay of the only other known Edc3p substrate, namely 
RPS28B mRNA (Badis et al., 2004). The cis-element dictating Edc3p-specificy of 
RPS28B mRNA decay is localized in the 3΄-UTR of the transcript where it appears to 
form a stem-loop structure that binds Rps28bp and recruits Edc3p to activate decapping 
and subsequent translation-dependent 5΄ to 3΄ decay (Badis et al., 2004). The combined 
activities of the YRA1 and RPS28B regulatory elements strongly suggest that, although 
Edc3p association with a transcript appears to promote decapping and 5΄ to 3΄ decay, this 
association can be indirect, i.e., mediated by an additional factor, and does not require 
translational repression. Moreover, interaction of Edc3p with different mRNPs may 
involve distinct domains of this modular protein. Localization of the YRA1 elements 
within the intron limits their activity to the appropriate substrate, namely the pre-mRNA. 
Hence, translational repression of the pre-mRNA may be essential to prevent intron-
associated Edc3p-targeting factors from being displaced by translocating ribosomes. 
However, a more complex issue related to the YRA1 pre-mRNA decay requirement for 
translational repression pertains to the concomitant avoidance of NMD, i.e., why is this 
transcript not simply a substrate for NMD? One possibility is that there may be 
physiological conditions where NMD is inactive and decay of the YRA1 pre-mRNA 
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needs to be maintained, or vice versa, i.e., conditions where NMD is active, but YRA1 
pre-mRNA decay needs to be reduced.     
Complex cis-regulatory elements control other aspects of mRNA function. In 
Drosophila melanogaster, for example, localized translation of nanos mRNA is 
controlled by multiple, partially independent sequences localized in the 3΄-UTR of the 
transcript. The translational repression element and the localization signal overlap 
partially, and function independently, but act synergistically to ensure that nanos mRNA 
is translated in the proper location (Crucs et al., 2000; Forrest et al., 2004). In Xenopus 
oocytes, the Vg1 mRNA also contains 3΄-UTR sequences controlling localization and 
translation of the transcript. When Vg1 mRNA is localized properly, a Vg mRNA-binding 
protein, VgBP71, binds to the localization element and stimulates cleavage at a 
polyadenylation signal to remove the downstream translational repression element and, 
therefore, activate translation (Kolev and Huber, 2003). As shown here, Edc3p-mediated 
YRA1 pre-mRNA degradation requires two types of functional elements (EREs and TREs) 
that exhibit both independent and synergistic activities. These results suggest that mRNA 
decay may share common regulatory mechanisms with mRNA localization.  
 
Mex67p Functions in the Repression of YRA1 Pre-mRNA Translation to Promote 
Edc3p-mediated Decay  
YRA1 pre-mRNA is translationally repressed in both wild-type and edc3Δ cells and the 
elimination of TRE function results in partial susceptibility of the transcript to the 
translation-dependent NMD pathway. Hence, translational repression is a critical 
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component of Edc3p-mediated YRA1 pre-mRNA decay. Three lines of experimentation 
indicate that the general mRNA exporter Mex67p plays a specific role in this repression 
of YRA1 pre-mRNA translation. First, we previously observed that inactivation of 
Mex67p in edc3Δ cells renders the YRA1 pre-mRNA transcript susceptible to translation-
dependent NMD (Dong et al., 2007). Second, tethering Mex67p to an NMD-susceptible 
partial Edc3p substrate inhibits the transcript’s degradation by NMD but promotes its 
degradation by the Edc3p-mediated pathway. Finally, the NMD-inhibitory effect of 
tethering Mex67p requires the presence of specific YRA1 intronic cis-regulatory elements.  
Mex67p-mediated translational repression of YRA1 pre-mRNA is most likely 
mediated through the intronic TREs since both the elimination of the TREs and 
inactivation of Mex67p have similar consequences on YRA1 pre-mRNA decay, i.e., 
increased susceptibility to NMD and diminished susceptibility to the Edc3p pathway. 
One interesting possibility is that Mex67p binds directly to at least one of the TREs. In 
support of this idea, we have shown that the NMD-inhibitory effect of tethering Mex67p 
requires at least part of TRE module D (Figures 3.13B and 3.13D). Importantly, the 
human homolog of Mex67p, Tap, is a sequence-specific RNA-binding protein that binds 
directly to the constitutive transport elements (CTE) of both viral and cellular intron-
containing mRNAs (Gruter et al., 1998; Li et al., 2006; Pasquinelli et al., 1997). The 
molecular mechanism by which Mex67p represses YRA1 pre-mRNA translation is 
currently unknown, but our observation that YRA1 pre-mRNA is mainly localized in the 
free mRNP fractions in both wild-type and edc3Δ cells suggest that Mex67p-mediated 
translational repression of YRA1 pre-mRNA occurs at the level of translation initiation. 
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The requirement of a general mRNA export factor (i.e., Mex67p) for the translational 
repression of a specific mRNA is intriguing and raises the possibility that this factor may 
also have a role in the translational control of additional mRNAs.  
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EXPERIMENTAL PROCEDURES 
 
General procedures 
Most strains, protocols, and materials used in this study have been described previously 
(Dong et al., 2007). Additional procedures used herein are summarized below. 
 
Yeast strains 
All strains used in this study are listed in Table 3.2. Strains containing deletions of EDC3 
or UPF1 were constructed by gene replacement (Guthrie and Fink, 1991), using DNA 
fragments harboring the corresponding null alleles. Each genomic DNA deletion was 
confirmed by PCR analysis. Strains harboring the temperature-sensitive prt1-1 or sup45-
2 alleles were constructed by the pop-in and pop-out technique (Guthrie and Fink, 1991).  
 
Plasmids 
All plasmids used in this study are listed in Table 3.3. YRA1 alleles harboring deletions of 
intron sequences, or containing insertions of a stem-loop structure, were generated by 
PCR and molecular cloning. YRA1-MS2 constructs were prepared by annealing two 
oligonucleotides containing two tandem MS2-coat protein recognition sites and inserting 
the resulting DNA fragment into the BamHI and EcoRI sites in the intronic region of the 
F7, R1-F7, F12, and N-399 YRA1 alleles. All YRA1 alleles were confirmed by DNA 
sequencing. Plasmids expressing the MS2-coat protein fusions with Crm1p, Edc3p, 
Mex67p, Sub2p, and Yra1p were generated by PCR and molecular cloning. In each case, 
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a DNA fragment harboring the coding and 3΄-UTR sequences of CRM1, EDC3, MEX67, 
SUB2, or YRA1 was amplified using a pair of oligonucleotides that contain the NheI (5΄ 
primer) and SalI (3΄ primer) sites. The resulting DNA fragment was then inserted 
between the NheI and SalI sites of a plasmid that contains the ADH1 promoter and the 
MS2 coding sequence.  Each of these fusion proteins was expressed in vivo under the 
control of the ADH1 promoter. 
 
Oligonucleotides 
The oligonucleotides used in this study were obtained from Operon, Inc., and are listed in 
Table 3.4. 
 
RNA analysis 
Cells were grown in either YEPD (Figures 3.1 and 3.2A), or synthetic complete (SC) 
medium lacking tryptophan (Figures 3.2C, 3.3, 3.4, 3.7, and 3.11), or leucine and 
tryptophan (Figure 3.13). For normal cell cultures, cells (15 ml) were grown at 30 °C to 
an OD600 of 0.7 and harvested by centrifugation. For cultures involving cycloheximide 
treatment, cells (100 ml) were grown at 30°C to an OD600 of 0.7, harvested by 
centrifugation, and resuspended in 20 ml of the same medium. Cycloheximide was added 
to cell cultures at a final concentration of 100µg/ml and 2ml of cell cultures were 
harvested at different time points. For cultures involving temperature-shifts, cells were 
grown at 25°C and treated as described previously (He and Jacobson, 1995). In each case, 
cell pellets were frozen on dry ice and then stored at -80°C until RNA isolation. The 
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procedures for RNA isolation and northern blotting were as previously described (He and 
Jacobson, 1995). Transcript-specific signals were determined with a FUJI film analyzer. 
 
Polysome analysis 
Cells were grown at 30°C in either YEPD medium or SC medium lacking tryptophan to 
an OD600 of 0.7. Cell extracts were prepared and fractionated on 7-47% sucrose gradients 
as previously described (Mangus and Jacobson, 1999).  
 
Computational analysis 
Putative homologs of S. cerevisiae Yra1p were identified by BLASTn serches of public 
databases (including 
http://www.ncbi.nlm.nih.gov/sutils/genome_table.cgi?organism=fungi; 
http://www.broad.mit.edu/cgi-bin/annotation/fgi/blast_page.cgi). The multiple sequence 
alignment was performed through http://www.ebi.ac.uk/Tools/clustalw2/index.html. The 
Mfold analysis was done through http://frontend.bioinfo.rpi.edu/applications/mfold/cgi-
bin/rna-form1.cgi. Default search parameters were used. 
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FIGURE LEGENDS 
 
Figure 3.1. YRA1 pre-mRNA Is Translationally Repressed and Edc3p Plays a Minor 
Role in Repressing YRA1 Pre-mRNA Translation. 
The polyribosomal association of YRA1 pre-mRNA and mRNA was analyzed by sucrose 
gradient fractionation and northern blotting. Upper panels: OD260 tracings; lower panels: 
northern blots of individual gradient fractions. Blots were hybridized with a probe 
complementary to YRA1 transcripts. (A) wild-type cells and (B) edc3Δ cells. 
 
Figure 3.2. Trans- and Cis-inhibition of Translation Have no Effect on Edc3p-
Mediated YRA1 Pre-mRNA Degradation.  
(A) Effects of trans-inhibition of translation on the steady-state levels of YRA1 pre-
mRNA and mRNA. Initiation was inhibited by inactivation of Prt1p, termination was 
inhibited by inactivation of Sup45p, and elongation was inhibited by treating cells with 
cycloheximide.  At the indicated times post-inhibition, RNA was isolated from culture 
aliquots and subjected to northern analysis. Blots were hybridized with probes 
complementary to the YRA1 or SCR1 transcripts, with the latter serving as a loading 
control. 
(B) Schematic diagram of full-length YRA1 pre-mRNA and the related transcripts derived 
from the SL31-YRA1, C-775, and SL31-C-775 alleles. Smaller rectangles denote the 5΄- 
and 3΄-UTRs and larger rectangles denote the exons and the intron. The relative position 
of the 5΄-UTR stem-loop structure is indicated, as are the nucleotides comprising the A of 
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the initiator AUG (1), the 5΄ (285) and 3΄ (1052) boundaries of the intron, and the 
terminal nucleotide of the termination codon (1447). 
(C) The effects of cis-inhibition of translation initiation. Stem-loop structures were 
inserted into the 5΄-UTRs of the YRA1 gene or its C-775 allele and the relative steady-
state levels of the respective pre-mRNA and mRNA transcripts were determined by 
northern blotting as in (A). (1) wild-type cells, (2) upf1Δ cells, (3) edc3Δ cells, and (4) 
upf1Δedc3Δ cells. 
 
Figure 3.3. Effects of 3΄ Deletions of YRA1 Intron on Edc3p-mediated YRA1 Pre-
mRNA Decay. 
(A) Schematic diagram of full-length YRA1 pre-mRNA and related transcripts derived 
from yra1 alleles containing 3΄ deletions of the YRA1 intron. The relative position of each 
deletion is indicated. The transcripts are divided into three groups by broken lines based 
on their distinct decay phenotypes manifested in the northern blots of panels B, C, and D. 
(B-D) Northern blotting analyses of the steady-state levels of YRA1 pre-mRNAs 
harboring 3΄ deletions of the YRA1 intron up to nt 744 (B), or further deletions up to nt 
372 (C), or nt 312 (D) in wild-type (1), upf1Δ (2), edc3Δ (3), and upf1Δedc3Δ (4) cells. 
Blots were hybridized with probes complementary to the YRA1 or SCR1 transcripts, with 
the latter serving as a loading control. 
 
Figure 3.4. Effects of 5΄ Deletions of the YRA1 Intron on Edc3p-mediated YRA1 Pre-
mRNA Decay. 
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(A) Schematic diagram of full-length YRA1 pre-mRNA and related transcripts derived 
from yra1 alleles containing 5΄ deletions of YRA1 intron. The relative position of each 
deletion is indicated. The transcripts are divided into three groups by broken lines based 
on their distinct decay phenotypes manifested in the northern blots of panels B, C, and D. 
(B-D) Northern blotting analyses of the steady-state levels of YRA1 pre-mRNAs 
harboring 5΄ deletions of the YRA1 intron up to nt 559 (B), nt 673 (C) or nt 943 (D) in 
wild-type (1), upf1Δ (2), edc3Δ (3), and upf1Δedc3Δ (4) cells. Blots were hybridized with 
probes complementary to the YRA1 or SCR1 transcripts, with the latter serving as a 
loading control. 
  
Figure 3.5. Intronic Modules B and C Lack Independent Activity in Edc3p-mediate 
YRA1 Pre-mRNA Decay.  
(A) Schematic diagram of the YRA1 pre-mRNAs derived from yra1 alleles containing 
different internal fragments of the module B and C region of the YRA1 intron. The 
relative position of each deletion is indicated.  
(B) Northern blotting analysis of the steady-state levels of YRA1 pre-mRNAs encoded by 
each of the above depicted yra1 alleles in wild-type (1), upf1Δ (2), edc3Δ (3), and 
upf1Δedc3Δ (4) cells. The blot was hybridized with a probe complementary to the YRA1 
transcripts. 18S rRNA serves as a loading control. 
 
Figure 3.6. ERE Modules A and B Function Redundantly in Edc3p-mediated YRA1 
Pre-mRNA Decay.  
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(A) Schematic diagram of the YRA1 pre-mRNAs derived from yra1 alleles harboring 
complete loss-of-function deletions of either module A or B. The relative position of each 
deletion is indicated.  
(B) Northern blotting analysis of the steady-state levels of the YRA1 pre-mRNAs encoded 
by each of the above depicted yra1 alleles in wild-type (1), upf1Δ (2), edc3Δ (3), and 
upf1Δedc3Δ (4) cells. The blot was hybridized with a probe complementary to the YRA1 
transcripts. 18S rRNA serves as a loading control. 
 
Figure 3.7. YRA1 Intron Modules Exhibit Synergistic and Partially Redundant 
Activities.   
(A) Schematic diagram of full-length YRA1 pre-mRNA and related transcripts derived 
from yra1 alleles containing different combinations of the YRA1 intron modules. The 
relative positions and the implicated functions of modules A, B, C, D, and E are indicated. 
(B) Northern blotting analyses of the steady-state levels of YRA1 pre-mRNAs containing 
different combinations of YRA1 intron modules in wild-type (1), upf1Δ (2), edc3Δ (3), 
and upf1Δedc3Δ (4) cells. Blots were hybridized with probes complementary to the YRA1 
or SCR1 transcripts, with the latter serving as a loading control.  
 
Figure 3.8. The ERE Module A Collaborates with TRE Module C to Promote 
Edc3p-mediated YRA1 Pre-mRNA Decay.  
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(A) Schematic diagram of the YRA1 pre-mRNAs derived from the yra1 alleles containing 
ERE module A and different fragments of the putative TRE region of the YRA1 intron. 
The relative position of each deletion is indicated.  
(B) Northern blotting analysis of the steady-state levels of the YRA1 pre-mRNAs encoded 
by each of the above depicted yra1 alleles in wild-type (1), upf1Δ (2), edc3Δ (3), and 
upf1Δedc3Δ (4) cells. The blot was hybridized with a probe complementary to the YRA1 
transcripts. 18S rRNA serves as a loading control. 
 
Figure 3.9. ERE Module B Collaborates with TRE Modules C and D to Promote 
Edc3p-mediated YRA1 Pre-mRNA Decay.  
(A) Schematic diagram of the YRA1 pre-mRNAs derived from the yra1 alleles containing 
ERE module B and different fragments of the putative TRE region of theYRA1 intron. 
The relative position of each deletion is indicated.  
(B) Northern blotting analysis of the steady-state levels of the YRA1 pre-mRNAs encoded 
by each of the above depicted yra1 alleles in wild-type (1), upf1Δ (2), edc3Δ (3), and 
upf1Δedc3Δ (4) cells. The blot was hybridized with a probe complementary to the YRA1 
transcripts. 18S rRNA serves as a loading control. 
 
Figure 3.10. TRE Modules C, D, and E Together Inhibit YRA1 Pre-mRNA 
Degradation by NMD.  
(A) Schematic diagram of the YRA1 pre-mRNAs derived from the yra1 alleles containing 
a complete or a 3´ truncated TRE region of the YRA1 intron. The relative position of each 
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deletion is indicated. The bar on the F15B-NR15 allele represents an introduced NcoI 
restriction site.  
(B) Northern blotting analysis of the steady-state levels of the YRA1 pre-mRNAs encoded 
by each of the above depicted yra1 alleles in wild-type (1), upf1Δ (2), edc3Δ (3), and 
upf1Δedc3Δ (4) cells. The blot was hybridized with a probe complementary to the YRA1 
transcripts. 18S rRNA serves as a loading control. 
 
Figure 3.11. Intron Modules C, D and E Mediate Translational Repression of YRA1 
Pre-mRNA. 
(A-C) Analysis of the polyribosomal association of the YRA1 transcripts encoded by the 
C-565 allele in wild-type cells (A), or the C-775 and SL31-C-775 alleles in upf1Δ cells (B 
and C) by sucrose gradient fractionation and northern blotting. Upper panels: OD260 
tracings; lower panels: northern blots of individual gradient fractions. Blots were 
hybridized with a probe complementary to YRA1 transcripts.  
(D) Schematic diagram of the YRA1 pre-mRNA transcripts derived from the F7, SL31-F7, 
and SL31-N-399 alleles. The relative positions of the 5΄-UTR stem-loop structure, the 
intron modules, and the intron deletions are indicated. 
(E) Northern blotting analyses of the steady-state levels of YRA1 pre-mRNAs encoded by 
the F7, SL31-F7, and SL31-N-399 alleles in wild-type (1), upf1Δ (2), edc3Δ (3), and 
upf1Δedc3Δ (4) cells. Blots were hybridized with probes complementary to the YRA1 or 
SCR1 transcripts, with the latter serving as a loading control. The positions of exogenous 
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YRA1 pre-mRNA and mRNA are marked by arrowheads (◄) and asterisks (*), 
respectively. 
 
Figure 3.12. YRA1 Pre-mRNA Lacking Modules A, B, and C Is a Substrate for 
NMD.  
(A) Schematic diagram of the YRA1 pre-mRNA derived from the R1-F7 allele. The 
relative position of the intron deletion is indicated.  
(B) Northern blotting analysis of the steady-state levels of the YRA1 pre-mRNA encoded 
by R1-F7 allele in wild-type (1), upf1Δ (2), edc3Δ (3), and upf1Δedc3Δ (4) cells. The blot 
was hybridized with a probe complementary to the YRA1 or SCR1 transcripts, with the 
latter serving as a loading control. 
 
Figure 3.13. Tethering Mex67p Can Inhibit Translation-dependent NMD and 
Enhance Edc3p-mediated Decay. 
(A) Schematic diagram of the YRA1 pre-mRNAs derived from the F7-MS2, R1-F7-MS2, 
F12-MS2, and N-399-MS2 alleles. The relative positions of the intron deletions and the 
inserted MS2 coat protein binding sites are indicated. 
(B-C) Northern blotting analyses of the steady-state levels of the YRA1 pre-mRNA 
transcripts encoded by the F7-MS2 (B) and R1-F7-MS2 (C) alleles in wild-type (1), 
upf1Δ (2), edc3Δ (3), and upf1Δedc3Δ (4) cells that express or do not express the Edc3p-, 
Crm1p-, Mex67p-, Sub2p-, or Yra1p-MS2p fusion proteins.  
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(D) Northern blotting analyses of the steady-state levels of the YRA1 pre-mRNA 
transcripts encoded by the F12-MS2 and N-399-MS2 alleles in wild-type (1), upf1Δ (2), 
edc3Δ (3), and upf1Δedc3Δ (4) cells that express the Mex67p-MS2p fusion protein. Blots 
were hybridized with probes complementary to the YRA1 (B), MS2 (C and D), or SCR1 
transcripts, with the latter serving as a loading control. 
 
Figure 3.14. The Sequences of YRA1 Exons and Intron Elements Are Conserved 
among Saccharomyces. Alignment of YRA1 DNA sequences in 4 Saccharomyces species 
including S. cerevisae, S. paradoxus, S. bayanus, S. kudriavzevi. The numbers indicate 
the position of the nucleotide start from translation initiator. The stars (*) indicate the 
nucleotide identical in the 4 Saccharomyces species. The translation initiator, 5΄SS, 
branch point, 3΄SS, translation terminator are highlighted. The different intron modules 
are underlined.  
 
Figure 3.15. The Second Structures of Modules A and C Are Conserved among 
Saccharomyces. Mfold analyses for secondary structure prediction of modules A and C. 
The stars (*) indicate the nucleotide identical in the 4 Saccharomyces species. The 
highlighted areas indicate the regions which are 100% conserved in the 4 Saccharomyces 
species.  
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FIGURE 3.5
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FIGURE 3.9
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FIGURE 3.10
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Sequences identity *
Exon1
A
B
C
D
E
Exon2
BetweenA-B
81% (230/285)
78%  (68/87)
56% (64/115)
76% (55/72)
43% (85/198)
65% (71/109)
64% (254/396)
20% (37/186)
TABLE 3.1. Nucleotide Conservation of YRA1 DNA Sequence 
in 4 Saccharomyces Species 
* The “identity” is calculated by the percentage of the numbers 
of nucleotide identical in 4 Saccharomyces species to the total 
numbers of nucleotide in the relative region.  
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TABLE 3.2. Yeast Strains Used in this Study
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TABLE 3.3. Plasmids Used in this Study
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TABLE 3.4. Oligonucleotides Used in this Study
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CHAPTER IV 
 
General Discussion 
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Main findings 
 
The work of this thesis demonstrates that autoregulation of the YRA1 gene is 
accomplished through the coordination of multiple steps in its expression, particularly the 
splicing, nuclear export, and cytoplasmic degradation of its pre-mRNA. My work was the 
first to show that a yeast endogenous intron-containing pre-mRNA is exported to the 
cytoplasm through a Crm1p-dependent pathway and to identify an endogenous intron 
containing pre-mRNA that is degraded in the cytoplasm through a non-NMD mechanism 
despite the presence of multiple in-frame PTCs in the intron sequence.  
In this thesis, microarray analysis together with other approaches revealed that 
Edc3p specifically mediates the degradation of only two yeast transcripts, YRA1 pre-
mRNA and RPS28B mRNA (Chapter II). Edc3p-mediated YRA1 pre-mRNA degradation 
was shown to occur in the cytoplasm (Chapter II) and to be independent of translation 
(Chapter III). Further work found that Edc3p-mediated YRA1 pre-mRNA degradation is a 
component of the negative feedback loop involved in YRA1 autoregulation (Chapter II). 
The roles of specific trans-regulating factors (Edc3p, Yra1p, Mex67p and Crm1p) 
involved in the autoregulation of YRA1 and Edc3p-mediated YRA1 pre-mRNA decay 
were then characterized (Chapter II and III). The cis-acting elements regulating YRA1 
pre-mRNA splicing and decay were also delineated (Chapter II and III). Additional work 
presented in the thesis indicated that Edc3p-mediated YRA1 pre-mRNA degradation is 
accomplished through the cooperative effects of cis- and trans-regulation (Chapter III).  
 The major findings of this thesis include: 
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1) Edc3p directly controls YRA1 pre-mRNA degradation. 
2) YRA1 pre-mRNA degradation occurs through a 5΄ to 3΄ decay mechanism that 
requires the Dcp1p/Dcp2p decapping enzyme and the Xrn1p 5΄ to 3΄ 
exoribonuclease. 
3) Edc3p-mediated YRA1 pre-mRNA degradation occurs in the cytoplasm. 
4) YRA1 pre-mRNA is translationally repressed and Edc3p-mediated YRA1 pre-
mRNA degradation is independent of translation.  
5) Edc3p activates but does not catalyze decapping of the YRA1 pre-mRNA. 
6) Edc3p-mediated YRA1 pre-mRNA degradation is a component of the negative 
feedback loop involved in YRA1 autoregulation. 
7) YRA1 autoregulation involves splicing inhibition, nuclear export, and 
cytoplasmic degradation of its pre-mRNA.  
8) Yra1p autoregulates its own expression by inhibiting YRA1 pre-mRNA splicing 
and committing the pre-mRNA to nuclear export.  
9) YRA1 exon1 sequences inhibit its pre-mRNA splicing in a size-dependent but 
sequence independent manner.  
10) YRA1 exon1 in cis, and Yra1p in trans, inhibit YRA1 pre-mRNA splicing at or 
before the first step of the splicing reaction. 
11) Crm1p is required for YRA1 pre-mRNA nuclear export. 
12) Mex67p functions in both nuclear export and cytoplasmic degradation of YRA1 
pre-mRNA. 
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13) The YRA1 intron contains five functionally different but interdependent modules 
required for efficient Edc3p-mediated YRA1 pre-mRNA degradation. Two 
modules are required for triggering an Edc3p-response and the other three 
modules are required for translational repression, thus inhibiting NMD of the 
transcript. 
14) Mex67p appears to interact with sequences in the YRA1 intron to inhibit NMD, 
most likely through translational repression, and to enhance the Edc3p response 
of YRA1 pre-mRNA. 
 
 Since most of these findings have already been discussed in Chapters II and III I 
will just propose our current model of YRA1 autoregulation and discuss the potential roles 
of Edc3p-mediated YRA1 pre-mRNA degradation based on our findings. Then I will 
explore questions raised by these findings and the larger issues that remain unanswered in 
Edc3p-mediated transcript specific RNA degradation. 
. 
A model for YRA1 autoregulation and Edc3p-mediated YRA1 pre-mRNA 
degradation 
 
To integrate all of our data, we propose the following model for YRA1 autoregulation, in 
which Edc3-mediated YRA1 pre-mRNA degradation plays a key role (Figure 4.1): When 
nuclear Yra1p levels are low, YRA1 is transcribed into pre-mRNA. U1 snRNP binds to 
the 5′ SS by a base-pairing interaction to initiate the formation of spliceosome. Then, 
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YRA1 pre-mRNA is spliced to mRNA. The mature mRNA is exported to the cytoplasm, 
translated to generate Yra1p, and the latter is imported into the nucleus, recruited to 
elongating RNAPII, and then packaged into nascent mRNPs to serve a function in 
general mRNA export (Figure 4.1A). However, when nuclear Yra1p levels reach a 
threshold, Yra1p is likely recruited to the YRA1 gene by THO and Sub2p during an early 
phase of transcription elongation. Recruitment of Yra1p inhibits formation of 
spliceosome and promotes export of YRA1 pre-mRNA. Yra1p then recruits Mex67p, 
inhibiting its pre-mRNA splicing and committing the pre-mRNA to export by the Crm1p-
dependent pathway. Once in the cytoplasm, the YRA1 pre-mRNA is degraded 
immediately through an Edc3p-mediated pathway without engaging the translation 
apparatus. Edc3p interacts with Crm1p and is recruited to the Edc3p response elements 
localized in the YRA1 intron. Mex67p in the exported YRA1 pre-mRNP is also involved 
in the degradation of YRA1 pre-mRNA by repressing translation of YRA1 pre-mRNA, 
thus inhibiting NMD and enhancing Edc3p’s function (Figure 4.1B). Edc3p ultimately 
recruits the Dcp1p/Dcp2p decapping enzyme and this leads to decapping activation 
followed by 5΄ to 3΄ decay of YRA1 pre-mRNA independent of deadenylation.  
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Transcript-specific decay mediated by Edc3p  
 
Our results, combined with those from the Jacquier group (Badis et al., 2004), strongly 
indicate that Edc3p is a transcript-specific decapping activator. In turn, this conclusion 
suggests that there must be unique features of the YRA1 pre-mRNP and the RPS28B 
mRNP that render them Edc3p-responsive. However, the interactions of Edc3p with its 
two substrates are very different: First, the cis-regulatory elements involved in Edc3p-
mediated RPS28B mRNA and YRA1 pre-mRNA degradation show no sequence similarity 
and are not interchangeable. Second, Edc3p-mediated RPS28B mRNA and YRA1 pre-
mRNA degradation also have different functional requirements for Edc3p. The former 
requires the function of full-length Edc3p and the latter only requires the function of the 
N-terminal 70 amino acids of Edc3p (data not shown in this thesis). Third, Edc3p-
mediated RPS28B mRNA degradation requires translation (data not shown in this thesis). 
In contrast, Edc3p-mediated YRA1 pre-mRNA degradation is independent of translation. 
These observations indicate that, even for transcripts regulated by the same decay factor 
or pathway, the decay mechanisms can be still distinct. We speculate that Edc3p may 
utilize different domains to identify different features of its mRNP substrates.  
 
Possible regulatory functions of the Edc3p-mediated mRNA decay pathway 
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Our genome-wide microarray analysis has identified only two transcripts regulated by 
Edc3p, the YRA1 pre-mRNA and the RPS28B mRNA. The existence of a specific 
cytoplasmic pathway dedicated to only two transcripts raises an important question of the 
biological function of this pathway, i.e., does the Edc3p-mediated decay pathway have 
additional regulatory functions in yeast cells? In support of the notion that Edc3p may 
have broader functions, there are observations that Edc3p physically interacts with the 
Dcp1p/Dcp2p decapping enzyme (Gavin et al., 2002; Ho et al., 2002; Ito et al., 2001; 
Uetz et al., 2000) and that Edc3p appears to have a comparable number of molecules per 
cell as that of Dcp1p (Gavin et al., 2002; Ho et al., 2002; Huh et al., 2003). In addition, 
biochemical evidence from both yeast and human cells suggests that Edc3p appears to be 
a core component of a large decapping enzyme complex (Fenger-Gron et al., 2005; Gavin 
et al., 2002; Ho et al., 2002; Huh et al., 2003). Third, deletions of EDC3 and mutations in 
DCP1 or DCP2 exhibit synthetic or addictive effects on both cell growth and decapping 
of general reporter mRNAs (Kshirsagar and Parker, 2004). The prediction that Edc3p 
might have additional regulatory functions and the reasons that we identified only two 
transcripts regulated by the Edc3p-mediated pathway in this work might be:     
1) Edc3p might regulate additional mRNAs during different stages of cell 
cycle progression. Since our microarray studies utilized asynchronous cells, some 
potential Edc3p substrates subject to cell cycle regulation could have been missed. In fact, 
two observations suggest that Edc3p may have a role in cell cycle regulation. First, EDC3 
exhibits a synthetic lethal interaction with NDD1, whose product is involved in G2/M 
specific gene transcription (Badis et al., 2004; Koranda et al., 2000). Second, 
 173
overexpression of YRA1, which is regulated by Edc3p, results in G1 arrest (Espinet et al., 
1995). Yra1p is required for S phase entry and plays a role in DNA replication 
(Swaminathan et al., 2007). Therefore, additional Edc3p substrates might be identified in 
synchronous cells arrested in different cell cycle stages. 
2) Edc3p might regulate additional mRNAs under different growth 
conditions. Another possibility is that Edc3p functions as a regulatory subunit of the 
decapping enzyme and its function in mRNA decapping is dispensable under normal 
growth conditions but becomes essential under different growth conditions. Our data 
indicate that Edc3p-mediated YRA1 pre-mRNA degradation is functionally linked to 
Crm1p-mediated pre-mRNA nuclear export. The fact that Edc3p and Crm1p also interact 
suggests that the nuclear mRNA export pathway may impart specificity to this mRNA 
decay pathway, i.e., that transcripts exported by the Crm1p-mediated decay pathway are 
exclusively degraded by the Edc3p-mediated decay pathway. Since mammalian mRNAs 
exported by the Crm1p pathway largely encode factors involved in "early" or stress 
responses (Brennan et al., 2000; Gallouzi et al., 2000; Higashino et al., 2005; Kimura et 
al., 2004; Schutz et al., 2006), it is possible that a fraction of yeast mRNA is also 
exported by the Crm1p-mediated export pathway under certain stress conditions such as 
heat shock, osmotic stress, and oxidative stress. This group of mRNAs might also be 
controlled by Edc3p-mediated pathway under the stress conditions. 
3) Edc3p might control the degradation of a limited class of intron-
containing pre-mRNAs that enter the cytoplasm. Most intron-containing pre-mRNAs 
are retained in the nucleus to be spliced. However, it has previously been shown that 
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several inefficiently spliced pre-mRNAs enter the cytoplasm where they are degraded by 
the NMD pathway (He et al., 1993; Vilardell et al., 2000). It is possible that the Edc3p-
mediated decay pathway is another mRNA surveillance system that targets a different 
class of intron-containing pre-mRNAs, such as those whose intron is localized far from 
the translation initiation codon or whose branch point region deviates from the consensus 
motif. These pre-mRNAs may be intrinsically low in abundance and thus under the limit 
of microarray analysis. The potential pre-mRNAs regulated by Edc3p might include 
those that have large introns or have similar splicing signals as those in YRA1 pre-mRNA, 
and those whose intron is located far from the translation initiation codon. In addition, 
splicing defective pre-mRNAs and intermediates are also exported to the cytoplasm 
(Hilleren and Parker, 2003). Interestingly, these pre-mRNAs are at least partially 
degraded by a decapping-dependent mechanism and appear to be resistant to NMD 
(Hilleren and Parker, 2003), much as we observed for YRA1 pre-mRNA. It is possible 
that Edc3p also targets these splicing defective pre-mRNAs and their intermediates.  
4) Edc3p might function in a step that is not rate-limiting or be functionally 
redundant to other protein(s). As a part of an emerging set of proteins functioning in 
decapping, Edc3p might assist decapping in a non-rate-limiting manner. This is supported 
by the fact that deletion of EDC3 in wild-type cells has almost no phenotype, but deletion 
of EDC3 in strains with compromised temperature-sensitive alleles of dcp1 and dcp2 
exaggerates the defect of general reporter mRNA degradation even at the permissive 
temperature.  Another possibility is that there are other functionally redundant proteins 
for Edc3p in cells. As reported by the Jacquier group, deletion of SCD6, a gene encoding 
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another Lsm-like domain containing protein, is synthetically lethal with deletion of EDC3. 
Scd6p also interacts with Edc3p physically and shares a number of physical interacting 
partners involved in decapping (Zemam K, 2007). These findings suggest that the two 
Lsm domain-containing proteins share a redundant function in mRNA decapping.   
 
Physiological Significance 
 
This YRA1 pre-mRNA regulation provides a further illustration of the extensive coupling 
of transcription, RNA processing, export, and cytoplacmic degradation. It will thus be 
very informative to elucidate the molecular mechanism of gene expression regulation in 
detail. In addition, the molecular mechanism uncovered here for YRA1 autoregulation is 
reminiscent of Rev-mediated unspliced pre-mRNA nuclear export that is required for 
HIV replication (Cullen, 2003a). This observation suggests that Rev may target the same 
cellular component or pathway as Yra1p to promote nuclear pre-mRNA export. 
Therefore, an understanding of the molecular mechanism involved in YRA1 
autoregulation may well shed light on the regulation of retroviral gene expression, 
possibly leading to novel anti-viral molecules. 
 
Future directions 
 
Our data have shown that the regulation of Edc3p-mediated YRA1 pre-mRNA 
degradation requires multiple sequence segments in cis and two factors in trans. The two 
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factors, Edc3p and Mex67p, appear to have distinct functions. Edc3p acts as a decapping 
activator and is thus likely to be involved in both substrate recognition and recruitment of 
the decapping enzyme. Mex67p is likely to be a component of the cytoplasmic YRA1 pre-
mRNP and to function as a repressor of YRA1 pre-mRNA translation by interacting with 
a cis-element(s) in the YRA1 intron. However, it is still unknown if Edc3p and/or Mex67p 
directly bind to the intronic cis-elements. In addition, the observation that inactivation of 
Mex67p switches YRA1 pre-mRNA from an Edc3p substrate to an NMD substrate also 
raises the question of whether Mex67p dictates the Edc3p substrate specificity or whether 
it just performs an essential function (i.e., translation repression) that is epistatic to the 
decapping activation function of Edc3p. Given the complexity of the cis-acting elements 
of the YRA1 intron, and the observation that tethering Mex67p to the YRA1 intron only 
largely but not completely restores the Edc3p response of a partial Edc3p substrate, there 
might be more factors besides Mex67p involved in Edc3p-mediated YRA1 pre-mRNA 
degradation. Finally, it is still a mystery as to how Edc3p executes its function. Edc3p 
contains an Lsm domain at its N-terminus, an FDF domain in its middle, and an YjeF-N 
domain at its C-terminus. Our data indicate that the 70 amino acid N-terminal Lsm 
domain of Edc3p is sufficient for Edc3p-mediated YRA1 pre-mRNA degradation. In 
addition, the Lsm domain of EDC3 in Drosophila mediates DCP1 binding and P-body 
targeting (Tritschler et al., 2007). However, it is unclear if Edc3p uses the same domain 
to recognize the substrate and recruit the decapping enzyme. To answer these molecular 
mechanism questions and to understand the possible regulatory function of Edc3p-
medated mRNA degradation, future work should consider:  
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1) Defining the functions and the functional relationships of Edc3p and 
Mex67p in Edc3p-mediated YRA1 pre-mRNA degradation. 
2) Identifying other trans-acting factors that bind to the YRA1 intron and 
evaluating the roles of these factors. 
3) Dissecting the molecular events and interactions that lead to decapping 
activation of YRA1 pre-mRNA. 
4) Identifying other substrates of Edc3p-mediated mRNA degradation.  
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